Id,Title,Link
40000,A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323196/
40001,Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043892/
40002,"Two Years into
the COVID-19 Pandemic: Lessons Learned",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380879/
40003,"SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504968/
40004,Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751/
40005,The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403893/
40006,Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894812/
40007,Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915126/
40008,Identification and Development of Therapeutics for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562484/
40009,"COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524328/
40010,Mol Syst Biol. 2021 Dec; 17(12): e10851. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696085/
40011,A Multidisciplinary Approach to Coronavirus Disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228528/
40012,Coronavirus Disease 2019–COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405836/
40013,SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205158/
40014,"Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434692/
40015,COVID-19: systemic pathology and its implications for therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692150/
40016,"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570423/
40017,Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299217/
40018,COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238037/
40019,Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857405/
40020,Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979261/
40021,SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353927/
40022,"A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952616/
40023,Therapeutic strategies for COVID-19: progress and lessons learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113999/
40024,SARS-CoV-2 in immunocompromised individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468314/
40025,The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981974/
40026,Identification and Development of Therapeutics for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941644/
40027,mSystems. 2021 Nov-Dec; 6(6): e00233-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562484/
40028,An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851053/
40029,"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296253/
40030,Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021130/
40031,Small molecules in the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719906/
40032,"COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301790/
40033,"A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465653/
40034,A 21st Century Evil: Immunopathology and New Therapies of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652766/
40035,"A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343749/
40036,COVID-19: breaking down a global health crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129964/
40037,COVID-19 vaccines: The status and perspectives in delivery points of view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759095/
40038,"SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519814/
40039,Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613808/
40040,Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032586/
40041,Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185820/
40042,COVID-19 and liver disease: mechanistic and clinical perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945972/
40043,Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869052/
40044,SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835786/
40045,The first 12 months of COVID-19: a timeline of immunological insights,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958099/
40046,Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142517/
40047,Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576507/
40048,Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359488/
40049,"SARS-CoV-2, fertility and assisted reproduction",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976972/
40050,Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156180/
40051,"Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712136/
40052,Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245055/
40053,JMIR Public Health Surveill. 2021 Jun; 7(6): e31554. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280829/
40054,"A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854082/
40055,Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784226/
40056,"Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801873/
40057,COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372472/
40058,Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356669/
40059,Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241372/
40060,PLoS Med. 2023 Jul; 20(7): e1004268. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356153/
40061,A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574485/
40062,Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142516/
40063,Clin Microbiol Rev. 2021 Oct; 34(4): e00163-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404690/
40064,"Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589856/
40065,Nat Rev Gastroenterol Hepatol. 2023; 20(3): 195. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836328/
40066,Recent developments in the immunopathology of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108124/
40067,COVID-19: Characteristics and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909801/
40068,"COVID-19: Immunology, Immunopathogenesis and Potential Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919479/
40069,"Recent review of COVID-19 management: diagnosis, treatment and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549062/
40070,Immunology of COVID-19: Current State of the Science,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200337/
40071,"SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278252/
40072,An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654464/
40073,Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651828/
40074,"Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem
Cells in COVID-19 Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328058/
40075,Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385778/
40076,SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894219/
40077,The 2019–2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384689/
40078,"ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690236/
40079,"ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690006/
40080,Eur Heart J. 2022 May 7; 43(18): 1776. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194802/
40081,Ivermectin for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/
40082,Cochrane Database Syst Rev. 2022; 2022(6): CD015017. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
40083,The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863906/
40084,The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223371/
40085,Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034329/
40086,"COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927760/
40087,"A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673752/
40088,COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592693/
40089,The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850341/
40090,"Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962551/
40091,Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390046/
40092,Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997755/
40093,"Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095162/
40094,Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025846/
40095,Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647069/
40096,SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833750/
40097,"Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053562/
40098,Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981760/
40099,NPJ Sci Food. 2024; 8: 26. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074247/
40100,Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375673/
40101,New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003544/
40102,"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874732/
40103,"Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406542/
40104,A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874604/
40105,"COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013908/
40106,COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738845/
40107,Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585911/
40108,Impaired function and delayed regeneration of dendritic cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523079/
40109,Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316821/
40110,The skin as a critical window in unveiling the pathophysiologic principles of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298003/
40111,Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388124/
40112,"Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386162/
40113,"Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985161/
40114,Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203446/
40115,Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278575/
40116,"Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700414/
40117,A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356061/
40118,An immune-based biomarker signature is associated with mortality in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821609/
40119,"COVID-19 Immunobiology: Lessons Learned, New Questions Arise",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427766/
40120,"COVID-19 vaccine development: milestones, lessons and prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062866/
40121,A 30-day follow-up study on the prevalence of SARS-COV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576909/
40122,Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061467/
40123,Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006950/
40124,Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016444/
40125,"SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167898/
40126,"Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395427/
40127,The COVID-19 pandemic — what have urologists learned?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007269/
40128,SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471641/
40129,"Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283317/
40130,"Animal models for COVID-19: advances, gaps and perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261903/
40131,"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular
targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919505/
40132,"Innate immunity, cytokine storm, and inflammatory cell death in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682745/
40133,"Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482959/
40134,COVID-19 and metabolic disease: mechanisms and clinical management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489878/
40135,Neuroprotective Agents with Therapeutic Potential for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669388/
40136,Characterization of the First SARS-CoV-2 Isolates from Aotearoa New Zealand as Part of a Rapid Response to the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877023/
40137,Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009586/
40138,Programmed cell death: the pathways to severe COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022977/
40139,"Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120813/
40140,"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905308/
40141,Immune responses in mildly versus critically ill COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923185/
40142,Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784663/
40143,SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411904/
40144,Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948998/
40145,Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569602/
40146,Role of miR-2392 in driving SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481092/
40147,Therapeutic Approaches to the Neurologic Manifestations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302225/
40148,Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836319/
40149,"COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545698/
40150,Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563316/
40151,Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778858/
40152,The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709793/
40153,A global picture: therapeutic perspectives for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884157/
40154,Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369331/
40155,An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100302/
40156,Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189267/
40157,"Update of the recommendations of the Sociedade Portuguesa de
Cuidados Intensivos and the Infection and Sepsis Group for the
approach to COVID-19 in Intensive Care Medicine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889599/
40158,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
40159,"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741849/
40160,Potential treatments of COVID-19: Drug repurposing and therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930377/
40161,"SARS-CoV-2 testing in patients with low COVID-19 suspicion at admission to a tertiary care hospital, Stockholm, Sweden, March to September 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855509/
40162,Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585639/
40163,Adaptive immunity to SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803150/
40164,Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863418/
40165,"COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381432/
40166,Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405641/
40167,Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977625/
40168,Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/
40169,Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111085/
40170,"Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771011/
40171,"SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253265/
40172,"Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319826/
40173,Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570475/
40174,After the virus has cleared—Can preclinical models be employed for Long COVID research?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451097/
40175,Remdesivir for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875553/
40176,COVID-19 therapeutics: Challenges and directions for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169797/
40177,Humoral and cellular response in convalescent COVID-19 lupus patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374301/
40178,"Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825982/
40179,Immunobiology and immunotherapy of COVID‐19: A clinically updated overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675260/
40180,Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052735/
40181,Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699414/
40182,Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610843/
40183,Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219649/
40184,Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383267/
40185,Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989408/
40186,Learning Through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831477/
40187,COVID-19 Mechanisms in the Human Body—What We Know So Far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592035/
40188,Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604481/
40189,SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022340/
40190,Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812357/
40191,Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646617/
40192,mRNA vaccines for COVID-19 and diverse diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935967/
40193,COVID-19 immunopathology: From acute diseases to chronic sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537925/
40194,COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970615/
40195,Oral antiviral treatments for COVID-19: opportunities and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309032/
40196,Pharmacol Rep. 2022; 74(6): 1326–1327. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510311/
40197,"Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905385/
40198,Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348242/
40199,Potential therapeutic options for COVID-19: an update on current evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755901/
40200,Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280938/
40201,The cGAS–STING pathway drives type I IFN immunopathology in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891013/
40202,Current clinical status of new COVID-19 vaccines and immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442597/
40203,Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931673/
40204,Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726002/
40205,Circulating microRNAs as emerging regulators of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800721/
40206,COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850933/
40207,Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584434/
40208,Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139838/
40209,Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756077/
40210,Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818320/
40211,Ivermectin for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
40212,Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929328/
40213,Recent advances in antibody‐based immunotherapy strategies for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427040/
40214,"Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016159/
40215,Current and Emerging Knowledge in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846833/
40216,COVID-19 and the human innate immune system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885626/
40217,COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369212/
40218,COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857087/
40219,Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134007/
40220,The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836196/
40221,Upregulation of interleukin-19 in saliva of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511465/
40222,When the clock ticks wrong with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670202/
40223,Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/
40224,Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID‐19 related cytokine storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014246/
40225,Therapeutic prospects of ceRNAs in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530275/
40226,"Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432953/
40227,"COVID‐19: A systematic review and update on prevention, diagnosis, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906461/
40228,"The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969831/
40229,Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972750/
40230,"Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758618/
40231,Antibody tests for identification of current and past infection with SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/
40232,Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652867/
40233,The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399171/
40234,SARS-CoV-2 Infection and Lung Regeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809385/
40235,Complement activation induces excessive T cell cytotoxicity in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712270/
40236,Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461092/
40237,Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675396/
40238,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363382/
40239,"COVID-19, cytokines, inflammation, and spices: How are they related?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884924/
40240,"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260568/
40241,An overview on the treatments and prevention against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906607/
40242,Rationale for combined therapies in severe-to-critical COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520558/
40243,Drug-based therapeutic strategies for COVID-19-infected patients and their challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610072/
40244,"A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843681/
40245,Iran J Sci. 2023; 47(1): 325. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894734/
40246,"COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699554/
40247,The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310117/
40248,Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375972/
40249,"Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967513/
40250,A comprehensive review on potential therapeutics interventions for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677683/
40251,Role of genomics in combating COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894692/
40252,"Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937660/
40253,The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346380/
40254,Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955234/
40255,Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873036/
40256,Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326824/
40257,Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637536/
40258,Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892939/
40259,Role of the Microbiome in the Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009446/
40260,The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799268/
40261,"Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732709/
40262,COVID-19 therapy: What weapons do we bring into battle?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481143/
40263,COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480030/
40264,Quantitative multiorgan proteomics of fatal COVID‐19 uncovers tissue‐specific effects beyond inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493576/
40265,Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595217/
40266,SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464065/
40267,"COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898934/
40268,SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330865/
40269,"COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969349/
40270,Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651100/
40271,Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126603/
40272,SARS‐CoV‐2 and pediatric solid organ transplantation: Current knowns and unknowns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237081/
40273,The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590742/
40274,Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233062/
40275,Impact of COVID-19 on Cardiovascular Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962056/
40276,High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11007208/
40277,The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185909/
40278,The (apparent) antibody paradox in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935454/
40279,Role of microRNAs in COVID-19 with implications for therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463393/
40280,COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531724/
40281,The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102044/
40282,The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473113/
40283,"COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911532/
40284,"COVID‐19 and plasma cells: Is there long‐lived protection?
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350162/
40285,Autoinflammatory and autoimmune conditions at the crossroad of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296326/
40286,From Emergence to Endemicity: A Comprehensive Review of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617653/
40287,A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692303/
40288,Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837559/
40289,The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678181/
40290,COVID-19 signalome: Potential therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744501/
40291,Challenges posed by COVID‐19 in cancer patients: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855916/
40292,"SARS-CoV-2, COVID-19 and the Ageing Immune System",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570568/
40293,Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543422/
40294,Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183699/
40295,Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872642/
40296,Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330992/
40297,Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485771/
40298,"COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569411/
40299,Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132185/
40300,Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114615/
40301,"A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914132/
40302,Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693193/
40303,Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494270/
40304,SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385766/
40305,IL-6 modulation for COVID-19: the right patients at the right time?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042594/
40306,A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935998/
40307,Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095020/
40308,Monoclonal antibody therapies in the management of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862171/
40309,An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779148/
40310,"COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639866/
40311,Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540097/
40312,Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727711/
40313,Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714803/
40314,The role of cell death in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509267/
40315,Approaches towards fighting the COVID-19 pandemic (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723515/
40316,Therapeutics for COVID-19 and post COVID-19 complications: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813675/
40317,Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297457/
40318,The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595355/
40319,Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499872/
40320,"Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359569/
40321,Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602751/
40322,Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications: SARS-CoV-2 (COVID-19)-mediated oxidative stress in neurons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465323/
40323,"Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304713/
40324,An integrative look at SARS-CoV-2 (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797443/
40325,COVID-19 Therapeutic Potential of Natural Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254072/
40326,MAFB shapes human monocyte–derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807725/
40327,Vasculopathy in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736280/
40328,Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979210/
40329,Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755416/
40330,Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780958/
40331,"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843115/
40332,Zebrafish models of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841970/
40333,Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363466/
40334,C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266787/
40335,The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213067/
40336,Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013654/
40337,Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280659/
40338,COVID-19 and Gut Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608818/
40339,"2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926109/
40340,Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746792/
40341,Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393107/
40342,Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727532/
40343,The Lancet Commission on lessons for the future from the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539542/
40344,A humanized mouse model of chronic COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203605/
40345,Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171294/
40346,Circ Res. 2023 Jul 21; 133(3): e49. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529800/
40347,"Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276767/
40348,"A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445802/
40349,Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224263/
40350,Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652506/
40351,Immune response in COVID-19: what is next?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/
40352,Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111040/
40353,The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350195/
40354,Twelve Months with COVID-19: What Gastroenterologists Need to Know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325547/
40355,Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328566/
40356,SARS-CoV-2 infection and immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113164/
40357,MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249409/
40358,Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077482/
40359,Cellular and molecular atlas of the placenta from a COVID‐19 pregnant woman infected at midgestation highlights the defective impacts on foetal health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055894/
40360,"Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469568/
40361,Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551237/
40362,Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378842/
40363,Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386676/
40364,Optimizing testing regimes for the detection of COVID-19 in children and older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425447/
40365,Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695449/
40366,COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857047/
40367,Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358265/
40368,"COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082934/
40369,"COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154064/
40370,Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935217/
40371,SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430572/
40372,"Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863423/
40373,Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654229/
40374,Antibodies to watch in 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765076/
40375,Liver injury in COVID-19: A minireview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813934/
40376,Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206116/
40377,Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424194/
40378,"An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366108/
40379,Association between bisphosphonate use and COVID-19 related outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691801/
40380,A scoping review of the pathophysiology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477699/
40381,Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669333/
40382,"COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343368/
40383,Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149241/
40384,A Comprehensive Overview on COVID-19: Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476999/
40385,"The role of immune activation and antigen persistence in acute and long
COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996119/
40386,"Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226031/
40387,Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865546/
40388,The development of COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909293/
40389,Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015257/
40390,T‐cell responses and therapies against SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730020/
40391,Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521484/
40392,Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517300/
40393,Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001044/
40394,"HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962407/
40395,COVID-19 illness and autoimmune diseases: recent insights,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914392/
40396,The landscape of antibody binding in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245122/
40397,In vitro high-content tissue models to address precision medicine challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384546/
40398,Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046708/
40399,Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286275/
40400,Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989492/
40401,Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355618/
40402,Severe COVID-19: Drugs and Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142549/
40403,"Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372538/
40404,Post-acute COVID-19 syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893149/
40405,Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289353/
40406,Animal models for studying coronavirus infections and developing antiviral agents and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122840/
40407,"Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530779/
40408,Characteristics of SARS-CoV-2 and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537588/
40409,Nat Rev Microbiol. 2022; 20(5): 315. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864972/
40410,"Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722419/
40411,Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876335/
40412,"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373339/
40413,"COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638821/
40414,A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728249/
40415,Wuhan to World: The COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042280/
40416,Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910677/
40417,SARS-CoV-2 accessory proteins reveal distinct serological signatures in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135746/
40418,Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935365/
40419,Efficacy and safety of COVID‐19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/
40420,How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249429/
40421,The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836975/
40422,"Methodology-Centered Review of Molecular Modeling,
Simulation, and Prediction of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159519/
40423,COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247890/
40424,Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844132/
40425,Next-generation treatments: Immunotherapy and advanced therapies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907543/
40426,The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040543/
40427,Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402624/
40428,COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568271/
40429,Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110836/
40430,Application of omics technology to combat the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554664/
40431,Understanding COVID-19-associated coagulopathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362465/
40432,Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127167/
40433,"Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711598/
40434,"Association of
COVID-19 with Comorbidities: An Update",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000013/
40435,COVID-19 and gut immunomodulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678818/
40436,Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381032/
40437,Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806161/
40438,COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757141/
40439,"COVID-19: Discovery, diagnostics and drug development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543767/
40440,JAK inhibitors and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035837/
40441,J Immunother Cancer. 2023; 11(4): e002838corr1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152002/
40442,Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10871123/
40443,"The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852932/
40444,Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946177/
40445,Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290522/
40446,"A critical assessment of SARS-CoV-2 in aqueous environment: Existence, detection, survival, wastewater-based surveillance, inactivation methods, and effective management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035368/
40447,Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336874/
40448,COVID‐19 breakthroughs: separating fact from fiction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300672/
40449,Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349657/
40450,COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521087/
40451,Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675677/
40452,Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270414/
40453,Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443512/
40454,Clin Sci (Lond). 2020 Sep; 134(17): 2315–2317. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484393/
40455,Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490130/
40456,"European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690255/
40457,An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101866/
40458,Detection and quantification of SARS-CoV-2 RNA in wastewater influent in relation to reported COVID-19 incidence in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865022/
40459,RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694673/
40460,Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206114/
40461,The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394394/
40462,Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795783/
40463,"From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917907/
40464,Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498392/
40465,Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323250/
40466,COVID-19: The Immune Responses and Clinical Therapy Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432271/
40467,COVID‐19 metabolism: Mechanisms and therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363584/
40468,Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183109/
40469,Current and innovative methods for the diagnosis of COVID-19 infection (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043662/
40470,The immunology and immunotherapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723987/
40471,"A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015872/
40472,Current treatment strategies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548951/
40473,Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272625/
40474,Review of COVID-19 testing and diagnostic methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970625/
40475,Neurological Complications of COVID-19: Underlying Mechanisms and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071289/
40476,"Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311293/
40477,Integrated immune dynamics define correlates of COVID-19 severity and antibody responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862905/
40478,"Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781116/
40479,Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851516/
40480,Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783682/
40481,An update on emerging therapeutics to combat COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239852/
40482,COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/
40483,Brief review on repurposed drugs and vaccines for possible treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905377/
40484,Hyperimmune immunoglobulin for people with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887673/
40485,Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734735/
40486,COVID-19 and cellular senescence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533263/
40487,"A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477646/
40488,Correlation of SARS-CoV-2 to cancer: Carcinogenic or anticancer? (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923649/
40489,"Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784533/
40490,Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405735/
40491,Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892334/
40492,Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554795/
40493,Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740029/
40494,Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054641/
40495,Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204679/
40496,Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441799/
40497,Testosterone in COVID-19: An Adversary Bane or Comrade Boon,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455954/
40498,SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537523/
40499,Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146233/
40500,COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887620/
40501,New-onset IgG autoantibodies in hospitalized patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440763/
40502,Pharmacological therapies and drug development targeting SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558743/
40503,"Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547481/
40504,mSystems. 2022 Jan-Feb; 7(1): e01447-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788317/
40505,SARS-CoV-2 infection and multi-organ system damage: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901898/
40506,"Emerging roles of extracellular vesicles in COVID‐19, a double‐edged sword?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251486/
40507,Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038195/
40508,SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021850/
40509,Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381213/
40510,T cell perturbations persist for at least 6 months following hospitalization for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393525/
40511,Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190731/
40512,"An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742611/
40513,Multiomics integration-based molecular characterizations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769889/
40514,Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080872/
40515,Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733219/
40516,Biomarkers of COVID-19 and technologies to combat SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435336/
40517,Plausibility of natural immunomodulators in the treatment of COVID-19–A comprehensive analysis and future recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284624/
40518,COVID-19 and Cancer: Current Challenges and Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528740/
40519,COVID-19 in patients with hematologic malignancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098396/
40520,Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369763/
40521,Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408214/
40522,"COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569292/
40523,"Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233421/
40524,Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044506/
40525,Effects of COVID-19 Infection and Vaccination on the Female Reproductive System: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175880/
40526,Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719059/
40527,"Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723419/
40528,Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142027/
40529,SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339657/
40530,SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139428/
40531,"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/
40532,Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808408/
40533,Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231592/
40534,COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370876/
40535,Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869965/
40536,Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523127/
40537,Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802346/
40538,Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422807/
40539,An update of anti-viral treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771049/
40540,Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486678/
40541,"A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957225/
40542,"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505773/
40543,COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563344/
40544,Neuro–Immune Interactions in Severe COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699641/
40545,"SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062420/
40546,"SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393547/
40547,Understanding COVID-19: From Origin to Potential Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460442/
40548,The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243884/
40549,"The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763336/
40550,Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556776/
40551,J Clin Immunol. 2022; 42(2): 230–231. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626280/
40552,The intersection of COVID-19 and cancer: signaling pathways and treatment implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126512/
40553,ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365123/
40554,Psychotropics and COVID-19: An analysis of safety and prophylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410507/
40555,SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626230/
40556,Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694479/
40557,The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802596/
40558,Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909959/
40559,Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594263/
40560,Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486642/
40561,The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395814/
40562,Blockade of SARS-CoV-2 spike protein-mediated cell–cell fusion using COVID-19 convalescent plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946952/
40563,Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106882/
40564,Immunity. 2022 Feb 8; 55(2): 366–375. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822770/
40565,Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102001/
40566,"COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/
40567,Race to arsenal COVID-19 therapeutics: Current alarming status and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588316/
40568,"Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864018/
40569,Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689952/
40570,Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246416/
40571,COVID‐19 and ischemic stroke,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444875/
40572,Long COVID: a review and proposed visualization of the complexity of long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157068/
40573,Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756003/
40574,COVID‐19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538900/
40575,"Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection—A Missing Piece of the Puzzle in the COVID-19 Pathogenesis?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304299/
40576,COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305262/
40577,BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113676/
40578,The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322591/
40579,Antiviral response and immunopathogenesis of interleukin 27 in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261846/
40580,Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689305/
40581,Neurological complications and infection mechanism of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609271/
40582,Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969719/
40583,Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147674/
40584,Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874581/
40585,Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244875/
40586,Cell-Specific Mechanisms in the Heart of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171292/
40587,Circ Res. 2023 Jun 23; 133(1): e18. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470426/
40588,Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510054/
40589,Multi-omics for COVID-19: driving development of therapeutics and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627145/
40590,COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705947/
40591,American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011620/
40592,Natural history of COVID-19 and current knowledge on treatment therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332915/
40593,"Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877127/
40594,SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529056/
40595,"Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767775/
40596,SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128284/
40597,Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886553/
40598,Immunomodulation and immunotherapeutics of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393504/
40599,Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699636/
40600,"A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance of relative IgA and IgM antigen binding over time",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062637/
40601,The find of COVID-19 vaccine: Challenges and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773313/
40602,SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991062/
40603,"COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921693/
40604,Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687542/
40605,"Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014809/
40606,COVID-19 and kidney disease: insights from epidemiology to inform clinical practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006492/
40607,Understanding COVID-19 Situation in Nepal and Implications for SARS-CoV-2 Transmission and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178984/
40608,"Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/
40609,The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967364/
40610,Cerebrospinal fluid in COVID-19: A systematic review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833669/
40611,"Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148894/
40612,Mechanisms of COVID-19 pathogenesis in diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359655/
40613,Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367272/
40614,COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166656/
40615,Plasmacytoid dendritic cells during COVID-19: Ally or adversary?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279298/
40616,COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961091/
40617,SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454552/
40618,A Peek into Pandora’s Box: COVID-19 and Neurodegeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870638/
40619,"A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772081/
40620,COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670749/
40621,Current and prospective computational approaches and challenges for developing COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871111/
40622,"COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573237/
40623,"COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420274/
40624,Deciphering SARS-CoV-2 Virologic and Immunologic Features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460647/
40625,"Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786532/
40626,Pathophysiology of Post-COVID syndromes: a new perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548310/
40627,Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368053/
40628,Cellular therapies for the treatment and prevention of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896869/
40629,"Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959277/
40630,"MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679035/
40631,Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292635/
40632,Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802458/
40633,"Morphological, cellular, and molecular basis of brain infection in COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436354/
40634,SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759609/
40635,Pulmonary surfactant as a versatile biomaterial to fight COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605818/
40636,Neurologic complications of coronavirus and other respiratory viral infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418023/
40637,A review of potential suggested drugs for coronavirus disease (COVID-19) treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816644/
40638,SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120039/
40639,COVID‐19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111382/
40640,Humoral immune mechanisms involved in protective and pathological immunity during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245343/
40641,Hum Immunol. 2023 May-July; 84(5): 355. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082609/
40642,The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169418/
40643,Inhaled corticosteroids for the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724831/
40644,Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560774/
40645,"Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885419/
40646,Transl Neurodegener. 2023; 12: 23. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175047/
40647,"The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516728/
40648,Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157596/
40649,COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970285/
40650,"Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092649/
40651,The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619763/
40652,"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173833/
40653,"Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326263/
40654,Traditional herbs against COVID-19: back to old weapons to combat the new pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510171/
40655,"SARS-CoV-2 Variants, Vaccines, and Host Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761766/
40656,"Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938645/
40657,Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492337/
40658,COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239481/
40659,Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318295/
40660,COVID-19 in cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992310/
40661,From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179575/
40662,Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165825/
40663,Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407655/
40664,Insights into SARS-CoV-2 Persistence and Its Relevance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228265/
40665,One year update on the COVID-19 pandemic: Where are we now?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695590/
40666,"Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490511/
40667,Drug repurposing and cytokine management in response to COVID-19: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/
40668,Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213254/
40669,Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403711/
40670,Advances in the possible treatment of COVID-19: A review.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366101/
40671,COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461057/
40672,Endothelial cells and SARS-CoV-2: An intimate relationship,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834309/
40673,The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622307/
40674,Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806403/
40675,Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351210/
40676,Antibiotics for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536098/
40677,"Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874934/
40678,"Dry eye symptoms are prevalent in moderate-severe COVID-19, while SARS-COV-2 presence is higher in mild COVID-19: Possible ocular transmission risk of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10998079/
40679,Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796696/
40680,Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868520/
40681,Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385744/
40682,Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068236/
40683,"The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590402/
40684,"A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694590/
40685,COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450831/
40686,"Effectiveness of public health measures
in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19
mortality: systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423125/
40687,BMJ. 2021; 375: n2997. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640736/
40688,The potential link between Covid‐19 and multiple myeloma: A new saga,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673426/
40689,Tackling COVID-19 with neutralizing monoclonal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152891/
40690,Cell. 2021 Aug 19; 184(17): 4593–4595. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375150/
40691,The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271749/
40692,"SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723891/
40693,Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962967/
40694,Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398942/
40695,Development and management of gastrointestinal symptoms in long-term COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10752947/
40696,"Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260489/
40697,SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551145/
40698,Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975445/
40699,Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156796/
40700,Antiviral Drug Discovery for the Treatment of COVID-19 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143071/
40701,COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857060/
40702,Cell. 2021 Nov 11; 184(23): 5838. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582084/
40703,Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688265/
40704,Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160920/
40705,SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488868/
40706,Approach to COVID-19 in older adults and indications for improving the outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578089/
40707,Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278217/
40708,Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943572/
40709,COVID-19 and diabetes—Two giants colliding: From pathophysiology to management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437522/
40710,No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691144/
40711,COVID-19 therapies: do we see substantial progress?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152818/
40712,Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243822/
40713,Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478577/
40714,Diabetes and COVID-19; A Bidirectional Interplay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891603/
40715,"Wastewater, waste, and water-based epidemiology (WWW-BE): A novel hypothesis and decision-support tool to unravel COVID-19 in low-income settings?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481624/
40716,COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778857/
40717,"COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870870/
40718,Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032659/
40719,Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380479/
40720,Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739883/
40721,"Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109707/
40722,Nanocarrier vaccines for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794055/
40723,Understanding the neurological implications of acute and long COVID using brain organoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387352/
40724,"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637516/
40725,Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621307/
40726,Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619886/
40727,Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236961/
40728,Organoid and microfluidics-based platforms for drug screening in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695520/
40729,An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669259/
40730,Human genetic basis of coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450706/
40731,COVID-19—Lessons Learned and Questions Remaining,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797746/
40732,How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386070/
40733,Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828218/
40734,Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963977/
40735,COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187022/
40736,Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539757/
40737,"‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452662/
40738,Potential intestinal infection and faecal–oral transmission of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883337/
40739,High SARS-CoV-2 tropism and activation of immune cells in the testes of non-vaccinated deceased COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933832/
40740,"COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10868124/
40741,Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532351/
40742,"Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473593/
40743,COVID-19 and Dentistry in 72 Questions: An Overview of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919689/
40744,Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416549/
40745,Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031737/
40746,A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260561/
40747,Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746856/
40748,A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851973/
40749,SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960624/
40750,"Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500019/
40751,A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857284/
40752,SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413769/
40753,"Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343379/
40754,Vitamin D—A prominent immunomodulator to prevent COVID‐19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874620/
40755,"COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459904/
40756,Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304657/
40757,Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833205/
40758,Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862910/
40759,Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800604/
40760,Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313047/
40761,Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001285/
40762,Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427918/
40763,COVID-19: imbalanced cell-mediated immune response drives to immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553190/
40764,"How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/
40765,SARS-CoV-2 and male infertility: from short- to long-term impacts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013302/
40766,COVID-19 Blind Spots: A Consensus Statement on the Importance of Competent Political Leadership and the Need for Public Health Cognizance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045535/
40767,Potential drug development and therapeutic approaches for clinical intervention in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143914/
40768,"Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534458/
40769,Immune dysregulation and system pathology in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993139/
40770,"Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174470/
40771,No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488724/
40772,Circulating multimeric immune complexes contribute to immunopathology in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513013/
40773,Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582279/
40774,"Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341908/
40775,A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924267/
40776,COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079314/
40777,TLRs: Innate Immune Sentries against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178469/
40778,"Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263255/
40779,Experimental Models of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791197/
40780,A comprehensive review of imaging findings in COVID-19 - status in early 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087891/
40781,Application of Nanotechnology in the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847377/
40782,Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307820/
40783,Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083253/
40784,Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283561/
40785,Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776790/
40786,Multi-organ proteomic landscape of COVID-19 autopsies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794601/
40787,Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547971/
40788,FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071495/
40789,Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177376/
40790,Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579910/
40791,Neurological involvement in the respiratory manifestations of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906194/
40792,Lessons from SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260876/
40793,Contemporary Concise Review 2021: COVID‐19 and other respiratory infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347613/
40794,In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289744/
40795,A review of current effective COVID-19 testing methods and quality control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189236/
40796,"RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322689/
40797,Immunotherapies and immunomodulatory approaches in clinical trials - a mini review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885722/
40798,"Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856332/
40799,"Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834857/
40800,Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753942/
40801,Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767873/
40802,The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464468/
40803,Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879704/
40804,Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865837/
40805,Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534551/
40806,Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721294/
40807,Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584756/
40808,The Nervous System During COVID-19: Caught in the Crossfire,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350403/
40809,The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347179/
40810,Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315341/
40811,"T cell responses to COVID-19 infection and vaccination in patients with
multiple sclerosis receiving disease-modifying therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708532/
40812,"Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020–February 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359681/
40813,Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786057/
40814,COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003176/
40815,SARS-CoV-2 Antiviral Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404831/
40816,Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690151/
40817,Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582773/
40818,Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622671/
40819,Traditional Chinese medicine against COVID-19: Role of the gut microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901378/
40820,Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer’s Disease via Transcriptomic Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821526/
40821,Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787839/
40822,COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574866/
40823,"Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418728/
40824,"Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885912/
40825,mSystems. 2021 Sep-Oct; 6(5): e00095-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547481/
40826,"SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600393/
40827,Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223875/
40828,Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470049/
40829,Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142524/
40830,Nat Commun. 2022; 13: 4732. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372969/
40831,Post-COVID Syndrome in Adults—An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056158/
40832,Immune-mediated approaches against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355525/
40833,Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002648/
40834,Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761492/
40835,"T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861234/
40836,Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259103/
40837,Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729421/
40838,"Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467145/
40839,Molecular signatures in the progression of COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768786/
40840,"COVID-19 Vaccines, Effectiveness, and Immune Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737588/
40841,COVID-19: Vaccines and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472710/
40842,System-wide transcriptome damage and tissue identity loss in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784611/
40843,High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579840/
40844,Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222315/
40845,Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408367/
40846,Colchicine for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521385/
40847,Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843151/
40848,Pharmacotherapeutics of SARS-CoV-2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785334/
40849,The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833462/
40850,"Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010765/
40851,A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936379/
40852,Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783150/
40853,Proteomic approaches to study SARS-CoV-2 biology and COVID-19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839417/
40854,Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759301/
40855,The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538066/
40856,Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182831/
40857,Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/
40858,Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491181/
40859,Clin Microbiol Rev. 2023 Jun; 36(2): e00052-23. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283480/
40860,"Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800420/
40861,Health influence of SARS-CoV-2 (COVID-19) on cancer: a review: Health influence of SARS-CoV-2 (COVID-19) on cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828497/
40862,The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168478/
40863,The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549189/
40864,COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435247/
40865,Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200788/
40866,"Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776352/
40867,"Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127834/
40868,Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135462/
40869,Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823949/
40870,Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438210/
40871,"Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924650/
40872,COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473087/
40873,Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472619/
40874,A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624722/
40875,Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040362/
40876,Therapeutic approaches for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/
40877,"Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015436/
40878,"SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876355/
40879,The Omic Insights on Unfolding Saga of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564481/
40880,Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969758/
40881,Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071775/
40882,"An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946785/
40883,Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622998/
40884,"Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208071/
40885,Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324763/
40886,Microbiota and COVID-19: Long-term and complex influencing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417543/
40887,Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029451/
40888,Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616235/
40889,SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353388/
40890,SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302220/
40891,Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350347/
40892,The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767501/
40893,"SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504858/
40894,The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689956/
40895,Potential role of interferons in treating COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608019/
40896,Age at SARS-CoV-2 infection and psychological and physical recovery among Chinese health care workers with severe COVID-19 at 28 months after discharge: A cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992871/
40897,Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272134/
40898,Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280735/
40899,Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387562/
40900,Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953148/
40901,Overview of SARS-CoV-2 infection in adults living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075775/
40902,COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486977/
40903,"Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281043/
40904,Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210448/
40905,COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045432/
40906,Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928747/
40907,Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206920/
40908,The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837329/
40909,SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709832/
40910,Treatments for COVID-19: Lessons from 2020 and new therapeutic options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598952/
40911,"COVID-19: molecular targets, drug repurposing and new avenues for
drug discovery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534958/
40912,"An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968612/
40913,An update on host immunity correlates and prospects of re-infection in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787841/
40914,Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003049/
40915,"COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377623/
40916,Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143992/
40917,Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919104/
40918,"Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130726/
40919,The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772030/
40920,"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459193/
40921,Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626754/
40922,Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250924/
40923,The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886238/
40924,Clinical features and mechanistic insights into drug repurposing for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570392/
40925,COVID-19 Infection and Circulating Microparticles—Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235918/
40926,Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390103/
40927,Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283621/
40928,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237901/
40929,Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750669/
40930,Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505554/
40931,Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583882/
40932,Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573230/
40933,Contemporary narrative review of treatment options for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446994/
40934,Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795739/
40935,Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981598/
40936,The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823618/
40937,"Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346130/
40938,Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126446/
40939,Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786163/
40940,Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411261/
40941,Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425433/
40942,"SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459327/
40943,Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237940/
40944,"COVID-19 and the eye: alternative facts The 2022 Bowman Club, David L. Easty lecture",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114314/
40945,"COVID-19 and its impact on cancer, HIV, and mentally ill patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347297/
40946,Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368024/
40947,The Perspective of Vitamin D on suPAR-Related AKI in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500944/
40948,The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759121/
40949,Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503550/
40950,Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058163/
40951,"Ultra-Rapid and Ultra-Sensitive Detection of SARS-CoV-2 Antibodies in
COVID-19 Patients via A 3D-Printed Nanomaterial-Based Biosensing
Platform",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538259/
40952,Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858603/
40953,Unmasking the Enigma: An In-Depth Analysis of COVID-19 Impact on the Pediatric Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299956/
40954,"Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832772/
40955,Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574860/
40956,"SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874490/
40957,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849242/
40958,Convalescent plasma for people with COVID‐19: a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171886/
40959,Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574046/
40960,Plasma cell-free RNA characteristics in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805721/
40961,Variants in ACE2; potential influences on virus infection and COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886638/
40962,"SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940980/
40963,Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576114/
40964,Marginal effects of public health measures and COVID-19 disease burden in China: A large-scale modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538769/
40965,Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448301/
40966,Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670819/
40967,SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111768/
40968,Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020189/
40969,COVID-19 and diabetes mellitus: from pathophysiology to clinical management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664589/
40970,A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525642/
40971,Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564600/
40972,"Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317171/
40973,The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385722/
40974,Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375293/
40975,Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899452/
40976,Cell. 2021 Sep 2; 184(18): 4713–4733.e22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299217/
40977,Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998661/
40978,"How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685122/
40979,COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206176/
40980,Co-infection associated with SARS-CoV-2 and their management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912272/
40981,Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989595/
40982,Adv Nutr. 2021 Sep; 12(5): 2040–2044. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483944/
40983,"COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254311/
40984,"Review of Burden, Clinical Definitions, and Management of COVID-19 Cases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410412/
40985,Cardiac Manifestations in Patients with COVID-19: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757387/
40986,Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641406/
40987,SARS-CoV-2 and COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486701/
40988,The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694873/
40989,Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611753/
40990,"COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of Tests",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512798/
40991,"Diabetes Mellitus, Energy Metabolism, and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911957/
40992,Host factors: Implications in immunopathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505027/
40993,Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118709/
40994,Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610092/
40995,"Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145020/
40996,Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091347/
40997,Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836230/
40998,Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534795/
40999,Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453010/
41000,State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463543/
41001,Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464362/
41002,Impact of COVID-19 in solid organ transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800718/
41003,"COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950852/
41004,"Transmission of SARS‐CoV‐2 through breast milk and
breastfeeding: a living systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970667/
41005,Year‐long wastewater monitoring for SARS‐CoV‐2 signals in combined and separate sanitary sewers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350404/
41006,Recent advances in small-molecular therapeutics for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579963/
41007,Immunological considerations for COVID-19 vaccine strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472682/
41008,Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230982/
41009,Disease severity during SARS-COV-2 reinfection: a nationwide study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786677/
41010,Pathophysiology of COVID-19-associated acute kidney injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256398/
41011,COVID-19 associated complications and potential therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486300/
41012,The role of B cells in COVID-19 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468879/
41013,Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057012/
41014,Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354572/
41015,"COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137603/
41016,The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer’s Like Brain Changes on Severely SARS-CoV-2 Infected Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655662/
41017,Asthma and COVID-19: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674937/
41018,Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020611/
41019,Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201269/
41020,Commonalities Between COVID-19 and Radiation Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861125/
41021,Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455095/
41022,Hemolytic anemia in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263052/
41023,An update review of emerging small-molecule therapeutic options for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857046/
41024,Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350892/
41025,High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722807/
41026,Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105989/
41027,COVID-19: gastrointestinal and hepatobiliary manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288242/
41028,"Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296254/
41029,Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894098/
41030,"Number of COVID-19 cases required in a population to detect SARS-CoV-2 RNA in wastewater in the province of Alberta, Canada: Sensitivity assessment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068596/
41031,Cholinergic dysfunction in COVID-19: frantic search and hoping for the best,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735034/
41032,COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450840/
41033,Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300823/
41034,"An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747952/
41035,Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367741/
41036,"Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993408/
41037,Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960567/
41038,"Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615473/
41039,A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283703/
41040,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919858/
41041,"An Integrated Radiologic-Pathologic Understanding of COVID-19
Pneumonia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868683/
41042,Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757533/
41043,The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176665/
41044,"Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645867/
41045,Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754839/
41046,Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264656/
41047,A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940122/
41048,COVID-19: Insights into long-term manifestations and lockdown impacts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977467/
41049,Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486761/
41050,Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941074/
41051,"A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108708/
41052,Convalescent plasma treatment of critically ill intensive care COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251157/
41053,"Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150955/
41054,Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348627/
41055,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260597/
41056,Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537111/
41057,"COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283670/
41058,Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747131/
41059,The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612330/
41060,A comparison of conventional and advanced electroanalytical methods to detect SARS-CoV-2 virus: A concise review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270057/
41061,Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567168/
41062,Impact of COVID-19 on male urogenital health: Success of vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316714/
41063,Advances in COVID-19 mRNA vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940982/
41064,SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938271/
41065,Nat Med. 2022; 28(3): 599. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815288/
41066,"COVID-19, Myocarditis and Pericarditis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171304/
41067,The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021400/
41068,Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667725/
41069,EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871226/
41070,Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235902/
41071,Myeloid dysregulation and therapeutic intervention in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576142/
41072,Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906453/
41073,ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233352/
41074,Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128303/
41075,Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581400/
41076,Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010236/
41077,Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876428/
41078,"Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775677/
41079,COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982560/
41080,Cardiovascular Manifestations of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699571/
41081,State of the art in epitope mapping and opportunities in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987558/
41082,Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310533/
41083,A Comprehensive Updated Review on SARS‐CoV‐2 and COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283834/
41084,"Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241670/
41085,"When stem cells meet COVID-19: recent advances, challenges and future perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744050/
41086,A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678434/
41087,Narrative Review of New Insight into the Influence of the COVID-19 Pandemic on Cardiovascular Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694465/
41088,Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150634/
41089,Innate immunity: the first line of defense against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935980/
41090,Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828434/
41091,Wastewater-Based Epidemiology (WBE) and Viral Detection in Polluted Surface Water: A Valuable Tool for COVID-19 Surveillance—A Brief Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764684/
41092,The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040821/
41093,Socioeconomic status correlations with confirmed COVID-19 cases and SARS-CoV-2 wastewater concentrations in small-medium sized communities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458761/
41094,Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572995/
41095,"Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925936/
41096,Functional Effects of Cardiomyocyte Injury in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791272/
41097,The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600760/
41098,Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788624/
41099,Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282241/
41100,"Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475817/
41101,"Covid-19: virology, variants, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951271/
41102,Pathophysiological mechanisms of liver injury in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753756/
41103,"Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312243/
41104,Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physician,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045761/
41105,Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214689/
41106,Human genetic and immunological determinants of critical COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957595/
41107,"The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459165/
41108,Immunity to SARS‐CoV‐2 induced by infection or vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447342/
41109,Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653368/
41110,COVID-19 surveillance in wastewater: An epidemiological tool for the monitoring of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854263/
41111,Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337829/
41112,Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111059/
41113,COVID-19 mRNA vaccines: Platforms and current developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856755/
41114,Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953531/
41115,"COVID‐19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446947/
41116,"Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307469/
41117,Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225114/
41118,"Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198676/
41119,"Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591157/
41120,"The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581732/
41121,"COVID‐19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349458/
41122,Comprehensive proteomics and meta-analysis of COVID-19 host response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516886/
41123,A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4+ and CD8+ T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734477/
41124,Immunosenescence and inflamm-ageing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741765/
41125,Correlation between Type I Interferon Associated Factors and COVID-19 Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506204/
41126,"Aging in COVID-19: Vulnerability, immunity and intervention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604159/
41127,Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949647/
41128,Human Body Performance with COVID-19 Affectation According to Virus Specification Based on Biosensor Techniques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704003/
41129,Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054913/
41130,Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173604/
41131,"Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829666/
41132,"Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616290/
41133,Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10987522/
41134,Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863934/
41135,"COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209245/
41136,A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162381/
41137,Cell Commun Signal. 2022; 20: 90. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199318/
41138,Cell Commun Signal. 2022; 20: 139. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453700/
41139,Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073701/
41140,The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994064/
41141,Sci Rep. 2022; 12: 6498. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019531/
41142,Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733616/
41143,Nervous system manifestations related to COVID-19 and their possible mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236920/
41144,The immune response to COVID‐19: Does sex matter?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111683/
41145,"Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124924/
41146,Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610842/
41147,Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513558/
41148,"Functional consequences of SARS-CoV-2 infection in pregnant women, fetoplacental unit, and neonate",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581789/
41149,"Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195694/
41150,Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887728/
41151,Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047796/
41152,Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647662/
41153,"Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481764/
41154,Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319396/
41155,SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288264/
41156,Lines of Treatment of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298380/
41157,Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422783/
41158,A comprehensive review of COVID-19 detection techniques: From laboratory systems to wearable devices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433350/
41159,An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163347/
41160,"ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444942/
41161,Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960675/
41162,Mouse models in COVID-19 research: analyzing the adaptive immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166226/
41163,SARS-CoV-2-Induced Myocarditis: A State-of-the-Art Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145666/
41164,A prenylated dsRNA sensor protects against severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612834/
41165,The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763337/
41166,Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903393/
41167,CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049468/
41168,Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834073/
41169,"Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350392/
41170,The role of antigen-presenting cells in the pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941975/
41171,Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393183/
41172,Seasonal coronavirus–specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553556/
41173,Diagnosis for COVID-19: current status and future prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938658/
41174,NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924116/
41175,Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231409/
41176,Vaccination in patients with kidney failure: lessons from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397175/
41177,Early cross-coronavirus reactive signatures of humoral immunity against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943686/
41178,"Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616523/
41179,Novel insight into the underlying dysregulation mechanisms of immune cell-to-cell communication by analyzing multitissue single-cell atlas of two COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122452/
41180,"Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266766/
41181,"Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181103/
41182,FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238652/
41183,"Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335243/
41184,COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641591/
41185,Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465349/
41186,A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811647/
41187,Visual Detection of COVID-19 from Materials Aspect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358106/
41188,Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444709/
41189,"Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436060/
41190,COVID-19: Imbalanced Immune Responses and Potential Immunotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878382/
41191,Sex-Related Factors in Cardiovascular Complications Associated to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773922/
41192,Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135326/
41193,Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825346/
41194,Elevated ubiquitination contributes to protective immunity against severe SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708907/
41195,Neutralizing monoclonal antibodies for treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054133/
41196,Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563522/
41197,A blood atlas of COVID-19 defines hallmarks of disease severity and specificity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776501/
41198,Molnupiravir and Its Antiviral Activity Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013824/
41199,The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765363/
41200,"SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100521/
41201,"COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039300/
41202,Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144443/
41203,A Review of Potential Therapeutic Strategies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696587/
41204,Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237927/
41205,Immunology of SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182659/
41206,Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320270/
41207,Immune system changes in those with hypertension when infected with SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183242/
41208,Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848491/
41209,COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284818/
41210,"COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253145/
41211,"Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836435/
41212,A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887598/
41213,The human genetic epidemiology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060414/
41214,Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134243/
41215,From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236413/
41216,Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236910/
41217,Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781813/
41218,Covid-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363819/
41219,"COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371980/
41220,A review of the potential neurological adverse events of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668235/
41221,Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564179/
41222,Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205551/
41223,Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377623/
41224,Recent advances of nanotechnology in COVID 19: A critical review and future perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749399/
41225,COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542506/
41226,Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919997/
41227,Multiple early factors anticipate post-acute COVID-19 sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786632/
41228,Acquired insights from the long-term surveillance of SARS-CoV-2 RNA for COVID-19 monitoring: The case of Monterrey Metropolitan Area (Mexico),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853965/
41229,COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297827/
41230,HIV and COVID-19: review of clinical course and outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442751/
41231,Neurological toll of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761097/
41232,Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury—The Current State of Knowledge and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268979/
41233,SARS-CoV-2 immunity in animal models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806257/
41234,SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920339/
41235,Advances in Targeting ACE2 for Developing COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581451/
41236,The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021247/
41237,"European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690026/
41238,Eur Heart J. 2022 May 7; 43(18): 1776. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194802/
41239,Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515020/
41240,"Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552043/
41241,"Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402990/
41242,"Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/
41243,How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929558/
41244,COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666993/
41245,The status of COVID-19 vaccines in India: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126226/
41246,"Three-Dimensional Visualization of Viral Structure,
Entry, and Replication Underlying the Spread of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344915/
41247,Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739500/
41248,Targeting SARS-CoV-2 and host cell receptor interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792186/
41249,COVID-19: Molecular and Cellular Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904902/
41250,Exploring the Utility of NK Cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138257/
41251,COVID-19: The question of genetic diversity and therapeutic intervention approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075701/
41252,Long COVID and its Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305273/
41253,The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815717/
41254,Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600245/
41255,"Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143518/
41256,Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245316/
41257,Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955649/
41258,Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802525/
41259,Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861611/
41260,SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591899/
41261,Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235474/
41262,Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631592/
41263,Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331543/
41264,"COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842412/
41265,Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420909/
41266,Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743495/
41267,Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355161/
41268,Targeted wastewater surveillance of SARS-CoV-2 on a university campus for COVID-19 outbreak detection and mitigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163699/
41269,HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111820/
41270,The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019247/
41271,Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899355/
41272,Exploring the impact of selection bias in observational studies of COVID-19: a simulation study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908043/
41273,Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987233/
41274,"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012513/
41275,Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949831/
41276,A comprehensive review on efficient approaches for combating coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531103/
41277,"A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910562/
41278,Advances in Biosensing Technologies for Diagnosis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599206/
41279,The Gut Microbiome of Children during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783902/
41280,Remdesivir: A Review in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474216/
41281,Drugs. 2023; 83(14): 1349. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511569/
41282,COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136203/
41283,Molecular consequences of SARS-CoV-2 liver tropism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964418/
41284,"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19—Mechanisms and Therapeutic Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397545/
41285,Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545089/
41286,"Diagnosis of COVID-19, vitality of emerging technologies and preventive measures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103773/
41287,Putative Role of Vitamin D for COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396570/
41288,"The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210450/
41289,Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954060/
41290,Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/
41291,Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435122/
41292,GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423996/
41293,Mechanisms of SARS-CoV-2 Transmission and Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556779/
41294,Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406181/
41295,COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862165/
41296,The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875987/
41297,Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769772/
41298,SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268159/
41299,"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786601/
41300,Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308954/
41301,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
41302,Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367663/
41303,J Enzyme Inhib Med Chem. 2022; 37(1): 2574. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518647/
41304,Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020): Statement of the Austrian Society of Pneumology (ASP),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291190/
41305,CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634688/
41306,Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256583/
41307,Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088038/
41308,Review on acute pancreatitis attributed to COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134139/
41309,Experience of Rwanda on COVID-19 Case Management: From Uncertainties to the Era of Neutralizing Monoclonal Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834306/
41310,"Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910145/
41311,Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719161/
41312,"Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302717/
41313,Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226430/
41314,Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606959/
41315,From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805901/
41316,CD8+ T cells contribute to survival in COVID-19 patients with hematologic cancers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291091/
41317,Immunologic resilience and COVID-19 survival advantage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425719/
41318,Focused role of nanoparticles against COVID-19: Diagnosis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022514/
41319,Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458058/
41320,"COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665991/
41321,Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717699/
41322,"Dependency of sanitation infrastructure on the discharge of faecal coliform and SARS-CoV-2 viral RNA in wastewater from COVID and non-COVID hospitals in Dhaka, Bangladesh",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822545/
41323,COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749645/
41324,Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105364/
41325,Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381434/
41326,Determining available strategies for prevention and therapy: Exploring COVID-19 from the perspective of ACE2 (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891831/
41327,COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000583/
41328,Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407425/
41329,Cochrane Database Syst Rev. 2022; 2022(5): CD013665. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/
41330,Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937729/
41331,Recent advances of functional nucleic acid-based sensors for point-of-care detection of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889384/
41332,"Long COVID: major findings, mechanisms and recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839201/
41333,Nat Rev Microbiol. 2023; 21(6): 408. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408714/
41334,High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631501/
41335,Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734866/
41336,Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072050/
41337,Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512984/
41338,SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384834/
41339,Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415352/
41340,A hitchhiker's guide through the COVID-19 galaxy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461017/
41341,Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566192/
41342,Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604694/
41343,Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814864/
41344,COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394601/
41345,Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322013/
41346,Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107526/
41347,Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905703/
41348,COVID-19 and comorbidities of hepatic diseases in a global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015303/
41349,Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197521/
41350,The Pathophysiology of Long COVID throughout the Renin-Angiotensin System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101946/
41351,Recent Advancements on COVID-19: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713878/
41352,"Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638095/
41353,Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071761/
41354,Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319039/
41355,Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376347/
41356,The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865950/
41357,Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083369/
41358,Vaccines against SARS-CoV-2 variants and future pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979704/
41359,Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399077/
41360,"Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180541/
41361,Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233170/
41362,COVID-19: Pulmonary and Extra Pulmonary Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505777/
41363,Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11018982/
41364,Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536001/
41365,"Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171305/
41366,Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539803/
41367,Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932519/
41368,"An opinion on Wastewater-Based Epidemiological Monitoring
(WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas
of community COVID-19 Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612100/
41369,"Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patients with COVID‐19 in Yiwu, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264799/
41370,"Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015644/
41371,Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746369/
41372,"The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435207/
41373,"Clinical outcomes of monoclonal antibody therapy during a COVID‐19 outbreak in a skilled nursing facility—Arizona, 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115062/
41374,The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870622/
41375,A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965011/
41376,"Combining viral genomics and clinical data to assess risk factors for severe COVID-19 (mortality, ICU admission, or intubation) amongst hospital patients in a large acute UK NHS hospital Trust",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035897/
41377,Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256663/
41378,Long Noncoding RNAs as Emerging Regulators of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366413/
41379,Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393334/
41380,Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047577/
41381,"Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321603/
41382,Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3000 COVID-19 patients from 2 centers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832689/
41383,Management of COVID-19 patients with chronic liver diseases and liver transplants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683212/
41384,Wastewater surveillance to infer COVID-19 transmission: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423771/
41385,Dissecting lipid metabolism alterations in SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869689/
41386,Immune landscape and redox imbalance during neurological disorders in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482955/
41387,Pannexin-1 channel opening is critical for COVID-19 pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603863/
41388,A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457835/
41389,A Review of Treatment and Prevention of Coronavirus Disease 2019 among Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471770/
41390,Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547582/
41391,Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943180/
41392,Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534532/
41393,Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945151/
41394,Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812869/
41395,The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301107/
41396,"Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224379/
41397,Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549749/
41398,Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930836/
41399,The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843226/
41400,Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446791/
41401,Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926508/
41402,COVID-19 challenges and its therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339548/
41403,"Timeline of SARS-CoV-2 Transmission in Sabah, Malaysia: Tracking the Molecular Evolution",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459040/
41404,"The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892446/
41405,"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393178/
41406,"The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267459/
41407,Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433544/
41408,The effects of the COVID-19 pandemic on community respiratory virus activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574826/
41409,Inflammatory arthritis in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897406/
41410,Safeguarding COVID-19 and cancer management: drug design and therapeutic approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445946/
41411,The enzymes in COVID-19: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789385/
41412,COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874401/
41413,Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224680/
41414,Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191606/
41415,"Molecular and Serologic Diagnostic Technologies for
SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094103/
41416,Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110804/
41417,A systematic review of pregnant women with COVID-19 and their neonates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017514/
41418,SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283956/
41419,Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415591/
41420,Immune responses during COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480812/
41421,The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065845/
41422,COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250750/
41423,The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385234/
41424,Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485368/
41425,The Role of Diet and Specific Nutrients during the COVID-19 Pandemic: What Have We Learned over the Last Three Years?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093865/
41426,Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020872/
41427,Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874960/
41428,Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144974/
41429,"COVID-19 Pathology in the Lung, Kidney, Heart and Brain: The Different Roles of T-Cells, Macrophages, and Microthrombosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563269/
41430,Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881900/
41431,"Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538893/
41432,Eur J Heart Fail. 2023 Feb 17; 25(3): 443. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117570/
41433,COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189260/
41434,"COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289644/
41435,Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900119/
41436,"Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361355/
41437,COVID-19 in early 2021: current status and looking forward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938042/
41438,"Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/
41439,Cochrane Database Syst Rev. 2022; 2022(7): CD013705. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/
41440,Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968437/
41441,Differential regulatory T cell signature after recovery from mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030602/
41442,"COVID-19, Pre-Eclampsia, and Complement System",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635918/
41443,Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060843/
41444,"Stillbirth after COVID-19 in Unvaccinated Mothers Can Result from SARS-CoV-2 Placentitis, Placental Insufficiency, and Hypoxic Ischemic Fetal Demise, Not Direct Fetal Infection: Potential Role of Maternal Vaccination in Pregnancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950737/
41445,"Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388545/
41446,Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539138/
41447,COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801996/
41448,Immune-Cell-Based Therapy for COVID-19: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674523/
41449,"Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041436/
41450,Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123480/
41451,Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189744/
41452,"Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576141/
41453,Aprotinin—Drug against Respiratory Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342444/
41454,Delineating COVID-19 immunological features using single-cell RNA sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299978/
41455,"miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781105/
41456,"A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863680/
41457,Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/
41458,"Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674400/
41459,Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132165/
41460,"Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370834/
41461,Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431281/
41462,Defining the risk of SARS-CoV-2 variants on immune protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345323/
41463,Animal models for COVID-19 and tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451089/
41464,The interferon landscape along the respiratory tract impacts the severity of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373821/
41465,The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013755/
41466,The Latest Cellular and Molecular Mechanisms of COVID-19 on Non-Lung Organs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046222/
41467,"The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913045/
41468,Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417850/
41469,SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110310/
41470,Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185544/
41471,COVID-19: A Multidisciplinary Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403483/
41472,SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221594/
41473,"Elucidating the role of environmental management of forests, air quality, solid waste and wastewater on the dissemination of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095661/
41474,Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568958/
41475,Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531659/
41476,Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603600/
41477,Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325261/
41478,Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171291/
41479,Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384470/
41480,Cancer Imaging and Patient Care during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706101/
41481,SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273046/
41482,The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386875/
41483,SARS-CoV-2 infection and liver involvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243815/
41484,SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282065/
41485,Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819874/
41486,Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737069/
41487,Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590867/
41488,Management of Patients With Glucocorticoid-Related Diseases and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476969/
41489,Drugs for COVID-19 Treatment: A New Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037400/
41490,SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427053/
41491,"Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334659/
41492,Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165493/
41493,A specific molecular signature in SARS-CoV-2–infected kidney biopsies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077488/
41494,Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113973/
41495,The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304937/
41496,Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908006/
41497,Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819631/
41498,Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782468/
41499,Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296981/
41500,"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935456/
41501,Diet Quality and Risk of SARS-CoV-2 Infection or COVID-19: A Systematic Review of Observational Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721534/
41502,Crosstalk between Platelets and SARS-CoV-2: Implications in Thrombo-Inflammatory Complications in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531760/
41503,Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456372/
41504,Strategies for the Management of Spike Protein-Related Pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222799/
41505,COVID-19 and One-Carbon Metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026976/
41506,Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602709/
41507,"The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748929/
41508,"Covid‐19 and oral diseases: Crosstalk, synergy or association?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014590/
41509,Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781412/
41510,Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038708/
41511,Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135693/
41512,Cochrane Database Syst Rev. 2023; 2023(2): CD013600. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891348/
41513,COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556541/
41514,Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166307/
41515,Immunopharmacological perspective on zinc in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015651/
41516,Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system: Intrarenal RAS in COVID-19-associated AKI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828085/
41517,Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702705/
41518,X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532080/
41519,SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163842/
41520,Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856197/
41521,Emerging Therapeutic Modalities against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465781/
41522,Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028144/
41523,Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11050031/
41524,COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323448/
41525,Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476649/
41526,Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376308/
41527,SARS-CoV-2 infection of the oral cavity and saliva,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240394/
41528,Clinical Patterns and Morphology of COVID-19 Dermatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165088/
41529,The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541470/
41530,COVID-19 and cardiovascular complications: updates of emergency medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10836842/
41531,Can anti-parasitic drugs help control COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940209/
41532,The Immunopathobiology of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632753/
41533,Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578597/
41534,A critical evaluation of risk to reward ratio of quercetin supplementation for COVID‐19 and associated comorbid conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111035/
41535,Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757952/
41536,A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906417/
41537,Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813547/
41538,"Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040416/
41539,Therapy Targets SARS-CoV-2 Infection-Induced Cell Death,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152132/
41540,Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347407/
41541,The role of type I interferon in the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662121/
41542,"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826147/
41543,"COVID-19: Transmission, prevention, and potential therapeutic opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256510/
41544,Clinical development of antivirals against SARS-CoV-2 and its variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750039/
41545,SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141009/
41546,"COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625547/
41547,Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025561/
41548,Women’s Lives Matter—The Critical Need for Women to Prioritize Optimal Physical Activity to Reduce COVID-19 Illness Risk and Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507774/
41549,Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421373/
41550,"Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491202/
41551,A single-cell transcriptomic landscape of the lungs of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650955/
41552,The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754221/
41553,Environment and COVID-19 incidence: A critical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858699/
41554,"Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640495/
41555,Adaptive Immune Responses and Immunity to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114812/
41556,The signal pathways and treatment of cytokine storm in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261820/
41557,Signal Transduct Target Ther. 2021; 6: 326. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406011/
41558,Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182441/
41559,Animal Models for the Study of SARS-CoV-2–induced Respiratory Disease and Pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948904/
41560,SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010106/
41561,Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209116/
41562,The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063252/
41563,Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130411/
41564,Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009677/
41565,Antibody response and intra‐host viral evolution after plasma therapy in COVID‐19 patients pre‐exposed or not to B‐cell‐depleting agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539045/
41566,COVID-19 Vaccines: Where Did We Stand at the End of 2023?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893040/
41567,Molecular mechanisms implicated in SARS-CoV-2 liver tropism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827585/
41568,"COVID-19: Progress in diagnostics, therapy and vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359073/
41569,Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341707/
41570,Nat Rev Neurol. 2021; 17(4): 260. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375453/
41571,A Comprehensive Summary of the Knowledge on COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801274/
41572,COVID-19 diagnostics: Molecular biology to nanomaterials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673061/
41573,Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998971/
41574,The Mechanisms and Animal Models of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111004/
41575,COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193275/
41576,Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015715/
41577,"Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461067/
41578,CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872363/
41579,Nat Med. 2021 Jul; 27(7): 1280–1289. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291091/
41580,"A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS – CoV- 2 (COVID – 19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265145/
41581,"The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10743882/
41582,COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115278/
41583,High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608966/
41584,Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500408/
41585,A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441828/
41586,Inhibition of HECT E3 ligases as potential therapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987752/
41587,COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775477/
41588,Regulated necrosis in COVID-19: A double-edged sword,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452688/
41589,Identification of SARS-CoV-2–specific immune alterations in acutely ill patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262478/
41590,COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871825/
41591,Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665363/
41592,Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637815/
41593,Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030519/
41594,SARS-CoV-2: The Monster Causes COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861077/
41595,Flavonoids against the SARS-CoV-2 induced inflammatory storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906511/
41596,SARS-CoV-2 infection induces beta cell transdifferentiation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133495/
41597,"Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405053/
41598,Correlation between SARS-CoV-2 RNA concentration in wastewater and COVID-19 cases in community: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420035/
41599,In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231791/
41600,Intestinal barrier dysfunction as a key driver of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075050/
41601,Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486547/
41602,Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281279/
41603,Does COVID-19 Vaccination Warrant the Classical Principle “ofelein i mi vlaptin”?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999356/
41604,COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608106/
41605,JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784782/
41606,Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546941/
41607,Immunological mechanisms of vaccine-induced protection against COVID-19 in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246128/
41608,A review of clinical efficacy data supporting emergency use authorization for COVID‐19 therapeutics and lessons for future pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538903/
41609,Gut microbiota in COVID-19: new insights from inside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120564/
41610,"SARS-CoV-2, COVID-19, and Reproduction: Effects on Fertility, Pregnancy, and Neonatal Life",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331824/
41611,Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280161/
41612,"Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111447/
41613,Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965371/
41614,"Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899608/
41615,Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463074/
41616,Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646950/
41617,"A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979130/
41618,An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065335/
41619,Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130952/
41620,Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543044/
41621,Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405444/
41622,Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243164/
41623,Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652524/
41624,"Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973820/
41625,What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594888/
41626,Niclosamide—A promising treatment for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111792/
41627,COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942063/
41628,Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222863/
41629,Latest Insights on the Diagnostic Approaches and Treatment Strategies of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148896/
41630,Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917804/
41631,COVID-19 and Cardiovascular Disease: From Bench to Bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048382/
41632,Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984452/
41633,Mental Health Issues During and After COVID-19 Vaccine Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414813/
41634,Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706135/
41635,"Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493173/
41636,Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412261/
41637,Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436159/
41638,CRISPR systems: Novel approaches for detection and combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832022/
41639,Neurological consequences of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524739/
41640,Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403867/
41641,Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967999/
41642,"Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563267/
41643,Characteristics and roles of severe acute respiratory syndrome coronavirus 2‐specific antibodies in patients with different severities of coronavirus 19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405228/
41644,SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805264/
41645,Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910434/
41646,Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687182/
41647,"The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912782/
41648,Gastrointestinal Involvement in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228950/
41649,CD4+ T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875894/
41650,A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250068/
41651,Upregulation of the Renin–Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997276/
41652,Adaptive immunity to SARS-CoV-2 infection: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589156/
41653,"Drug repurposing for COVID-19: Approaches, challenges and promising candidates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220862/
41654,Redox stress in COVID-19: Implications for hematologic disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374492/
41655,Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347967/
41656,Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334944/
41657,Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475962/
41658,Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193775/
41659,Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138286/
41660,COVID-19: Diabetes Perspective—Pathophysiology and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967788/
41661,IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108089/
41662,SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490490/
41663,Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629592/
41664,COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058749/
41665,Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905284/
41666,Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877634/
41667,Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306903/
41668,Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670929/
41669,Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235975/
41670,Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection—Induction of Autoimmune Dysregulation and Metabolic Disturbances,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380525/
41671,Implications of cardiac markers in risk-stratification and management for COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074282/
41672,COVID-19 and Male Infertility: Is There a Role for Antioxidants?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451649/
41673,Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451184/
41674,The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221350/
41675,Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617539/
41676,Epidemiology and Clinical Presentation of COVID-19 in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633621/
41677,Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080216/
41678,The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775791/
41679,Renal involvement in COVID-19: focus on kidney transplant sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491762/
41680,"SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948283/
41681,Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054389/
41682,Janus kinase inhibitors for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190191/
41683,HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013568/
41684,Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749994/
41685,"Mechanisms of COVID-19-induced cardiovascular disease, is sepsis or exosome the missing link?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920909/
41686,Overview of Breastfeeding Under COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192965/
41687,COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124289/
41688,Long COVID: pathophysiological factors and abnormalities of coagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113134/
41689,Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856663/
41690,The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283057/
41691,Interactions between Humans and Dogs during the COVID-19 Pandemic: Recent Updates and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913536/
41692,"Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162476/
41693,Diabetes and SARS-CoV-2–Is There a Mutual Connection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234398/
41694,Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082484/
41695,Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406414/
41696,The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658029/
41697,Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254234/
41698,The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199258/
41699,Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382669/
41700,A review about COVID-19 in the MENA region: environmental concerns and machine learning applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554385/
41701,The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783106/
41702,Diminished antiviral innate immune gene expression in the placenta following a maternal SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482164/
41703,Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139419/
41704,Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744064/
41705,Animal Transmission of SARS-CoV-2 and the Welfare of Animals during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300090/
41706,Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347150/
41707,Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349450/
41708,High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322982/
41709,Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393056/
41710,A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452395/
41711,"Review article: prevention, diagnosis and management of COVID‐19 in the IBD patient",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267115/
41712,COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652673/
41713,"Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605515/
41714,COVID-19: The Impact on Cardiovascular System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615470/
41715,"The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618229/
41716,Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643921/
41717,Rapid identification of SARS-CoV-2 in the point-of-care using digital PCR-based Dr. PCR™ Di20K COVID-19 Detection Kit without viral RNA extraction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965542/
41718,"Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367207/
41719,Where do T cell subsets stand in SARS-CoV-2 infection: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399648/
41720,Environmental perspectives of COVID-19 outbreaks: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475003/
41721,Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961012/
41722,Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569487/
41723,Antibody tests for identification of current and past infection with SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/
41724,Cochrane Database Syst Rev. 2022; 2022(11): CD013652. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/
41725,Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214158/
41726,COVID-19—The Shift of Homeostasis into Oncopathology or Chronic Fibrosis in Terms of Female Reproductive System Involvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217917/
41727,Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130970/
41728,Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539179/
41729,Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363872/
41730,"Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675435/
41731,"Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735460/
41732,COVID-19: The Emerging Immunopathological Determinants for Recovery or Death,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736111/
41733,SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674272/
41734,"Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683955/
41735,Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408568/
41736,Recent progress on wastewater-based epidemiology for COVID-19 surveillance: A systematic review of analytical procedures and epidemiological modeling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028212/
41737,Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008982/
41738,Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595358/
41739,An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150915/
41740,Management of COVID-19: current status and future prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052512/
41741,Autoimmunity and COVID-19 – The microbiotal connection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189735/
41742,COVID-19 inflammation and implications in drug delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045711/
41743,An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612126/
41744,COVID-19 on Oral Health: A New Bilateral Connection for the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813615/
41745,Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488389/
41746,Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691108/
41747,Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401116/
41748,Association of COVID-19 transmission with high levels of ambient pollutants: Initiation and impact of the inflammatory response on cardiopulmonary disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960028/
41749,Overview of Nonhuman Primate Models of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594265/
41750,Breast Milk and COVID-19: From Conventional Data to “Omics” Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199242/
41751,"The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214726/
41752,Correlation between COVID-19 and hepatitis B: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782843/
41753,Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864014/
41754,"The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405220/
41755,Combined assessment of S‐ and N‐specific IL‐2 and IL‐13 secretion and CD69 neo‐expression for discrimination of post–infection and post‐vaccination cellular SARS‐CoV‐2‐specific immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348018/
41756,Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560738/
41757,"Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221734/
41758,Host and Viral Zinc-Finger Proteins in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998646/
41759,"Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048970/
41760,ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776253/
41761,Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295197/
41762,Wastewater surveillance of SARS-CoV-2 at intra-city level demonstrated high resolution in tracking COVID-19 and calibration using chemical indicators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825140/
41763,A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259575/
41764,From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599155/
41765,Insights into organoid-based modeling of COVID-19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959938/
41766,Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460261/
41767,SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891752/
41768,COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428033/
41769,"Potential Therapeutic Agents and Associated Bioassay
Data for COVID-19 and Related Human Coronavirus Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447080/
41770,SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884156/
41771,Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241359/
41772,Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736643/
41773,Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773251/
41774,Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793823/
41775,Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832557/
41776,Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859986/
41777,"Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156902/
41778,Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228192/
41779,ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863949/
41780,Diagnostics for COVID-19: moving from pandemic response to control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687671/
41781,Racial Health Disparity and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426163/
41782,Prospective selected biomarkers in COVID-19 diagnosis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454595/
41783,"Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697235/
41784,COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872837/
41785,COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810638/
41786,Cureus. 2024 Feb; 16(2): r137. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897748/
41787,Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758236/
41788,Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978324/
41789,Neurological effects of COVID‐19 in infants and children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111795/
41790,"Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707029/
41791,Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583059/
41792,BMC Infect Dis. 2022; 22: 883. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700875/
41793,Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114669/
41794,"COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/
41795,COVID-19: comprehensive review on mutations and current vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647783/
41796,IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935909/
41797,A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971900/
41798,Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862162/
41799,COVID-19 Vaccine: Between Myth and Truth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950941/
41800,"Can Lactoferrin, a Natural Mammalian Milk Protein, Assist in the Battle against COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782828/
41801,Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414363/
41802,COVID-19 vaccines in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061132/
41803,Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163295/
41804,"SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876838/
41805,Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504206/
41806,Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907212/
41807,Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153212/
41808,Airway Epithelial-Derived Immune Mediators in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458661/
41809,Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972900/
41810,Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579698/
41811,Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492383/
41812,Blood. 2023 Jun 15; 141(24): 3007. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268901/
41813,"Prognosis of COVID-19 in the middle eastern population, knowns and unknowns",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471247/
41814,Existing Drugs Considered as Promising in COVID-19 Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196765/
41815,Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427556/
41816,Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955932/
41817,Abnormal global alternative RNA splicing in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089920/
41818,Environmental perspective of COVID-19: Atmospheric and wastewater environment in relation to pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086803/
41819,Mouse Models for the Study of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594264/
41820,SARS‐CoV‐2 infection of human‐induced pluripotent stem cells‐derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088312/
41821,Comprehensive mapping of immune perturbations associated with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402634/
41822,New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993661/
41823,Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984030/
41824,Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/
41825,Updated insight into COVID-19 disease and health management to combat the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237642/
41826,SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671056/
41827,"Linkages between COVID-19, solar UV radiation, and the Montreal Protocol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062285/
41828,"COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986731/
41829,One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074502/
41830,Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400054/
41831,Acute Cardiac Events During COVID-19-Associated Hospitalizations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901494/
41832,Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516468/
41833,Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057798/
41834,Anticoagulants for people hospitalised with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895460/
41835,The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826539/
41836,A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528653/
41837,COVID‐19 disease and vaccination in pregnant and lactating women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111214/
41838,Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902244/
41839,Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753271/
41840,Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352718/
41841,J Exp Med. 2021 Oct 4; 218(10): jem.2021121108132021c. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493864/
41842,Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784975/
41843,Gut distress and intervention via communications of SARS-CoV-2 with mucosal exposome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150023/
41844,COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141344/
41845,Human cell receptors: potential drug targets to combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097256/
41846,Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632224/
41847,"Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466451/
41848,Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852243/
41849,Cell Rep. 2021 Jul 20; 36(3): 109414. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238659/
41850,COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375253/
41851,Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108100/
41852,Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749477/
41853,Neutrophils in COVID-19: Not Innocent Bystanders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199383/
41854,Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538086/
41855,"Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956496/
41856,Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135663/
41857,Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834523/
41858,Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID‐19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107240/
41859,Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252140/
41860,Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467311/
41861,"Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422376/
41862,COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183245/
41863,"Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154191/
41864,Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355083/
41865,"The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877231/
41866,Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647045/
41867,Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647025/
41868,"Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046427/
41869,"Systematic Guidelines for Effective Utilization of COVID-19 Databases in Genomic, Epidemiologic, and Clinical Research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059256/
41870,When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934603/
41871,"COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443335/
41872,Implications of preexisting asthma on COVID-19 pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143784/
41873,The prevention and treatment of COVID-19 in patients treated with hemodialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563282/
41874,Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799473/
41875,Assessment of a mass balance equation for estimating community-level prevalence of COVID-19 using wastewater-based epidemiology in a mid-sized city,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645338/
41876,Systemic corticosteroids for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406706/
41877,Cochrane Database Syst Rev. 2022; 2022(11): CD014963. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670242/
41878,New Insights into Potential Beneficial Effects of Bioactive Compounds of Bee Products in Boosting Immunity to Fight COVID-19 Pandemic: Focus on Zinc and Polyphenols,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912813/
41879,HDL cholesterol levels and susceptibility to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284176/
41880,"Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551651/
41881,Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498005/
41882,Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755516/
41883,Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501599/
41884,An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/
41885,COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046787/
41886,Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242686/
41887,Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143801/
41888,Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117163/
41889,nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083482/
41890,Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051392/
41891,Nasal sprays for treating COVID-19: a scientific note,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969373/
41892,Cardiovascular protective properties of oxytocin against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837104/
41893,Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292035/
41894,Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631336/
41895,SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364801/
41896,Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622117/
41897,"Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708617/
41898,Spectrum of COVID-19 induced liver injury: A review report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11056898/
41899,Hyperthrombotic Milieu in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694011/
41900,Outbreak of COVID-19: An emerging global pandemic threat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334916/
41901,"Diagnosing COVID‐19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323136/
41902,Food Safety and Employee Health Implications of COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906301/
41903,Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396366/
41904,JAMA Netw Open. 2022 Sep; 5(9): e2235424. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482051/
41905,Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742681/
41906,Hamster models of COVID-19 pneumonia reviewed: How human can they be?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207993/
41907,"Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621157/
41908,Preventative and therapeutic potential of animal milk components against COVID‐19: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261805/
41909,Vaccination-Associated Myocarditis and Myocardial Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171307/
41910,Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457875/
41911,Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582956/
41912,"Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399076/
41913,Role of ethno-phytomedicine knowledge in healthcare of COVID-19: advances in traditional phytomedicine perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362587/
41914,Organokines in COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216619/
41915,COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685720/
41916,Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658031/
41917,"Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744910/
41918,Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716022/
41919,Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622816/
41920,A Review on Currently Available Potential Therapeutic Options for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387864/
41921,Aptamer-Based Strategies to Address Challenges in COVID-19 Diagnosis and Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406522/
41922,Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537473/
41923,Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715325/
41924,"An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245675/
41925,Tracking the COVID-19 vaccines: The global landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101659/
41926,Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664001/
41927,Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451000/
41928,Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111797/
41929,Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404907/
41930,Nat Commun. 2022; 13: 2774. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120039/
41931,Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845038/
41932,The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226687/
41933,Socio-demographic Heterogeneity in Prevalence of SARS-COV-2 Infection and Death Rate: Relevance to Black College Student Knowledge of COVID-19 and SARS-COV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815385/
41934,Research progress of traditional Chinese medicine against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857050/
41935,Traditional Chinese medicine in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450055/
41936,Immunopathology of Hyperinflammation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484812/
41937,SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512529/
41938,Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027286/
41939,Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758763/
41940,"Investigation of a COVID-19 outbreak on the Charles de Gaulle aircraft carrier, March to April 2020: a retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137271/
41941,Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808353/
41942,Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119324/
41943,Monocytes and Macrophages in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335157/
41944,Impact of COVID-19 on the outcomes of gastrointestinal surgery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083095/
41945,Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989888/
41946,Potential Physiological and Cellular Mechanisms of Exercise That Decrease the Risk of Severe Complications and Mortality Following SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472997/
41947,IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807312/
41948,Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459192/
41949,"The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908443/
41950,Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601717/
41951,Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000463/
41952,Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601735/
41953,Coagulation Disorders in Sepsis and COVID-19—Two Sides of the Same Coin? A Review of Inflammation–Coagulation Crosstalk in Bacterial Sepsis and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866352/
41954,SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840920/
41955,A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823263/
41956,COVID‐19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta‐analysis of the relationship to CSF SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242764/
41957,Mechanisms of action of fluvoxamine for COVID-19: a historical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739627/
41958,Elements and COVID-19: A Comprehensive Overview of Studies on Their Blood/Urinary Levels and Supplementation with an Update on Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869171/
41959,Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810550/
41960,Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010738/
41961,The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305488/
41962,Pathophysiological mechanisms of thrombosis in acute and long COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709252/
41963,"SARS-CoV-2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685174/
41964,"Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912597/
41965,An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742215/
41966,"Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365905/
41967,Alcohol use disorder as a potential risk factor for COVID-19 severity: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722573/
41968,A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305344/
41969,The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815719/
41970,COVID-19 update: The race to therapeutic development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584885/
41971,COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777766/
41972,"Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500278/
41973,Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581726/
41974,Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099573/
41975,Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113594/
41976,Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198595/
41977,National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802/
41978,Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773891/
41979,Antiviral Therapy of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218869/
41980,Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446638/
41981,"New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981536/
41982,Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966717/
41983,Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126711/
41984,The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428603/
41985,The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062042/
41986,COVID-19 and Alzheimer’s disease: how one crisis worsens the other,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090526/
41987,Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132168/
41988,SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187021/
41989,Infection with SARS-CoV-2 can cause pancreatic impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014980/
41990,The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828435/
41991,Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429819/
41992,Immunity to SARS-CoV-2: Lessons Learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018176/
41993,"COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220438/
41994,"Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571424/
41995,Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734653/
41996,Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716413/
41997,"Biochemical composition, transmission and diagnosis of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350435/
41998,SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients: SARS-CoV-2 infection impairs islet function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037197/
41999,Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297082/
42000,Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016198/
42001,Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657033/
42002,Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546701/
42003,B lymphocytes in COVID-19: a tale of harmony and discordance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147999/
42004,COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142898/
42005,Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916836/
42006,Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667650/
42007,"Tackling the cytokine storm in COVID-19, challenges and hopes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832727/
42008,Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833668/
42009,"The Interplay of Lung Cancer, COVID-19, and Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738445/
42010,Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846644/
42011,Immunomodulatory Role of Microelements in COVID-19 Outcome: a Relationship with Nutritional Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170122/
42012,The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720170/
42013,The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040683/
42014,COVID-19 and solid organ transplantation: Finding the right balance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251959/
42015,Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553615/
42016,"The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416781/
42017,Wastewater surveillance of SARS-CoV-2 and chemical markers in campus dormitories in an evolving COVID − 19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795800/
42018,Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670186/
42019,Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732504/
42020,Know your enemy and know yourself – the case of SARS-CoV-2 host factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379091/
42021,Antibody-mediated neutralization of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118976/
42022,Clinical laboratory evaluation of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086377/
42023,Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336315/
42024,"COVID-19: inflammatory responses, structure-based drug design and potential therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782055/
42025,"A Review: Highlighting the Links between Epigenetics, COVID-19 Infection, and Vitamin D",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603374/
42026,Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471532/
42027,COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935450/
42028,COVID-19 and the pituitary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089131/
42029,Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282797/
42030,Tissue factor in COVID-19-associated coagulopathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525243/
42031,Pathophysiological Response to SARS-CoV-2 Infection Detected by Infrared Spectroscopy Enables Rapid and Robust Saliva Screening for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962262/
42032,Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084627/
42033,Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549041/
42034,"Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640235/
42035,Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018497/
42036,Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832503/
42037,"High-throughput approaches of diagnosis and therapies for COVID-19: antibody panels, proteomics and metabolomics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714045/
42038,"OMICRON: Virology, immunopathogenesis, and laboratory diagnosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350010/
42039,Neutralizing antibodies for the prevention and treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424621/
42040,Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730822/
42041,Potential strategies for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416802/
42042,COVID-19: Has the Liver Been Spared?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866733/
42043,"Discovery Proteomics
for COVID-19: Where We Are Now",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482317/
42044,COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413321/
42045,SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210449/
42046,Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322111/
42047,COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148927/
42048,Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289353/
42049,Cardiac Fibrosis Is a Risk Factor for Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569622/
42050,COVID-19 and thyroid function: What do we know so far?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806267/
42051,"Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798788/
42052,Neuroimmune disorders in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120100/
42053,SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418384/
42054,Animal Models for the Study of Neurologic Manifestations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948905/
42055,Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202832/
42056,TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095161/
42057,TIM3+TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685281/
42058,Evaluation of a Wastewater-Based Epidemiological Approach to Estimate the Prevalence of SARS-CoV-2 Infections and the Detection of Viral Variants in Disparate Oregon Communities at City and Neighborhood Scales,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241984/
42059,"An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357519/
42060,"COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196863/
42061,"The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057562/
42062,Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791004/
42063,Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075420/
42064,"Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161962/
42065,Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385172/
42066,COVID-19 convalescent plasma composition and immunological effects in severe patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826092/
42067,Seasonal UV exposure and vitamin D: association with the dynamics of COVID‐19 transmission in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653358/
42068,"A Prospective Cohort Study of COVID-19 Vaccination, SARS-CoV-2 Infection, and Fertility",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807200/
42069,Review on therapeutic targets for COVID-19: insights from cytokine storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016930/
42070,Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865578/
42071,N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738300/
42072,The interplay between the immune system and SARS-CoV-2 in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097254/
42073,COVID-19 and Sepsis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771020/
42074,SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416286/
42075,Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985038/
42076,Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886570/
42077,Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300748/
42078,Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504186/
42079,COVID-19 and the heart: what we have learnt so far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016902/
42080,Novel coronavirus mutations: Vaccine development and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561474/
42081,COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515781/
42082,"Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698370/
42083,Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980456/
42084,Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806999/
42085,"Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731678/
42086,Adv Ther. 2022; 39(5): 2281. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918596/
42087,Monitoring of SARS-CoV-2 in sewersheds with low COVID-19 cases using a passive sampling technique,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020515/
42088,An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731922/
42089,"Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886785/
42090,Pituitary and SARS CoV-2: An unremitting conundrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969757/
42091,SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079620/
42092,Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170572/
42093,Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408139/
42094,Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021940/
42095,Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237415/
42096,Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516879/
42097,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413721/
42098,mSystems. 2023 Mar-Apr; 8(2): e00927-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
42099,Attitude and Level of COVID-19 Vaccination among Women in Reproductive Age during the Fourth Pandemic Wave: A Cross-Sectional Study in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180577/
42100,Maternal Transmission of SARS-CoV-2: Safety of Breastfeeding in Infants Born to Infected Mothers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696119/
42101,Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880117/
42102,Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719300/
42103,Pseudoscience and fraudulent products for COVID-19 management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282830/
42104,"Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456276/
42105,Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551858/
42106,Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841511/
42107,Long-term neurologic outcomes of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671811/
42108,Implications of SARS‐CoV‐2 infection for neurogastroenterology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995160/
42109,Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635945/
42110,Can We Cryopreserve the Sperm of COVID-19 Patients During the Pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197193/
42111,"Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442988/
42112,Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558250/
42113,Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312028/
42114,Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156361/
42115,T Cells: Warriors of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664351/
42116,Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248499/
42117,Impact of COVID-19 on the Endocrine System: A Mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500009/
42118,"Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597285/
42119,Immunologic and Autoimmune-Related Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Clinical Symptoms and Mechanisms of Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086105/
42120,The Complex Association between COPD and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253799/
42121,Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675426/
42122,Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769394/
42123,"COVID-19 and chronic kidney disease: a comprehensive
review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428633/
42124,Positive association between outdoor air pollution and the incidence and severity of COVID-19. A review of the recent scientific evidences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378989/
42125,Exposure to avian coronavirus vaccines is associated with increased levels of SARS‐CoV‐2‐cross‐reactive antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467642/
42126,Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878030/
42127,"SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413106/
42128,Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021444/
42129,Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260046/
42130,Insights into biological therapeutic strategies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860937/
42131,T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957405/
42132,Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121138/
42133,Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934388/
42134,Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552808/
42135,COVID-19 vaccine: where are we now and where should we go?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898300/
42136,Cerebrovascular Disease in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385090/
42137,Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743779/
42138,Protons to Patients: targeting endosomal Na+/H+ exchangers against COVID‐19 and other viral diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646450/
42139,Neutrophils during SARS‐CoV‐2 infection: Friend or foe?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877900/
42140,Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461432/
42141,Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538099/
42142,Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180529/
42143,"Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645495/
42144,PNAS Nexus. 2024 Jan; 3(1): pgad477. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10825409/
42145,Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832981/
42146,Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064073/
42147,Severe asthma in the era of COVID-19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084617/
42148,The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248768/
42149,The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214323/
42150,"The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484810/
42151,"Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911975/
42152,The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384479/
42153,Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343376/
42154,The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026271/
42155,Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773180/
42156,Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146514/
42157,Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929476/
42158,Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238137/
42159,Differentiating COVID-19 and dengue from other febrile illnesses in co-epidemics: Development and internal validation of COVIDENGUE scores,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656151/
42160,Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997688/
42161,Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub–Saharan Africa: A prospective longitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942258/
42162,A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653843/
42163,Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586167/
42164,Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971992/
42165,"Abstract Book for the 27th Congress of the European Hematology
Association",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429973/
42166,An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938630/
42167,"Epidemiology and diagnosis, environmental resources quality and socio-economic perspectives for COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687413/
42168,Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832856/
42169,"Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898979/
42170,SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260486/
42171,Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218128/
42172,Complement activation in COVID-19 and targeted therapeutic options: A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338830/
42173,Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980688/
42174,Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107063/
42175,"A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/
42176,The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636940/
42177,Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646640/
42178,A systematic review of current status and challenges of vaccinating children against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557115/
42179,Multidimensional futuristic approaches to address the pandemics beyond COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257889/
42180,Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272948/
42181,COVID-19: A promising cure for the global panic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128376/
42182,Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833882/
42183,SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128218/
42184,Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836341/
42185,"Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054532/
42186,Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206563/
42187,Drugs for COVID-19: An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740261/
42188,Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224751/
42189,Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995004/
42190,Current status of potential therapeutic candidates for the COVID-19 crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175848/
42191,"Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732402/
42192,Localized delivery of nanomedicine and antibodies for combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502448/
42193,Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267033/
42194,Association of SARS-CoV-2 presence in sewage with public adherence to precautionary measures and reported COVID-19 prevalence in Tehran,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697476/
42195,Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119876/
42196,Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewersheds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879159/
42197,SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102605/
42198,COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676802/
42199,Nanobioengineering: A promising approach for early detection of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335015/
42200,"Musculoskeletal Manifestations of COVID-19: Currently Described
Clinical Symptoms and Multimodality Imaging Findings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341171/
42201,Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867096/
42202,In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491932/
42203,"Hypertension, a Moving Target in COVID-19: Current Views and Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011346/
42204,SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135402/
42205,Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393104/
42206,An outlook on potential protein targets of COVID-19 as a druggable site,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256362/
42207,"Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869061/
42208,Next-Generation Sequencing Reveals the Progression of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991797/
42209,"Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660177/
42210,Pregnancy and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686875/
42211,A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237953/
42212,Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221624/
42213,The COVID-19 pandemic: a global health crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686876/
42214,Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069977/
42215,"Long-term Lung Abnormalities Associated with COVID-19
Pneumonia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462591/
42216,Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342588/
42217,Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409275/
42218,SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452867/
42219,COVID-19 and corticosteroids: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106274/
42220,SARS-CoV-2-reactive IFN-γ-producing CD4+ and CD8+ T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395536/
42221,Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268645/
42222,Utilizing Electrochemical-Based Sensing Approaches for the Detection of SARS-CoV-2 in Clinical Samples: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312918/
42223,Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646827/
42224,Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126690/
42225,New Onset of Autoimmune Diseases Following COVID-19 Diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700122/
42226,Immunological Approaches to the Treatment of New Coronavirus Infection (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482822/
42227,Multisystem screening reveals SARS‐CoV‐2 in neurons of the myenteric plexus and in megakaryocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325073/
42228,Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900892/
42229,What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837315/
42230,Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384365/
42231,Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364317/
42232,Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611096/
42233,Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738776/
42234,Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313152/
42235,"A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774670/
42236,"Potential SARS-CoV-2 vaccines: Concept, progress, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006194/
42237,High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075475/
42238,Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541834/
42239,Cardiovascular complications of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410051/
42240,"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099315/
42241,Lancet. 2021 17-23 July; 398(10296): 212. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285114/
42242,Platelets contribute to disease severity in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646651/
42243,"COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684224/
42244,Biomarkers of ageing and frailty may predict COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611822/
42245,Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679329/
42246,The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516881/
42247,Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238659/
42248,Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489278/
42249,SARS-CoV-2 infection and COVID-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931577/
42250,Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712848/
42251,The central role of neutrophil extracellular traps (NETs) and by‐products in COVID‐19 related pulmonary thrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461423/
42252,Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724067/
42253,Immunological and physiopathological approach of COVID-19 in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093597/
42254,The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020811/
42255,Chronic Rhinosinusitis and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926942/
42256,People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636386/
42257,Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921094/
42258,Targeting a free viral fraction enhances the early alert potential of wastewater surveillance for SARS-CoV-2: a methods comparison spanning the transition between delta and omicron variants in a large urban center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400354/
42259,New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850309/
42260,A systematic review on SARS‐CoV‐2‐associated fungal coinfections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661750/
42261,COVID-19 induced Diabetes: A novel presentation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355745/
42262,Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182089/
42263,Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502216/
42264,"Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372492/
42265,COVID-19 in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808705/
42266,Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410018/
42267,Angiotensin-Converting Enzyme 2-Based Biosensing Modalities and Devices for Coronavirus Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688389/
42268,SARS-CoV-2 Initiates Programmed Cell Death in Platelets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409903/
42269,Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023084/
42270,"Neutrophil Extracellular Traps, Sepsis and COVID-19 – A Tripod Stand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226304/
42271,Nano-Enabled COVID-19 Vaccines – Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029448/
42272,Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005345/
42273,COVID-19 Vaccines: Current and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025326/
42274,COVID-19 and cancer: start the resolution!,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860263/
42275,Environmental challenges of COVID-19 pandemic: resilience and sustainability – A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576205/
42276,Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929547/
42277,Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815083/
42278,Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718518/
42279,Primed for global coronavirus pandemic: Emerging research and clinical outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501876/
42280,A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547312/
42281,Importance of Magnesium Status in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215232/
42282,"Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646410/
42283,Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274757/
42284,Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588584/
42285,"Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142625/
42286,"Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493723/
42287,The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266848/
42288,Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452420/
42289,A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171306/
42290,"The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389822/
42291,Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833904/
42292,Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226495/
42293,Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790847/
42294,Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409133/
42295,Epidemiology and clinical features of SARS-CoV-2 infection in children and adolescents in the pre-Omicron era: A global systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10902805/
42296,Immunology of SARS-CoV-2 infections and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429035/
42297,"Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692185/
42298,Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290182/
42299,Identification of Transcription Factors Regulating SARS-CoV-2 Tropism Factor Expression by Inferring Cell-Type-Specific Transcriptional Regulatory Networks in Human Lungs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026071/
42300,Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP:TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132835/
42301,"Genome-Wide B-Cell, CD4+ and CD8+ T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Pre-Emptive Pan-Coronavirus Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722450/
42302,Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107283/
42303,Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858946/
42304,Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777559/
42305,Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325622/
42306,Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960989/
42307,Immune profiling of COVID-19: preliminary findings and implications for the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108128/
42308,Advances in gene-based vaccine platforms to address the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789827/
42309,Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523015/
42310,Fomites and the environment did not have an important role in COVID-19 transmission in a Brazilian mid-sized city,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342429/
42311,Looking at COVID-19 from a Systems Biology Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961533/
42312,Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837232/
42313,Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890022/
42314,Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059115/
42315,Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760112/
42316,The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226610/
42317,COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101987/
42318,Insights on Covid‐19 with superimposed pulmonary histoplasmosis: The possible nexus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540147/
42319,Hypercoagulability of COVID-19 and Neurological Complications: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547944/
42320,COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910221/
42321,Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711057/
42322,Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231170/
42323,Molecules. 2023 Nov; 28(21): 7337. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649723/
42324,Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127183/
42325,Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676175/
42326,Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436482/
42327,The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305049/
42328,Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592180/
42329,Coronavirus Disease 2019 in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193095/
42330,A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259013/
42331,COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067136/
42332,Brain Behav Immun. 2024 Jan; 115: 758. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021210/
42333,"Transmission of SARS-CoV-2 from mother to fetus or
neonate: What to know and what to do?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010052/
42334,COVID-19: Myths and Reality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265000/
42335,On the whereabouts of SARS-CoV-2 in the human body: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679000/
42336,"Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409845/
42337,Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171311/
42338,"COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943223/
42339,Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874507/
42340,"Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675490/
42341,"A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179092/
42342,SARS-CoV-2 and cancer: Are they really partners in crime?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351667/
42343,"SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404682/
42344,Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921795/
42345,Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368904/
42346,Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119395/
42347,Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456726/
42348,Neurological associations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332267/
42349,Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413099/
42350,"The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326733/
42351,Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398861/
42352,Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983412/
42353,Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808699/
42354,Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194484/
42355,Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035683/
42356,Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753785/
42357,Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115405/
42358,COVID-19-Related Brain Injury: The Potential Role of Ferroptosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994634/
42359,"COVID‐19 vaccinations: The unknowns, challenges, and hopes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015467/
42360,Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580499/
42361,Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321495/
42362,SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057594/
42363,Candesartan could ameliorate the COVID-19 cytokine storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439834/
42364,Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554200/
42365,Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116486/
42366,IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418717/
42367,Commun Biol. 2021; 4: 290. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935909/
42368,COVID-19 disease and autoimmune disorders: A mutual pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350728/
42369,The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030970/
42370,Longitudinal monitoring of SARS-CoV-2 in wastewater using viral genetic markers and the estimation of unconfirmed COVID-19 cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743272/
42371,Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733958/
42372,Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824626/
42373,Neutrophil extracellular traps and long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565006/
42374,Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653009/
42375,A Review of the Presence of SARS-CoV-2 in Wastewater: Transmission Risks in Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324675/
42376,Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374569/
42377,Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304875/
42378,Surveillance for SARS‐CoV‐2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880705/
42379,Recent advances in the diagnosis of COVID-19: a bird’s eye view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938659/
42380,Parkinson’s Disease and the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150477/
42381,"SARS‐CoV‐2 infection, COVID‐19 pathogenesis, and exposure to air pollution: What is the connection?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675684/
42382,High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687121/
42383,Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829441/
42384,Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441838/
42385,"Promising natural products against SARS‐CoV‐2: Structure, function, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538226/
42386,Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238396/
42387,"The COVID-19 pandemic, an environmental neurology perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938187/
42388,Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804842/
42389,Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/
42390,SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910743/
42391,Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226500/
42392,Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639419/
42393,"Ambient Air Pollution in Relation to SARS-CoV-2 Infection, Antibody Response, and COVID-19 Disease: A Cohort Study in Catalonia, Spain (COVICAT Study)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597405/
42394,COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878380/
42395,Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865633/
42396,High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152668/
42397,COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596942/
42398,COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998583/
42399,"SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143972/
42400,Repurposing anticancer drugs for the management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508523/
42401,Point-of-Care Devices for Viral Detection: COVID-19 Pandemic and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535693/
42402,Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194714/
42403,Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135696/
42404,"The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939769/
42405,mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511551/
42406,Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411527/
42407,Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295749/
42408,Analysis of the effect of cytomegalovirus infection in clinical outcomes and prolonged duration of SARS-CoV-2 shedding in intensive care unit patients with COVID-19 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640799/
42409,"Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738873/
42410,Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050884/
42411,The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535197/
42412,NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613976/
42413,Trained Immunity: An Overview and the Impact on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891531/
42414,Post‐hospitalization rehabilitation alleviates long‐term immune repertoire alteration in COVID‐19 convalescent patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542649/
42415,"Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453465/
42416,Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314259/
42417,Recent biotechnological advances as potential intervention strategies against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796695/
42418,Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161360/
42419,COVID-19 and HSCT (Hematopoietic stem cell transplant),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547387/
42420,"Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309048/
42421,Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240959/
42422,"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293463/
42423,Convalescent plasma for people with COVID‐19: a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891348/
42424,Cochrane Database Syst Rev. 2023; 2023(5): CD013600. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171886/
42425,COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459551/
42426,Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255361/
42427,"Interactions of Renin-Angiotensin System and COVID-19: The Importance of Daily Rhythms in ACE2, ADAM17 and TMPRSS2 Expression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884363/
42428,Antibody Responses in COVID-19: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081880/
42429,Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025828/
42430,Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095160/
42431,"Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105035/
42432,Space-time analysis of COVID-19 cases and SARS-CoV-2 wastewater loading: A geodemographic perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142176/
42433,Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031702/
42434,Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811630/
42435,"Digestive system infection by SARS-CoV-2: Entry mechanism, clinical symptoms and expression of major receptors (Review)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911086/
42436,"Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388682/
42437,COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213508/
42438,Neurological complications after COVID-19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700397/
42439,Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698532/
42440,Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233550/
42441,"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301183/
42442,COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674414/
42443,Liver injury in the era of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856845/
42444,The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503434/
42445,COVID-19: an update on diagnostic and therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196187/
42446,Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423878/
42447,"SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104783/
42448,Recent advances in point of care testing for COVID-19 detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371983/
42449,Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346797/
42450,Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160963/
42451,Revealing the mystery of persistent smell loss in Long COVID patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305264/
42452,"Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406387/
42453,Forensic Sci Med Pathol. 2022; 18(1): 120. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671035/
42454,Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645832/
42455,Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866527/
42456,Medications for early treatment of COVID‐19 in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828711/
42457,Inflammasome activation in infected macrophages drives COVID-19 pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288243/
42458,Multidistrict Host–Pathogen Interaction during COVID-19 and the Development Post-Infection Chronic Inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607297/
42459,Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665859/
42460,DOCK2 is involved in the host genetics and biology of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492544/
42461,Integrative COVID-19 biological network inference with probabilistic core decomposition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689992/
42462,Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088080/
42463,The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173764/
42464,"Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022834/
42465,Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882037/
42466,mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452492/
42467,Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426976/
42468,Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993231/
42469,8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093219/
42470,"COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
42471,Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039152/
42472,COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035598/
42473,Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542887/
42474,Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886571/
42475,Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181835/
42476,The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126380/
42477,Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948269/
42478,ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100737/
42479,Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779084/
42480,"“Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563589/
42481,Role of the humoral immune response during COVID-19: guilty or not guilty?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530436/
42482,Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022): Updated statement of the Austrian Society of Pneumology (ASP),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022736/
42483,SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858686/
42484,The role of berberine in Covid-19: potential adjunct therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526677/
42485,"SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134119/
42486,"Kidney injury in COVID-19 patients, drug development and their renal complications: Review study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313500/
42487,Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338166/
42488,Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261892/
42489,Enhanced SARS-CoV-2-Specific CD4+ T Cell Activation and Multifunctionality in Late Convalescent COVID-19 Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954911/
42490,Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902850/
42491,The COVID-19 Pandemic and Explaining Outcomes in Africa: Could Genomic Variation Add to the Debate?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700373/
42492,In-line treatments and clinical initiatives to fight against COVID-19 outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567661/
42493,Viral coinfections in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242380/
42494,Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544568/
42495,"Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145892/
42496,"Prospective surveillance study in a 1,400‐bed university hospital: COVID‐19 exposure at home was the main risk factor for SARS‐CoV‐2 point seroprevalence among hospital staff",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014017/
42497,COVID-19 and hypopituitarism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363093/
42498,The impact of COVID-19 on liver transplantation programs in Austria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651874/
42499,COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536649/
42500,Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759055/
42501,COVID-19 and cerebrovascular diseases: a comprehensive overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727052/
42502,Association of vitamin D status with COVID-19 and its severity: Vitamin D and COVID-19: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724612/
42503,Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515795/
42504,Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769538/
42505,The COVID-19 pandemic: a threat to antimicrobial resistance containment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204817/
42506,Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654598/
42507,The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944866/
42508,Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/
42509,The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426503/
42510,Patients with COVID-19: in the dark-NETs of neutrophils,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142290/
42511,"COVID-19–associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791309/
42512,Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785763/
42513,Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324317/
42514,Extrapulmonary Clinical Manifestations in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646754/
42515,SARS-CoV-2 Infection and COVID-19 in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678836/
42516,Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606168/
42517,Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569495/
42518,Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801440/
42519,"A mid-pandemic night's dream: Melatonin, from harbinger of anti-inflammation to mitochondrial savior in acute and long COVID-19 (Review)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852014/
42520,Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608434/
42521,"Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275579/
42522,COVID-19 Therapeutic Options Under Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424051/
42523,Smoking and COVID-19: Adding Fuel to the Flame,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555793/
42524,"Comparative study of six SARS-CoV-2 serology assays: Diagnostic
performance and antibody dynamics in a cohort of hospitalized patients for
moderate to critical COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819577/
42525,The state of complement in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672651/
42526,The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974355/
42527,Long Term Immune Response Produced by the SputnikV Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537212/
42528,Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101257/
42529,"SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400328/
42530,Bidirectional association between COVID-19 and the environment: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833965/
42531,COVID-19: potential therapeutics for pediatric patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403523/
42532,COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397302/
42533,"VIP plasma levels associate with survival in severe COVID‐19 patients, correlating with protective effects in SARS‐CoV‐2‐infected cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088587/
42534,Dental Healthcare Amid the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583530/
42535,"Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710271/
42536,ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282004/
42537,"Detecting COVID-19 from Breath: A Game Changer for
a Big Challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043202/
42538,Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135759/
42539,COVID-19 and the Differences in Physiological Background Between Children and Adults and Their Clinical Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884370/
42540,Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389579/
42541,COVID-19 2022 update: transition of the pandemic to the endemic phase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156835/
42542,TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061140/
42543,What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652765/
42544,Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484582/
42545,Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622026/
42546,"Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787827/
42547,Challenges and future opportunities to unlock the critical supply chain of personal and protective equipment (PPE) encompassing decontamination and reuse under emergency use authorization (EUA) conditions during the COVID-19 pandemic: Through a reflective circularity and sustainability lens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815879/
42548,"Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964607/
42549,In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naïve B cells as a trigger for severe immune responses in the lungs of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710067/
42550,"The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911459/
42551,"Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992516/
42552,"SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966413/
42553,Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969450/
42554,"Treatment of COVID-19 by stage: any space left for mesenchymal stem
cell therapy?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127835/
42555,"COVID‐19: Virology, biology and novel laboratory diagnosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883242/
42556,A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635721/
42557,"A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811158/
42558,"Insight into COVID-19's epidemiology, pathology, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767941/
42559,B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358275/
42560,The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071774/
42561,Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445433/
42562,PLoS Pathog. 2022 Jan; 18(1): e1010220. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730411/
42563,"Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652692/
42564,More than a key—the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062797/
42565,Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549388/
42566,Intranasal COVID-19 vaccines: From bench to bed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/
42567,The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834135/
42568,SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228931/
42569,COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870718/
42570,Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631495/
42571,COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080053/
42572,Immune response variables and viral mutations impact on COVID-19 reinfection and relapse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423905/
42573,Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101789/
42574,The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933453/
42575,Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373136/
42576,A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436716/
42577,SARS-CoV-2 reinfection and implications for vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641611/
42578,COVID-19 Coagulopathy: From Pathogenesis to Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059042/
42579,"Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342011/
42580,Potential metal-related strategies for prevention and treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761834/
42581,Vaccine design and delivery approaches for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380485/
42582,Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900773/
42583,Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393109/
42584,"A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762623/
42585,Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681929/
42586,"Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169570/
42587,Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418288/
42588,Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579188/
42589,Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099545/
42590,Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267234/
42591,"COVID‐19: Risk Factors Associated with Infectivity and
Severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265317/
42592,COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816622/
42593,Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199540/
42594,Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642871/
42595,New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683562/
42596,Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130711/
42597,The Many Faces of JAKs and STATs Within the COVID-19 Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313986/
42598,The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027942/
42599,Novel approaches for rapid detection of COVID-19 during the pandemic: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406551/
42600,Involvement of the nervous system in COVID-19: The bell should toll in the brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537730/
42601,A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177430/
42602,Complement dysregulation is associated with severe COVID-19 illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052917/
42603,Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813941/
42604,SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409030/
42605,Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084634/
42606,COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436872/
42607,A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810755/
42608,Mechanisms contributing to adverse outcomes of COVID-19 in obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793096/
42609,The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492747/
42610,"Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499629/
42611,"Surveillance of SARS-CoV-2 in nine neighborhood sewersheds in Detroit Tri-County area, United States: Assessing per capita SARS-CoV-2 estimations and COVID-19 incidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419442/
42612,SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524640/
42613,The Oral Cavity Potentially Serving as a Reservoir for SARS-CoV-2 but Not Necessarily Facilitating the Spread of COVID-19 in Dental Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329531/
42614,Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Through Solid Organ Transplantation and Outcomes of Coronavirus Disease 2019 Among Recent Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297154/
42615,Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841804/
42616,"SARS-CoV-2 and other pathogens in municipal wastewater, landfill leachate, and solid waste: A review about virus surveillance, infectivity, and inactivation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332740/
42617,Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046575/
42618,Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467281/
42619,Immunological map in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114810/
42620,"Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958317/
42621,Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863214/
42622,Covid‐19 and SARS‐CoV‐2 infection in periodontology: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350118/
42623,Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934739/
42624,COVID-19: Relationship and Impact on Breastfeeding—A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470649/
42625,Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511881/
42626,Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479532/
42627,Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050587/
42628,Long COVID: Molecular Mechanisms and Detection Techniques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10778767/
42629,Androgenetic alopecia and COVID‐19: A review of the hypothetical role of androgens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209856/
42630,"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367812/
42631,SARS-CoV-2 incidence in secondary schools; the role of national and school-initiated COVID-19 measures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294357/
42632,Biological effects of COVID-19 on lung cancer: Can we drive our decisions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589049/
42633,A review of mass spectrometry‐based analyses to understand COVID‐19 convalescent plasma mechanisms of action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349457/
42634,The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766975/
42635,Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825841/
42636,Comparison of Vitamin D and Resveratrol Performances in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255599/
42637,Defining the role of natural killer cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538371/
42638,ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes – evidence from a translational clinical and experimental approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679867/
42639,mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179023/
42640,SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10705665/
42641,Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127497/
42642,Anticoagulant therapy in COVID‐19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499427/
42643,Host polymorphisms and COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381193/
42644,Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791638/
42645,"A narrative review on the role of temperature and humidity in COVID-19: Transmission, persistence, and epidemiological evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181277/
42646,SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819734/
42647,Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268312/
42648,Therapeutic advances in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574806/
42649,Nat Rev Nephrol. 2023; 19(4): 273. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901371/
42650,Mesenchymal Stem Cells in the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573267/
42651,Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/
42652,A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546647/
42653,IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520788/
42654,The Effects of COVID-19 on the Placenta During Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479199/
42655,Front Immunol. 2022; 13: 998406. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496642/
42656,Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800937/
42657,"Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538373/
42658,Current challenges and perspectives in lung cancer care during COVID-19 waves,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241323/
42659,SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of “the New Normal with COVID-19”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235682/
42660,Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027624/
42661,"Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857265/
42662,"Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941865/
42663,Structural biology of SARS-CoV-2: open the door for novel therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793099/
42664,Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447809/
42665,Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646697/
42666,COVID-19 and dengue coinfection in Latin America: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613782/
42667,"SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942583/
42668,C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268051/
42669,Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445447/
42670,"Chest CT in COVID-19: What the Radiologist Needs to
Know",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587296/
42671,Radiographics. 2022 Jan; 42(1): E32. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756353/
42672,Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026850/
42673,COVID-19 and autoimmune diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880581/
42674,"A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708628/
42675,Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927227/
42676,"Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773838/
42677,Druggable targets and therapeutic development for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581228/
42678,SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314866/
42679,COVID-19 Diagnosis: Current and Future Techniques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585557/
42680,SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779393/
42681,Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853984/
42682,An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415881/
42683,Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260991/
42684,"Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012322/
42685,Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127128/
42686,Detection and Molecular Characterization of the SARS-CoV-2 Delta Variant and the Specific Immune Response in Companion Animals in Switzerland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864232/
42687,Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006938/
42688,Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420435/
42689,Human genetic basis of severe or critical illness in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530247/
42690,Clinical Characteristics of Coronavirus Disease (COVID-19) in Mexican Children and Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611217/
42691,Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108257/
42692,COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552777/
42693,Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893150/
42694,Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468567/
42695,Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011898/
42696,Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773957/
42697,"Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742988/
42698,"Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826004/
42699,Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687760/
42700,A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337507/
42701,Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510150/
42702,Immune-based therapeutic approaches in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108029/
42703,"Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880237/
42704,Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012486/
42705,"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164881/
42706,Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021367/
42707,"Aging, inflammaging and immunosenescence as risk factors of severe COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650172/
42708,Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions—Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864905/
42709,SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420197/
42710,Type I interferons and SARS-CoV-2: from cells to organisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786610/
42711,"Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218760/
42712,"Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988546/
42713,SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220855/
42714,Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775685/
42715,Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587204/
42716,"Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942612/
42717,Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389743/
42718,Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977306/
42719,The role of Interleukin 6 inhibitors in therapy of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455113/
42720,Epidemiological and clinical characteristics of pregnant women and neonates with COVID‐19 in Northwest Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348056/
42721,Insights Into the Changing Landscape of Coronavirus Disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784834/
42722,COVID-19–Induced New-Onset Diabetes: Trends and Technologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660988/
42723,Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336126/
42724,Early warning of a COVID-19 surge on a university campus based on wastewater surveillance for SARS-CoV-2 at residence halls,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788089/
42725,Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164151/
42726,An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315735/
42727,Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824221/
42728,Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022880/
42729,Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381983/
42730,A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524440/
42731,The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225309/
42732,Advances in immunotherapy for COVID-19: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826020/
42733,COVID-19: from epidemiology to treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279517/
42734,First report on prevalence of SARS-CoV-2 infection among health-care workers in Nicaragua,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840011/
42735,Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072392/
42736,Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881590/
42737,Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558244/
42738,Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529231/
42739,"SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877664/
42740,Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502275/
42741,Immunology of SARS-CoV-2 infections in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981222/
42742,SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085785/
42743,Nat Commun. 2022; 13: 3139. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153867/
42744,Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538178/
42745,SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969448/
42746,SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/
42747,Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609612/
42748,DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096336/
42749,Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457011/
42750,Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717185/
42751,Genome‐wide screening of SARS‐CoV‐2 infection‐related genes based on the blood leukocytes sequencing data set of patients with COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242610/
42752,Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250669/
42753,"SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396141/
42754,Modifiable contributing factors to COVID-19: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/
42755,"Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208434/
42756,Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869493/
42757,"COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979375/
42758,COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312984/
42759,Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641215/
42760,Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
42761,RdRp inhibitors and COVID-19: Is molnupiravir a good option?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654603/
42762,Wastewater-based prediction of COVID-19 cases using a highly sensitive SARS-CoV-2 RNA detection method combined with mathematical modeling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824953/
42763,Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628159/
42764,Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323836/
42765,"COVID-19 Infections in Gonads: Consequences on
Fertility?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363149/
42766,Detailed stratified GWAS analysis for severe COVID-19 in four European populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703941/
42767,Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199303/
42768,A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776350/
42769,Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697230/
42770,"SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125301/
42771,Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552625/
42772,Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413162/
42773,Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533477/
42774,Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017719/
42775,Cytokines and microRNAs in SARS-CoV-2: What do we know?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233348/
42776,Demographics of COVID-19 hospitalisations and related fatality risk patterns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308136/
42777,Targeting ACLY efficiently inhibits SARS-CoV-2 replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305265/
42778,Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366271/
42779,Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379609/
42780,Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232454/
42781,Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869442/
42782,Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373048/
42783,Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288220/
42784,Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725157/
42785,Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215557/
42786,EClinicalMedicine. 2021 Nov; 41: 101168. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527185/
42787,Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052011/
42788,The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678390/
42789,SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512652/
42790,The COVID-19 pandemic in the African continent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059455/
42791,"Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094970/
42792,"COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068343/
42793,Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320437/
42794,Cancer management during the COVID-19 world pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10992624/
42795,COVID-19 Vaccine Platforms: Challenges and Safety Contemplations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537163/
42796,"A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868442/
42797,Post-acute COVID-19 syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924706/
42798,Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343371/
42799,SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935273/
42800,Platelet gene expression and function in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483430/
42801,Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296373/
42802,One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139306/
42803,COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214153/
42804,High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501786/
42805,A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441836/
42806,Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484857/
42807,Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348444/
42808,What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391172/
42809,Complement Activation in Kidneys of Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878379/
42810,BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962543/
42811,Omicron variant: Current insights and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482093/
42812,A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865603/
42813,COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247904/
42814,SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656179/
42815,Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929412/
42816,A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502533/
42817,The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706237/
42818,"SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291226/
42819,The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603679/
42820,Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249675/
42821,"Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400529/
42822,Tissue-Specific Immunopathology in Fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874430/
42823,Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763260/
42824,"SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554396/
42825,Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111424/
42826,Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199351/
42827,"The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221499/
42828,COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845520/
42829,"SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968901/
42830,Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179190/
42831,Cell therapy strategies for COVID-19: Current approaches and potential applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357240/
42832,CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID‐19 therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880667/
42833,"Targeting SARS-CoV-2
Proteases and Polymerase
for COVID-19 Treatment: State of the Art and Future Opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688049/
42834,Application of neighborhood-scale wastewater-based epidemiology in low COVID-19 incidence situations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436825/
42835,A multistate assessment of population normalization factors for wastewater-based epidemiology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096268/
42836,An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342586/
42837,Knowledge deficit and fear of COVID-19 among higher education students during the first wave of the pandemic and implications for public health: a multi-country cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172614/
42838,Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279859/
42839,Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258412/
42840,"Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131019/
42841,Long Covid: where we stand and challenges ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449925/
42842,Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406394/
42843,The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861788/
42844,COVID-19 in children: epidemic issues and candidate vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433085/
42845,Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769582/
42846,Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577202/
42847,"Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531997/
42848,Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371510/
42849,"Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757655/
42850,"Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545713/
42851,Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108634/
42852,"Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278180/
42853,Advances in clinical outcomes: What we have learned during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704728/
42854,SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647896/
42855,Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045417/
42856,Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634761/
42857,SARS-CoV-2 viral liver aggregates and scarce parenchymal infection implicate systemic disease as a driver of abnormal liver function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615432/
42858,The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842579/
42859,Sequential development of several RT‐qPCR tests using LNA nucleotides and dual probe technology to differentiate SARS‐CoV‐2 from influenza A and B,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111289/
42860,Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500013/
42861,Sci Rep. 2023; 13: 22513. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728131/
42862,The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784815/
42863,FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977684/
42864,Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193598/
42865,American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/
42866,Animal Models of COVID-19 II. Comparative Immunology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135340/
42867,The effects of COVID-19 on placental morphology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191727/
42868,Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892464/
42869,SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653322/
42870,Personalized therapy: can it tame the COVID-19 monster?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519185/
42871,Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456184/
42872,Reactivation of SARS-CoV-2 infection following recovery from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869688/
42873,Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385093/
42874,Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104435/
42875,Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878976/
42876,Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807711/
42877,SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073203/
42878,Drug Discovery Strategies for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569306/
42879,"The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009220/
42880,Glucocorticoids and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556882/
42881,"Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064502/
42882,Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241827/
42883,Complement Factors in COVID-19 Therapeutics and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733687/
42884,The COVID-19 pandemic: diverse contexts; different epidemics—how and why?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392634/
42885,The intestinal microbiota and improving the efficacy of COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578005/
42886,"Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946455/
42887,Coronary microvascular dysfunction pathophysiology in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236988/
42888,SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563343/
42889,Cell Rep. 2022 Jun 14; 39(11): 110968. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195561/
42890,COVID-19–Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149203/
42891,Plasma ACE2 species are differentially altered in COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441911/
42892,FASEB J. 2021 Sep; 35(9): e21857. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565610/
42893,Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091641/
42894,COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713605/
42895,"Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403331/
42896,"An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573837/
42897,The impact of infection with COVID-19 on the respiratory microbiome: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794016/
42898,Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094732/
42899,"Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566417/
42900,SARS-CoV-2 primed platelets–derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614402/
42901,Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007751/
42902,"Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690242/
42903,Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923949/
42904,In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354838/
42905,The way of SARS-CoV-2 vaccine development: success and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575680/
42906,Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994612/
42907,SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598911/
42908,COVID-19—from mucosal immunology to IBD patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893623/
42909,Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278827/
42910,Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941073/
42911,A review on detection of SARS-CoV-2 RNA in wastewater in light of the current knowledge of treatment process for removal of viral fragments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373619/
42912,"Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473425/
42913,Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155889/
42914,A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362596/
42915,Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071111/
42916,Immune Responses against SARS-CoV-2—Questions and Experiences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533170/
42917,Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726723/
42918,Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404249/
42919,COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404102/
42920,Precision therapeutic targets for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006140/
42921,Recent Advances in Novel Lateral Flow Technologies for Detection of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466143/
42922,Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983822/
42923,Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738208/
42924,"Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835928/
42925,Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031507/
42926,Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384731/
42927,Comprehensive Landscape of Heparin Therapy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581413/
42928,A comprehensive review on current COVID-19 detection methods: From lab care to point of care diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302821/
42929,A Pilot Study to Examine If Dietary Habits Can Affect Symptomology in Mild Pre-Vaccination COVID-19 Cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495586/
42930,SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423489/
42931,Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416209/
42932,Z Gastroenterol. 2020 Jul; 58(7): e367. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560976/
42933,Evaluation and limitations of different approaches among COVID-19 fatal cases using whole-exome sequencing data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830622/
42934,"Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059134/
42935,SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307803/
42936,Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452524/
42937,"Robust, persistent adaptive immune responses to SARS-CoV-2 in the oropharyngeal lymphoid tissue of children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963700/
42938,Nat Immunol. 2023 Jan; 24(1): 186–199. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10777159/
42939,Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162478/
42940,Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898160/
42941,Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350903/
42942,SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526006/
42943,Immune signatures underlying post-acute COVID-19 lung sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763087/
42944,The fight against COVID-19: Striking a balance in the renin–angiotensin system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049177/
42945,"Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364646/
42946,Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436399/
42947,Diagnostic techniques for COVID-19: A mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684097/
42948,How Does SARS-CoV-2 Affect Our Eyes—What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225256/
42949,Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768197/
42950,"Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342790/
42951,Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981268/
42952,An overview of human proteins and genes involved in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437745/
42953,Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630139/
42954,Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062931/
42955,Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282104/
42956,Clin Infect Dis. 2021 Aug 6 : ciab687. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436392/
42957,"Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357514/
42958,Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955763/
42959,Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827164/
42960,"Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705351/
42961,Cell-based passive immunization for protection against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629160/
42962,Testosterone and Covid‐19: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537909/
42963,Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779348/
42964,Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893330/
42965,Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404694/
42966,Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548030/
42967,Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905965/
42968,Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440318/
42969,Association Between What People Learned About COVID-19 Using Web Searches and Their Behavior Toward Public Health Guidelines: Empirical Infodemiology Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415385/
42970,"Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788851/
42971,Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646060/
42972,Immune response induced by novel coronavirus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641212/
42973,COVID-19 and neurologic manifestations: a synthesis from the child neurologist’s corner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044375/
42974,Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965458/
42975,"Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674074/
42976,"Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034058/
42977,SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844210/
42978,The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497461/
42979,COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024517/
42980,"Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480054/
42981,Sci Rep. 2021; 11: 13308. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233421/
42982,Clinical progress in MSC-based therapies for the management of severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259053/
42983,The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824166/
42984,Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202122/
42985,Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697563/
42986,"Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571905/
42987,Gut microbiota and COVID‐19: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881458/
42988,Health Sci Rep. 2023 Jul; 6(7): e1460. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368937/
42989,High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898096/
42990,Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719840/
42991,Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637636/
42992,Distinctive features of severe SARS-CoV-2 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279580/
42993,Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670242/
42994,"Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718396/
42995,Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121454/
42996,Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11098804/
42997,Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265855/
42998,Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372478/
42999,Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313818/
43000,Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889115/
43001,Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695108/
43002,Innate and adaptive immunity to SARS-CoV-2 and predisposing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203583/
43003,Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712944/
43004,COVID-19: A review of therapeutic strategies and vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670907/
43005,Persistence of SARS-CoV-2 RNA in wastewater after the end of the COVID-19 epidemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800135/
43006,Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026643/
43007,"Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874959/
43008,Current state-of-the-art and potential future therapeutic drugs against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485263/
43009,Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617268/
43010,Host genetic factors determining COVID-19 susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512556/
43011,Preoperative SARS-CoV-2 infection increases risk of early postoperative cardiovascular complications following noncardiac surgery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151044/
43012,"Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569991/
43013,A reasoned approach towards administering COVID‐19 vaccines to pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362094/
43014,Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855610/
43015,Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022339/
43016,"Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291337/
43017,"SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620514/
43018,Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671886/
43019,Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389076/
43020,Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951095/
43021,Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518070/
43022,Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10763188/
43023,SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081906/
43024,Iron dysregulation in COVID‐19 and reciprocal evolution of SARS‐CoV‐2: Natura nihil frustra facit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015563/
43025,Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876554/
43026,Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900484/
43027,Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319213/
43028,Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198038/
43029,Accelerating antiviral drug discovery: lessons from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176316/
43030,COVID-19 and Inborn Errors of Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550578/
43031,The intersection of COVID-19 and autoimmunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670833/
43032,Gastrointestinal manifestations in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989191/
43033,Blood DNA methylation and COVID-19 outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148415/
43034,"Wastewater-Based
Surveillance Is an Effective Tool
for Trending COVID-19 Prevalence in Communities: A Study of 10 Major
Communities for 17 Months in Alberta",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514327/
43035,High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055393/
43036,Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961667/
43037,Insights into Disparities Observed with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325576/
43038,COVID-19 and Pediatric Asthma: Clinical and Management Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908623/
43039,Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662264/
43040,Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161761/
43041,COVID-19: Some unresolved issues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548072/
43042,Increased Estimated GFR Is Negatively Associated With the Risk of SARS-CoV-2 Infection and Severe COVID-19 Within Normal to Mildly Decreased Levels: Nested Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727919/
43043,Cancer therapy and treatments during COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319627/
43044,Developmental Impacts of Epigenetics and Metabolism in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10885083/
43045,Characteristics and treatment of hospitalized pregnant women with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371979/
43046,A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831809/
43047,Clinical characteristics analysis of COVID-19 patients from the first significant community outbreak by SARS-CoV-2 variant B.1.1.7 in Taiwan as experienced from a single northern medical center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381423/
43048,An overview on role of nutrition on COVID-19 immunity: Accumulative review from available studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754583/
43049,"COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080222/
43050,"Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616091/
43051,Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605823/
43052,Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442563/
43053,Multi-omics approach to COVID-19: a domain-based literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649311/
43054,COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032523/
43055,The Impact of COVID-19 in Gastroenterology and Hepatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409901/
43056,Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650687/
43057,The impact of coronavirus SARS-CoV-2 (COVID-19) in water: potential risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397333/
43058,COVID-19 and the Endocrine System: A Comprehensive Review on the Theme,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269331/
43059,HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371950/
43060,SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402751/
43061,Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608010/
43062,Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684031/
43063,"Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365286/
43064,The Impact of SARS-CoV-2 Infection on Heart Rate Variability: A Systematic Review of Observational Studies with Control Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859268/
43065,Care for adults with COVID‐19: living guidelines from the National COVID‐19 Clinical Evidence Taskforce,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538623/
43066,Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409149/
43067,Cardiovascular impact of COVID-19 with a focus on children: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674714/
43068,Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107439/
43069,Long-term complications of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721906/
43070,"Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648142/
43071,Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884149/
43072,Front Immunol. 2023; 14: 1294153. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552672/
43073,Immunomodulation and Regenerative Capacity of MSCs for Long-COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625432/
43074,"Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475970/
43075,Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316478/
43076,"Coronavirus Disease-2019 (COVID-19): An Updated
Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516369/
43077,Spike in pollution to ignite the bursting of COVID-19 second wave is more dangerous than spike of SAR-CoV-2 under environmental ignorance in long term: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363867/
43078,Rheumatological complications of Covid 19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256657/
43079,Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444584/
43080,SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543950/
43081,"Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348290/
43082,"Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457995/
43083,Using in vivo animal models for studying SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567288/
43084,Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681736/
43085,"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366121/
43086,Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364037/
43087,Modalities and Mechanisms of Treatment for Coronavirus Disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908061/
43088,"Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056171/
43089,Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513326/
43090,"Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10745830/
43091,Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848203/
43092,Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377426/
43093,Real-time alerting system for COVID-19 and other stress events using wearable data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799466/
43094,"Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347333/
43095,"SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552795/
43096,"Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11055380/
43097,Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758383/
43098,Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139310/
43099,COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941816/
43100,The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299886/
43101,MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221922/
43102,COVID-19 and liver injury: An ongoing challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846934/
43103,An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492917/
43104,Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673592/
43105,Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350186/
43106,Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093414/
43107,Reactive Sulfur Compounds in the Fight against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220020/
43108,Harnessing immunological targets for COVID-19 immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375415/
43109,Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219777/
43110,Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676325/
43111,"Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815329/
43112,Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400561/
43113,Nat Rev Nephrol. 2022; 18(11): 738. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487852/
43114,Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550915/
43115,Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372636/
43116,Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288895/
43117,Pros and Cons of CAD/CAM Technology for Infection Prevention in Dental Settings during COVID-19 Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747329/
43118,The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385870/
43119,Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473490/
43120,COVID-19 in pregnancy: What we know from the first year of the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397492/
43121,Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907309/
43122,"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788316/
43123,Protection by metformin against severe Covid-19: An in-depth mechanistic analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154087/
43124,Monitoring the presence and persistence of SARS-CoV-2 in water-food-environmental compartments: State of the knowledge and research needs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142028/
43125,Symptoms and risk factors for long COVID in non-hospitalized adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388369/
43126,Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955129/
43127,Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891829/
43128,Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063443/
43129,Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888693/
43130,SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320676/
43131,Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380217/
43132,Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999244/
43133,"COVID-19: Invasion, pathogenesis and possible cure – A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669942/
43134,Vitamin D and COVID‐19—Revisited,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349414/
43135,Therapeutic mechanisms and impact of traditional Chinese medicine on COVID-19 and other influenza diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666147/
43136,Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646711/
43137,Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973081/
43138,The Experience of Testing for Coronavirus Disease (COVID-19) at a Single Diagnostic Center in Paraguay before the Introduction of Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220564/
43139,Impact of the SARS‐CoV‐2 virus on male reproductive health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444635/
43140,Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604067/
43141,SARS-CoV-2 spreads through cell-to-cell transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740724/
43142,The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571161/
43143,Bacterial Pneumonia and Respiratory Culture Utilization among Hospitalized Patients with and without COVID-19 in a New York City Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297819/
43144,"A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663145/
43145,COVID-19: advance in laboratory diagnostic strategy and technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778859/
43146,"Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070049/
43147,How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957861/
43148,Review of Current COVID-19 Diagnostics and Opportunities for Further Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138031/
43149,Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765509/
43150,"Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778574/
43151,Neuroinvasion of SARS-CoV-2 in human and mouse brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808299/
43152,Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089442/
43153,Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829820/
43154,Identification of the RNase-binding site of SARS-CoV-2 RNA for anchor primer-PCR detection of viral loading in 306 COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543284/
43155,The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773081/
43156,SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313683/
43157,Prevalence of SARS-CoV-2 in human post-mortem ocular tissues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649030/
43158,Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349860/
43159,"Thrombosis, cancer, and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106567/
43160,T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128286/
43161,"Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110321/
43162,Hunting coronavirus by transmission electron microscopy – a guide to SARS‐CoV‐2‐associated ultrastructural pathology in COVID‐19 tissues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537546/
43163,Repressed Ang 1–7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429950/
43164,"CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464593/
43165,Total network controllability analysis discovers explainable drugs for Covid-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478273/
43166,Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076251/
43167,"Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444156/
43168,Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447562/
43169,B-cell malignancies and COVID-19: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633106/
43170,Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807296/
43171,Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363633/
43172,Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253661/
43173,Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544555/
43174,Updates on the Biofunctionalization of Gold Nanoparticles for the Rapid and Sensitive Multiplatform Diagnosis of SARS-CoV-2 Virus and Its Proteins: From Computational Models to Validation in Human Samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252313/
43175,LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897555/
43176,"Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795751/
43177,Modeling the number of people infected with SARS-COV-2 from wastewater viral load in Northwest Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674110/
43178,Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412452/
43179,Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134725/
43180,Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525243/
43181,SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412036/
43182,Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640209/
43183,Missing science: A scoping study of COVID-19 epidemiological data in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555641/
43184,Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963401/
43185,"COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868660/
43186,Obesity and its impact on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023779/
43187,Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561478/
43188,Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258776/
43189,SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936079/
43190,American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/
43191,Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261314/
43192,Wastewater-Based Epidemiology of SARS-CoV-2: Assessing Prevalence and Correlation with Clinical Cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155169/
43193,Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565143/
43194,"SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054865/
43195,Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460425/
43196,Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541193/
43197,Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058655/
43198,SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746631/
43199,An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354075/
43200,Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115603/
43201,The time to offer treatments for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074648/
43202,Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071476/
43203,In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441699/
43204,Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579991/
43205,Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863796/
43206,Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093099/
43207,Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541562/
43208,Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436618/
43209,Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940330/
43210,National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546308/
43211,Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779861/
43212,Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844918/
43213,Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546390/
43214,Biological mechanisms underpinning the development of long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193768/
43215,Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226122/
43216,How COVID-19 shaped mental health: from infection to pandemic effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711928/
43217,Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789854/
43218,COVID-19 Spotlights Connections between Disease and Multiple Lifestyle Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445631/
43219,De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013672/
43220,Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286265/
43221,"Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839970/
43222,SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306106/
43223,Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820269/
43224,Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021598/
43225,Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683262/
43226,Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612291/
43227,mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783604/
43228,Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534589/
43229,Winter Is Coming: A Southern Hemisphere Perspective of the Environmental Drivers of SARS-CoV-2 and the Potential Seasonality of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459895/
43230,State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514616/
43231,A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648031/
43232,"Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446910/
43233,Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866189/
43234,"SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473168/
43235,Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086843/
43236,"Weathering the storm: COVID-19 infection in patients with hematological malignancies
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759451/
43237,Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089886/
43238,"COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865642/
43239,"Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231166/
43240,A living systematic review of the psychological problems in people suffering from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169237/
43241,The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393179/
43242,"Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210800/
43243,Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507138/
43244,Pulmonary vascular system: A vulnerable target for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662299/
43245,The psychological impact of the COVID-19 pandemic and a SARS-CoV-2 testing programme on obstetric patients and healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189525/
43246,Nanomedicine to deliver biological macromolecules for treating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149150/
43247,Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572790/
43248,Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756008/
43249,Neutralizing Antibody Therapeutics for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067572/
43250,Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622942/
43251,Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836549/
43252,mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559634/
43253,Considerations for the Safe Operation of Schools During the Coronavirus Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716382/
43254,COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214321/
43255,Human Coronaviruses: Counteracting the Damage by Storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402835/
43256,"The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809072/
43257,Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557262/
43258,Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694471/
43259,"Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018429/
43260,Acute kidney injury in critically ill patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290076/
43261,A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185226/
43262,Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668756/
43263,Cell. 2021 Apr 1; 184(7): 1858–1864.e10. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871851/
43264,Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577733/
43265,"COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10888568/
43266,Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019238/
43267,Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179128/
43268,Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141548/
43269,Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269209/
43270,Inhaled corticosteroids for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905579/
43271,Adverse Cardiovascular Effects of Anti-COVID-19 Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424204/
43272,Therapeutic implications of ongoing alveolar viral replication in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635460/
43273,Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510059/
43274,Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11052880/
43275,"Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831445/
43276,Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163958/
43277,"Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922403/
43278,"COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866514/
43279,Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258422/
43280,Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970139/
43281,Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin–Drug Interactions Exist?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604733/
43282,The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889464/
43283,COVID-19 and its effects on the digestive system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240057/
43284,"Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135679/
43285,Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531239/
43286,Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955701/
43287,J Pers Med. 2022 Jun; 12(6): 967. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225184/
43288,Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264177/
43289,"Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329427/
43290,A Scoping Review of the Health Impact of the COVID-19 Pandemic on Persons Experiencing Homelessness in North America and Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954292/
43291,Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011697/
43292,Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980227/
43293,Front Immunol. 2022; 13: 929770. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171241/
43294,Iron and iron-related proteins in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289930/
43295,"Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778641/
43296,Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527889/
43297,SARS-CoV-2 pneumonia—receptor binding and lung immunopathology: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870126/
43298,A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735105/
43299,Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127945/
43300,Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720688/
43301,Dengue and COVID-19: two sides of the same coin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251039/
43302,Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899776/
43303,Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839880/
43304,COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669825/
43305,"Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477205/
43306,Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874888/
43307,Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851580/
43308,Nat Commun. 2023; 14: 1581. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031713/
43309,Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638395/
43310,Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541099/
43311,Genetics Insight for COVID-19 Susceptibility and Severity: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047200/
43312,"Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513220/
43313,New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232979/
43314,Testing at scale during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094986/
43315,"Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579950/
43316,Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169260/
43317,"How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226076/
43318,Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823523/
43319,Interactions Between Specific Immune Status of Pregnant Women and SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387674/
43320,Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080180/
43321,Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756220/
43322,"Leaving no stone unturned in light of the COVID-19 faecal-oral hypothesis? A water, sanitation and hygiene (WASH) perspective targeting low-income countries",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438205/
43323,Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786335/
43324,COVID-19 : physiopathologie d’une maladie à plusieurs visages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250743/
43325,COVID-19 and HIV infection co-pandemics and their impact: a review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097669/
43326,Development and application of ribonucleic acid therapy strategies against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379410/
43327,Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322892/
43328,Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871851/
43329,Returning to Work after the COVID-19 Pandemic Earthquake: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024882/
43330,COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674974/
43331,Analysis of Prevalence and Predictive Factors of Long-Lasting Olfactory and Gustatory Dysfunction in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410278/
43332,Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830156/
43333,Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675115/
43334,Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423503/
43335,"Is self-reported depression, HIV status, COVID-19 health risk profile and SARS-CoV-2 exposure associated with difficulty in adhering to COVID-19 prevention measures among residents in West Africa?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648438/
43336,Pharmacological treatment of COVID-19: an opinion paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972693/
43337,SARS-CoV-2 therapeutics: how far do we stand from a remedy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778692/
43338,Systems serology detects functionally distinct coronavirus antibody features in children and elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016934/
43339,"Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223475/
43340,BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250979/
43341,"The Relationship between Mental Disorders and the COVID-19 Pandemic—Course, Risk Factors, and Potential Consequences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368061/
43342,The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395832/
43343,"How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996623/
43344,Competitive cleavage of SARS-CoV-2 spike protein and epithelial sodium channel by plasmin as a potential mechanism for COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639761/
43345,Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297660/
43346,Therapeutic strategies to fight COVID‐19: Which is the status artis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239658/
43347,Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708613/
43348,"Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776306/
43349,Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134036/
43350,Supportive care in patients with cancer during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808078/
43351,"Inflammation at the crossroads of COVID-19, cognitive deficits and depression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894741/
43352,"Antitarget,
Anti-SARS-CoV-2 Leads, Drugs, and
the Drug Discovery–Genetics Alliance Perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005815/
43353,Willingness to Receive SARS-CoV-2 Vaccination and Associated Factors among Chinese Adults: A Cross Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922368/
43354,"Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877736/
43355,Post-COVID-19 Syndrome and the Potential Benefits of Exercise,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156194/
43356,Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10883773/
43357,SARS‐CoV‐2 variants and vulnerability at the global level,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088647/
43358,Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676367/
43359,Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138433/
43360,Screening and testing for COVID‐19 before surgery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436563/
43361,Neuroinflammation and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239981/
43362,Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757397/
43363,Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009983/
43364,Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808608/
43365,Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372991/
43366,Disease-drug and drug-drug interaction in COVID-19: Risk and assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078916/
43367,Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901626/
43368,Environmentally-induced mdig contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315075/
43369,Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851814/
43370,Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864303/
43371,Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771611/
43372,Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071853/
43373,Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571584/
43374,Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004871/
43375,Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889026/
43376,"The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882857/
43377,"Future developments in the prevention, diagnosis and treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003455/
43378,A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/
43379,Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019929/
43380,Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625847/
43381,"A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852957/
43382,SARS-CoV-2 infection and COVID-19 severity in persons with HIV on antiretroviral treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824311/
43383,Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090758/
43384,Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618576/
43385,Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710484/
43386,Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426442/
43387,COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898786/
43388,COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656873/
43389,COVID-19 and liver dysfunction: What nutritionists need to know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048466/
43390,Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342976/
43391,Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774565/
43392,The immune mechanism of the nasal epithelium in COVID-19–related olfactory dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387544/
43393,"COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859698/
43394,"Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962632/
43395,Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699540/
43396,Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799400/
43397,Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946865/
43398,Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899457/
43399,Virus Res. 2021 Aug; 301: 198464. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/
43400,"COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362548/
43401,Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094123/
43402,Gut Microbiome Alterations in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478109/
43403,Short‐term complications and post‐acute sequelae in hospitalized paediatric patients with COVID‐19 and obesity: A multicenter cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874399/
43404,Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960124/
43405,"Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391183/
43406,SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428854/
43407,Covid 19: Diet Composition and Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472186/
43408,Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845132/
43409,Pathogenic Connections in Post-COVID Conditions: What Do We Know in the Large Unknown? A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413998/
43410,"The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042076/
43411,"An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378675/
43412,Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051174/
43413,Recent advances in developing small-molecule inhibitors against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260826/
43414,Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114699/
43415,Long-term gastrointestinal outcomes of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992516/
43416,Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483537/
43417,Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271492/
43418,An overview of COVID-19 in solid organ transplantation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855607/
43419,"Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036128/
43420,Prevalence of human pathogenic viruses in wastewater: A potential transmission risk as well as an effective tool for early outbreak detection for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352675/
43421,Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537738/
43422,Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698596/
43423,Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095019/
43424,Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484957/
43425,Molecular mimicry and autoimmunity in the time of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258587/
43426,Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198616/
43427,COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239905/
43428,Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062288/
43429,Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595377/
43430,Plasma miRNA profile at COVID-19 onset predicts severity status and mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890551/
43431,Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451811/
43432,Potential relationships between COVID-19 and the thyroid gland: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894980/
43433,Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310263/
43434,Viral reactivations and co-infections in COVID-19 patients: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131452/
43435,Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685624/
43436,Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953430/
43437,"COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673861/
43438,The Multifacets of COVID-19 in Adult Patients: A Concise Clinical Review on Pulmonary and Extrapulmonary Manifestations for Healthcare Physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927469/
43439,The role of trained immunity in COVID-19: Lessons for the next pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265767/
43440,Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923560/
43441,Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695521/
43442,SARS-CoV-2/COVID-19: a primer for cardiologists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360901/
43443,Phenotypes and Functions of SARS-CoV-2-Reactive T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245315/
43444,Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955803/
43445,New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611660/
43446,"COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933131/
43447,"Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782332/
43448,SARS-CoV-2 infection and thrombotic complications: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810105/
43449,SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421077/
43450,Plasma proteomics identify potential severity biomarkers from COVID‐19 associated network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874836/
43451,Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859725/
43452,Covid-19 and development of heart failure: mystery and truth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417660/
43453,CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277873/
43454,Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636722/
43455,Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190166/
43456,SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853071/
43457,Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11056634/
43458,Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430017/
43459,The Global Phosphorylation Landscape of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321036/
43460,Cardiovascular System during SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835041/
43461,Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929414/
43462,Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424153/
43463,Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124488/
43464,Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811745/
43465,Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509779/
43466,"The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412318/
43467,COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367547/
43468,Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498083/
43469,J Nat Med. 2022; 76(1): 38. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536900/
43470,Distinct Features of Vascular Diseases in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332421/
43471,Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194859/
43472,New-Onset Diabetes After COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009784/
43473,Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885108/
43474,"Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243768/
43475,Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431827/
43476,Neurological infection and complications of SARS-CoV-2: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901962/
43477,Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771237/
43478,Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818479/
43479,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580386/
43480,mSystems. 2023 Mar-Apr; 8(2): e00928-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
43481,Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126103/
43482,Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054059/
43483,Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350097/
43484,Analytical insights of COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567672/
43485,Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901184/
43486,"COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469368/
43487,Genetic Risk and Chronic Obstructive Pulmonary Disease Independently Predict the Risk of Incident Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787794/
43488,The COVID‐19 pandemic and its consequences for chronic pain: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350079/
43489,Modes of Transmission of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) and Factors Influencing on the Airborne Transmission: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825517/
43490,Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459411/
43491,"COVID-19 Disease, Women’s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391920/
43492,Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249441/
43493,SARS-CoV-2: Targeted managements and vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706592/
43494,Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346052/
43495,Struct Chem. 2022; 33(6): 2263. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428386/
43496,"High Frequencies of Phenotypically and Functionally Senescent and Exhausted CD56+CD57+PD-1+ Natural Killer Cells, SARS-CoV-2-Specific Memory CD4+ and CD8+ T cells Associated with Severe Disease in Unvaccinated COVID-19 Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347283/
43497,The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122186/
43498,Investigating the possible mechanisms of autonomic dysfunction post-COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789535/
43499,Potential mechanism of SARS‐CoV‐2‐associated central and peripheral nervous system impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349396/
43500,SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856880/
43501,SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209947/
43502,SARS-CoV-2 infection negatively affects ovarian function in ART patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550892/
43503,Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891701/
43504,Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850935/
43505,SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410013/
43506,Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356916/
43507,SARS-CoV-2 and the pandemic of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016996/
43508,The neurobiology of long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537254/
43509,Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663750/
43510,Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201996/
43511,European Respiratory Society statement on long COVID follow-up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349784/
43512,Multimodality imaging of COVID-19 pneumonia: from diagnosis to follow-up. A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430292/
43513,Eur J Radiol. 2021 Jan; 134: 109364. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718778/
43514,COVID-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093065/
43515,Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441773/
43516,Molnupiravir and risk of post-acute sequelae of covid-19: cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126525/
43517,Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684198/
43518,SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184784/
43519,In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832442/
43520,Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181544/
43521,"Psychological experience of patients with confirmed COVID-19 at the initial stage of pandemic in Wuhan, China: a qualitative study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665711/
43522,Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816569/
43523,PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783674/
43524,"Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811668/
43525,Recent advances and developments in COVID‐19 in the context of allergic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646609/
43526,The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498772/
43527,The role and uses of antibodies in COVID-19 infections: a living review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928637/
43528,COVID‐19 pathophysiology and ultrasound imaging: A multiorgan review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088355/
43529,Clinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855793/
43530,Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787249/
43531,The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804231/
43532,Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/
43533,Cochrane Database Syst Rev. 2023; 2023(11): CD015395. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688265/
43534,Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and Hypoxemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517511/
43535,Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268866/
43536,COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221722/
43537,Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659360/
43538,Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628960/
43539,What can the neurological manifestations of COVID-19 tell us: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381866/
43540,Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027657/
43541,"Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645766/
43542,Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049574/
43543,"Is Symptom Screening Useful for Identifying COVID-19 Infection in School Settings? Georgia, USA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911526/
43544,Sodium Toxicity in the Nutritional Epidemiology and Nutritional Immunology of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399536/
43545,"COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775739/
43546,The Immune Response to SARS-CoV-2 and Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537260/
43547,Roborovski hamster (Phodopus roborovskii) strain SH101 as a systemic infection model of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451461/
43548,COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342932/
43549,Lancet Healthy Longev. 2022 Sep; 3(9): e588. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448302/
43550,Possible mechanisms of cholesterol elevation aggravating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436106/
43551,An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709787/
43552,COVID-19 Vaccines: Current Conditions and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533517/
43553,Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210172/
43554,Nanotechnology-based approaches in the fight against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712532/
43555,Control and Prevention of SARS-CoV-2 Outbreaks among Healthcare Workers from 129 Healthcare Facilities in Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625209/
43556,Human genomics of COVID-19 pneumonia: contributions of rare and common variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879986/
43557,Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316835/
43558,SARS coronavirus 2: from genome to infectome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706175/
43559,Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961561/
43560,"Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930241/
43561,Antibody Responses to SARS-CoV-2 in Children With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992286/
43562,Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087393/
43563,Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940856/
43564,A COVID-19-association-dependent categorization of death causes in 100 autopsy cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435112/
43565,Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777759/
43566,Wastewater based epidemiology as a silent sentinel of the trend of SARS-CoV-2 circulation in the community in central Argentina,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066365/
43567,Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939774/
43568,The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918534/
43569,Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242464/
43570,"Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10742861/
43571,"The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374061/
43572,From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124764/
43573,COVID-19 vaccination challenges: A mini-review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302531/
43574,Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114728/
43575,Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years’ Evidence Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128408/
43576,Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008813/
43577,Circulating Peptidome Is Strongly Altered in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865723/
43578,Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527439/
43579,Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380980/
43580,"The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942481/
43581,"Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000440/
43582,"When silence goes viral, Africa sneezes! A perspective on Africa's subdued research response to COVID-19 and a call for local scientific evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837055/
43583,Environmental Factors Influencing COVID-19 Incidence and Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044492/
43584,Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648672/
43585,A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741840/
43586,The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801189/
43587,"Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223038/
43588,The role of extracellular histones in COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108027/
43589,Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934698/
43590,Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445716/
43591,Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005103/
43592,Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833276/
43593,COVID-19 in otolaryngologist practice: a review of current knowledge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166003/
43594,Advances in the design and development of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674100/
43595,"Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139192/
43596,Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102365/
43597,Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104461/
43598,Therapeutic approaches and vaccination in fighting COVID-19 infections: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066810/
43599,The SARS-CoV-2 as an instrumental trigger of autoimmunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892316/
43600,COVID-19 and Its Repercussions on Oral Health: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619825/
43601,SARS‐CoV‐2 and hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198473/
43602,SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146509/
43603,Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522258/
43604,An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404081/
43605,"Natural killer cells in COVID-19: from infection, to vaccination and therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013930/
43606,Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275141/
43607,Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458178/
43608,The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918006/
43609,SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355592/
43610,Lung Organoids as Model to Study SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455466/
43611,SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891488/
43612,A COVID-19 primer for primary care clinicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919786/
43613,Genetic Variants and Protective Immunity against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778397/
43614,Potential protective mechanisms of green tea polyphenol EGCG against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146271/
43615,"COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362854/
43616,Nanoparticles in clinical trials of COVID-19: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359769/
43617,Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315943/
43618,In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065667/
43619,Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307484/
43620,Nat Med. 2022; 28(7): 1509. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282140/
43621,Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259773/
43622,Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149929/
43623,Clinical practice in COVID-19: The most frequently asked questions to infectious diseases specialists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572702/
43624,Role of the SphK‐S1P‐S1PRs pathway in invasion of the nervous system by SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014301/
43625,Machine Learning for Prediction of Patients on Hemodialysis with an Undetected SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786002/
43626,Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459448/
43627,Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299646/
43628,Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107428/
43629,ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583933/
43630,"The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699619/
43631,"The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283855/
43632,COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405500/
43633,Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932815/
43634,Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757642/
43635,"A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420458/
43636,"Ischemic stroke in COVID‐19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299927/
43637,Hypersensitivity may be involved in severe COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652637/
43638,Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349640/
43639,The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489264/
43640,Humoral and cellular immune memory to four COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135677/
43641,SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256672/
43642,SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499592/
43643,Impact of COVID-19 on ischemic stroke care in Hungary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371604/
43644,Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033157/
43645,"Metabolic, Oxidative and Psychological Stress as Mediators of the Effect of COVID-19 on Male Infertility: A Literature Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099932/
43646,Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407542/
43647,The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345113/
43648,Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296357/
43649,COVID-19: Rethinking the Lockdown Groupthink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952324/
43650,Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487901/
43651,Widespread contamination of SARS‐CoV‐2 on highly touched surfaces in Brazil during the second wave of the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303906/
43652,A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572451/
43653,Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621220/
43654,"Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922586/
43655,"COVID‐19 coagulopathies: Human blood proteins mimic SARS‐CoV‐2 virus, vaccine proteins and bacterial co‐infections inducing autoimmunity: Combinations of bacteria and SARS‐CoV‐2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin‐binding proteins, platelet factor 4, prothrombin, and coagulation factors.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646673/
43656,Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616204/
43657,Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725357/
43658,Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585960/
43659,Research and development of Chinese anti-COVID-19 drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472487/
43660,SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130512/
43661,Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899014/
43662,Optimization and Application of a Multiplex Digital PCR Assay for the Detection of SARS-CoV-2 Variants of Concern in Belgian Influent Wastewater,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953730/
43663,Comorbidities of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456773/
43664,Considerations for diagnostic COVID-19 tests,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556561/
43665,Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242670/
43666,SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986052/
43667,COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105151/
43668,Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121515/
43669,A Literature Review on SARS-CoV-2 and Other Viruses in Thyroid Disorders: Environmental Triggers or No-Guilty Bystanders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916247/
43670,An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380468/
43671,Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802260/
43672,Pregnancy and Breastfeeding During COVID-19 Pandemic: A Systematic Review of Published Pregnancy Cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719788/
43673,The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272836/
43674,IL-13 is a driver of COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410056/
43675,SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628126/
43676,Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203880/
43677,Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475517/
43678,Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443335/
43679,Cell Metab. 2021 Dec 7; 33(12): 2484. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650200/
43680,Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414050/
43681,ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528903/
43682,Laboratory-Based Resources for COVID-19 Diagnostics: Traditional Tools and Novel Technologies. A Perspective of Personalized Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828525/
43683,Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300844/
43684,Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312095/
43685,"Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645923/
43686,Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538434/
43687,Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753679/
43688,Host mitochondria: more than an organelle in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485703/
43689,Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725462/
43690,CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321051/
43691,A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350981/
43692,PLoS Biol. 2020 Nov; 18(11): e3000970. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728249/
43693,Artificial neural network-based estimation of COVID-19 case numbers and effective reproduction rate using wastewater-based epidemiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006161/
43694,"COVID-19 Diagnostics, Tools, and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344926/
43695,"High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328563/
43696,Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190525/
43697,Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134961/
43698,Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012137/
43699,Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427128/
43700,Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256233/
43701,The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437504/
43702,Coagulopathy in COVID-19 and anticoagulation clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395291/
43703,Therapeutic modalities and novel approaches in regenerative medicine for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582055/
43704,"Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898057/
43705,Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092276/
43706,Natural killer cell immunotypes related to COVID-19 disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/
43707,Stroke Care during the COVID-19 Pandemic: International Expert Panel Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089455/
43708,Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250120/
43709,"Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983896/
43710,A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318707/
43711,Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910744/
43712,The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690341/
43713,SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498514/
43714,B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016889/
43715,"Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806455/
43716,Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496439/
43717,Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935270/
43718,The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897554/
43719,The current understanding and potential therapeutic options to combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207108/
43720,COVID-19 vaccination hesitancy and willingness among pregnant women in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575585/
43721,Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108189/
43722,Natural killer cell exhaustion in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389049/
43723,MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061879/
43724,Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953200/
43725,"Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136001/
43726,A narrative review of alternative transmission routes of COVID 19: what we know so far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614718/
43727,Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210586/
43728,SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10717444/
43729,The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181280/
43730,CD38 in the age of COVID-19: a medical perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313238/
43731,Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788580/
43732,Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617042/
43733,Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244024/
43734,"Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791541/
43735,SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535385/
43736,Nutraceuticals and Dietary Supplements for Older Adults with Long COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212635/
43737,Symmetrical peripheral gangrene: potential mechanisms and therapeutic approaches in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10718190/
43738,"In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997194/
43739,Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909161/
43740,Respiratory psychophysiology and COVID-19: A research agenda,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756651/
43741,Lung transplantation for patients with severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050952/
43742,Bioinformatics approach to identify the hub gene associated with COVID‐19 and idiopathic pulmonary fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725713/
43743,An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838355/
43744,Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10887136/
43745,Mesenchymal stem cells and COVID-19: What they do and what they can do,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474724/
43746,"Respiratory and systemic monocytes, dendritic cells, and myeloid‐derived suppressor cells in COVID‐19: Implications for disease severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538918/
43747,Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661333/
43748,Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685738/
43749,Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230210/
43750,"Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361071/
43751,"COVID-19 prophylaxis with doxycycline and zinc in health care workers: a prospective, randomized, double-blind clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212900/
43752,Progress and Challenges of Point-of-Need Photonic Biosensors for the Diagnosis of COVID-19 Infections and Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496547/
43753,The Interplay between HIV and COVID-19: summary of the data and responses to date,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735216/
43754,Cutaneous Manifestations of COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020517/
43755,The impact of the COVID‐19 pandemic on the short‐term survival of patients with cancer in Northern Portugal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014057/
43756,"The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879496/
43757,A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020204/
43758,Monoclonal antibody therapies against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255948/
43759,Lancet Infect Dis. 2022 Sep; 22(9): e239. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275794/
43760,Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357963/
43761,Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655106/
43762,Spatiotemporal observations of host-pathogen interactions in mucosa during SARS-CoV-2 infection indicate a protective role of ILC2s,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714800/
43763,A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835890/
43764,Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412090/
43765,A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813192/
43766,Associations between SARS-CoV-2 RNA concentrations in wastewater and COVID-19 rates in days after sampling in small urban areas of Seville: A time series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464400/
43767,COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059013/
43768,Development of Metal Complexes for Treatment of Coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223400/
43769,"COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335551/
43770,An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622245/
43771,Immunological co-ordination between gut and lungs in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380259/
43772,"COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675075/
43773,Bidirectional Relationship between Glycemic Control and COVID-19 and Perspectives of Islet Organoid Models of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045433/
43774,Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344879/
43775,Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399140/
43776,Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226688/
43777,The cytokine storm and thyroid hormone changes in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871522/
43778,Novel coronavirus disease (COVID-19) pandemic: A recent mini review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773542/
43779,High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384496/
43780,Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794076/
43781,Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378551/
43782,"Pathophysiological and molecular considerations of viral and bacterial infections during maternal-fetal and –neonatal interactions of SARS-CoV-2, Zika, and Mycoplasma infectious diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492386/
43783,IL-15 immunotherapy is a viable strategy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537239/
43784,Clinical Management of COVID-19: A Review of Pharmacological Treatment Options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229327/
43785,Psychophysical therapy and underlying neuroendocrine mechanisms for the rehabilitation of long COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570751/
43786,Effect of ArtemiC in patients with COVID‐19: A Phase II prospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170814/
43787,An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328017/
43788,Point‐of‐care CRISPR/Cas biosensing technology: A promising tool for preventing the possible COVID‐19 resurgence caused by contaminated cold‐chain food and packaging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874772/
43789,Impact of Diabetes in Patients Diagnosed With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736089/
43790,Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433611/
43791,"Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343994/
43792,Allogeneic hematopoietic stem cell transplantation in the COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993088/
43793,"Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434302/
43794,Transcriptomic profiling of cardiac tissues from SARS‐CoV‐2 patients identifies DNA damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537957/
43795,Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441183/
43796,Association of Tracheostomy With Outcomes in Patients With COVID-19 and SARS-CoV-2 Transmission Among Health Care Professionals: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160928/
43797,Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250970/
43798,JAK inhibition as a new treatment strategy for patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250821/
43799,Toward a next-generation diagnostic tool: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633689/
43800,A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929144/
43801,Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813381/
43802,Implications of liver injury in risk-stratification and management of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865118/
43803,Antibody and B cell responses to SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233571/
43804,Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149678/
43805,COVID-19: A pluralistic and integrated approach for efficient management of the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788213/
43806,"Impact of COVID-19 during pregnancy on placental pathology, maternal and neonatal outcome – A cross-sectional study on anemic term pregnant women from a tertiary care hospital in southern India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070875/
43807,COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605138/
43808,Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543703/
43809,"Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911974/
43810,Immune Response to SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312515/
43811,"Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324469/
43812,Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510253/
43813,The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454092/
43814,An Appraisal of the Current Scenario in Vaccine Research for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310376/
43815,Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936352/
43816,Cell and Animal Models for SARS-CoV-2 Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319816/
43817,Microvascular significance of TGF-β axis activation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852847/
43818,"Mass spectrometry applied to diagnosis, prognosis, and therapeutic targets identification for the novel coronavirus SARS-CoV-2: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687343/
43819,Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419057/
43820,Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172328/
43821,Nanomaterials‐based sensors for the detection of COVID‐19: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110902/
43822,A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102696/
43823,Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350035/
43824,Cognitive impact of COVID-19: looking beyond the short term,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772800/
43825,Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915504/
43826,New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323143/
43827,COVID-19 and interstitial lung diseases: a multifaceted look at the relationship between the two diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281233/
43828,Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463587/
43829,Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677559/
43830,The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897071/
43831,Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900755/
43832,Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360125/
43833,Dysglycemia after COVID-19 pneumonia: a six-month cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177035/
43834,Emerging Prevention and Treatment Strategies to Control COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350294/
43835,Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998734/
43836,Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10870569/
43837,Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188741/
43838,New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611551/
43839,Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651292/
43840,Pregnancy and COVID-19: high or low risk of vertical transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574177/
43841,Structure-guided antibody cocktail for prevention and treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530329/
43842,"Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170436/
43843,Hypertension and its management in COVID-19 patients: The assorted view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590508/
43844,The pathogenesis of coronavirus-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597981/
43845,Two distinct immunopathological profiles in autopsy lungs of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546638/
43846,"Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800022/
43847,Long-term diet and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384672/
43848,Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173496/
43849,"Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684852/
43850,"The trinity of COVID-19: immunity, inflammation and intervention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187672/
43851,HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256232/
43852,"Development of a multi‐recombinase polymerase amplification assay for rapid identification of COVID‐19, influenza A and B",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538624/
43853,Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499989/
43854,Antioxidant/anti‐inflammatory effect of Mg2+ in coronavirus disease 2019 (COVID‐19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111052/
43855,Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164443/
43856,Nat Immunol. 2023; 24(4): 604–611. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063443/
43857,The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146402/
43858,(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330360/
43859,Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161166/
43860,Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488171/
43861,Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014753/
43862,Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275758/
43863,The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060688/
43864,"Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422796/
43865,Pathogenesis and management of myocardial injury in coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405025/
43866,Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490512/
43867,Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021703/
43868,Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212109/
43869,COVID-19: neonatal–perinatal perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721617/
43870,A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447520/
43871,Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511113/
43872,"SARS-COV-2/COVID-19: scenario, epidemiology, adaptive mutations, and environmental factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363873/
43873,The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552556/
43874,Clinical Characterization of Patients With COVID-19 in Primary Care in Catalonia: Retrospective Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871981/
43875,Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079802/
43876,Radiological Findings Increased the Successful of COVID-19 Diagnosis in Hospitalized Patients Suspected of Respiratory Viral Infection but with a Negative First SARS-CoV-2 RT-PCR Result,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946968/
43877,"Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449357/
43878,What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250680/
43879,Association of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061239/
43880,Neutralizing activity to SARS‐CoV‐2 in 1.2 to 10.0 month convalescent plasma samples of COVID‐19: A transversal surrogate in vitro study performed in Quito‐Ecuador,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347805/
43881,Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014648/
43882,Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444583/
43883,Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352853/
43884,Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396277/
43885,"Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262904/
43886,COVID-19 and Parkinsonism: A Critical Appraisal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313170/
43887,Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981312/
43888,Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884364/
43889,An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173993/
43890,Therapeutic Potential of Bioactive Compounds from Edible Mushrooms to Attenuate SARS-CoV-2 Infection and Some Complications of Coronavirus Disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532592/
43891,Development and application of therapeutic antibodies against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071770/
43892,Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948465/
43893,Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070855/
43894,"Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570409/
43895,"Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908539/
43896,Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119950/
43897,The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494533/
43898,Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074652/
43899,Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227815/
43900,Predictors of COVID-19 vaccine uptake among people who inject drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868393/
43901,Coronavirus disease 2019 and the placenta: A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293390/
43902,Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539420/
43903,SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762734/
43904,A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535709/
43905,Does periodontitis influence the risk of COVID‐19? A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348428/
43906,Laboratory medicine in pandemic of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996317/
43907,Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610601/
43908,A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165147/
43909,Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395913/
43910,The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738379/
43911,Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470303/
43912,The COVID-19 Patient in the Surgical Intensive Care Unit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479422/
43913,A critical review on SARS-CoV-2 infectivity in water and wastewater. What do we know?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870439/
43914,Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406530/
43915,SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host–virus interaction studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957976/
43916,Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123609/
43917,"COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281639/
43918,Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372458/
43919,A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917781/
43920,"Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890389/
43921,Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954437/
43922,A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051499/
43923,Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386267/
43924,Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111046/
43925,Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10834093/
43926,Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226563/
43927,Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916187/
43928,Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599235/
43929,Neurological manifestations and comorbidity associated with COVID-19: an overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556575/
43930,Modified mRNA-Based Vaccines Against Coronavirus Disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021518/
43931,Healthy Immunity on Preventive Medicine for Combating COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912522/
43932,Metabolic Reprogramming in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584248/
43933,Lead time of early warning by wastewater surveillance for COVID-19: Geographical variations and impacting factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942437/
43934,Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415199/
43935,Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476961/
43936,Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841219/
43937,"Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171433/
43938,Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672162/
43939,Monitoring SARS-CoV-2 in municipal wastewater to evaluate the success of lockdown measures for controlling COVID-19 in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105641/
43940,COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570692/
43941,Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826013/
43942,An original deep learning model using limited data for COVID‐19 discrimination: A multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088453/
43943,Persistent Lung Injury and Prothrombotic State in Long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021447/
43944,COVID-19 plasma exosomes promote proinflammatory immune responses in peripheral blood mononuclear cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756928/
43945,The management of surgical patients in the emergency setting during COVID-19 pandemic: the WSES position paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983964/
43946,Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368663/
43947,Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094389/
43948,Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200255/
43949,COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455004/
43950,Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515900/
43951,mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947943/
43952,Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176264/
43953,Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413516/
43954,Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854752/
43955,Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362241/
43956,"Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813210/
43957,Identification and Analysis of SARS-CoV-2 Alpha Variants in the Largest Taiwan COVID-19 Outbreak in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081839/
43958,Front Med (Lausanne). 2023; 10: 1211944. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231225/
43959,Can human overcome viral hijack-? Comprehensive review on COVID-19 in the view of diagnosis and mitigation across countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521359/
43960,Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371319/
43961,The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568590/
43962,The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211890/
43963,Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10785701/
43964,Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433291/
43965,"The influence of structural racism, pandemic stress, and SARS-CoV-2 infection during pregnancy with adverse birth outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022447/
43966,Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315516/
43967,Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076825/
43968,Is pregnancy an immunological contributor to severe or controlled COVID‐19 disease?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435498/
43969,"Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584649/
43970,Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612986/
43971,Manipulation of ACE2 expression in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757413/
43972,Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594528/
43973,Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609972/
43974,COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353216/
43975,Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349465/
43976,Stem Cell Rev Rep. 2021; 17(6): 2368. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531906/
43977,Animal reservoirs of SARS-CoV-2: calculable COVID-19 risk for older adults from animal to human transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404404/
43978,"An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346325/
43979,Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626074/
43980,Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875077/
43981,"Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case–control study from western Rajasthan, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928693/
43982,Vaccine Protection Through Placenta and Breastfeeding: The Unmet Topic in COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203883/
43983,Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675463/
43984,The acid sphingomyelinase/ceramide system in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488928/
43985,Neonates and COVID-19: state of the art: Neonatal Sepsis series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712275/
43986,A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380544/
43987,Innate Immune Response in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950297/
43988,CYP19A1 mediates severe SARS-CoV-2 disease outcome in males,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518605/
43989,COVID-19-associated psychosis: A systematic review of case reports,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546431/
43990,"Coronavirus (SARS-CoV-2) in the environment: Occurrence, persistence, analysis in aquatic systems and possible management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531938/
43991,Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996199/
43992,COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592342/
43993,Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211875/
43994,"The vital role of animal, marine, and microbial natural products against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896193/
43995,Role of Probiotics in the Management of COVID-19: A Computational Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781206/
43996,COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237344/
43997,Current challenges in different approaches to control COVID-19: a comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892405/
43998,"Multifaceted Assessment of Wastewater-Based Epidemiology for SARS-CoV-2 in Selected Urban Communities in Davao City, Philippines: A Pilot Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324557/
43999,Repurposing existing drugs for COVID-19: an endocrinology perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523486/
44000,"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287165/
44001,COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411289/
44002,COVID-19 versus SARS: A comparative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064890/
44003,Patient-reported health outcomes of SARS-CoV-2–tested patients presenting to emergency departments: a propensity score–matched prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712064/
44004,Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100631/
44005,Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005383/
44006,Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604693/
44007,Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520793/
44008,Neurological manifestations of COVID-19: a systematic review and detailed comprehension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506813/
44009,"Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316333/
44010,SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931091/
44011,The glycosylation in SARS-CoV-2 and its receptor ACE2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591162/
44012,Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563945/
44013,Antimicrobial resistance and COVID-19: Intersections and implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886324/
44014,"Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232907/
44015,"SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915969/
44016,A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431030/
44017,Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504152/
44018,Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507771/
44019,Coagulation Profile of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604860/
44020,Multicenter observational survey on psychosocial and behavioral impacts of COVID-19 in people living with HIV in Northern Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663486/
44021,A Narrative Review of COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779282/
44022,Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566765/
44023,COVID-19 in Southeast Asia: current status and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974206/
44024,Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658542/
44025,Enteric nervous system as a target and source of SARS-CoV-2 and other viral infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390051/
44026,Immunological memory to SARS-CoV-2 assessed for up to eight months after infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805444/
44027,Science. 2021 Jan 6 : eabf4063. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919858/
44028,Host genomics of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244159/
44029,Alzheimer's‐like signaling in brains of COVID‐19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011576/
44030,Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11045416/
44031,Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465121/
44032,Impact of repurposed drugs on the symptomatic COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720699/
44033,Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553653/
44034,"PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834198/
44035,"Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720301/
44036,Trends Food Sci Technol. 2022 Mar; 121: 156–160. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802019/
44037,Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220844/
44038,Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592546/
44039,Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897647/
44040,Viral infiltration of pancreatic islets in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192507/
44041,Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189279/
44042,Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328115/
44043,Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757136/
44044,"Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434543/
44045,Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225943/
44046,Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857399/
44047,Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431412/
44048,Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194728/
44049,Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325923/
44050,"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524637/
44051,The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207763/
44052,Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075979/
44053,Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Systematic Review of the Literature and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035919/
44054,SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: Secondary bacterial pneumonia and viral co-infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568231/
44055,Neurological complications of COVID-19: from pathophysiology to rehabilitation. An overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477084/
44056,Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073159/
44057,Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547678/
44058,"COVID‐19, adaptative immune response and metabolic‐associated liver disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661993/
44059,T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347640/
44060,CD8+ T-cell immune escape by SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647062/
44061,Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612883/
44062,Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521454/
44063,"COVID-19 in patients with liver disease and liver transplant: clinical implications, prevention, and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372508/
44064,The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324880/
44065,Long-term monitoring of SARS-CoV-2 RNA in sewage samples from specific public places and STPs to track COVID-19 spread and identify potential hotspots,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110006/
44066,SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354764/
44067,Vaccination and immunotherapies in neuroimmunological diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985568/
44068,Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599356/
44069,Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143829/
44070,Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937809/
44071,Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894694/
44072,The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231077/
44073,Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911984/
44074,Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187764/
44075,"A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003174/
44076,Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904156/
44077,Genetic Examination of Hematological Parameters in SARS-CoV-2 Infection and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902884/
44078,Blood Cells Mol Dis. 2023 Nov; 103: 102782. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507673/
44079,Antiretrovirals for Prophylaxis Against COVID‐19: A Comprehensive Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753707/
44080,Skin manifestations associated with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577992/
44081,Monitoring COVID-19 spread in Prague local neighborhoods based on the presence of SARS-CoV-2 RNA in wastewater collected throughout the sewer network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936391/
44082,"Integrated Metabolic and Inflammatory Signatures Associated with Severity of, Fatality of, and Recovery from COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100880/
44083,"A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960157/
44084,Innate and adaptive immune responses to SARS‐CoV‐2 in humans: relevance to acquired immunity and vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013613/
44085,SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535803/
44086,"A Study on the Nature of SARS-CoV-2 Using the Shell Disorder Models: Reproducibility, Evolution, Spread, and Attenuation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599796/
44087,Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?—A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105991/
44088,"Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540564/
44089,Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791366/
44090,SARS-CoV-2-specific antibody response characteristics in COVID-19 patients of different ages: SARS-CoV-2 antibody response in different aged patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828714/
44091,Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402899/
44092,The immune response to SARS-CoV-2 in people with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806256/
44093,COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240782/
44094,Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/
44095,"Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761024/
44096,SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099777/
44097,COVID-19 and the brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022395/
44098,Metal-induced oxidative stress and human plasma protein oxidation after SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916496/
44099,Diagnosis value of SARS‐CoV‐2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013599/
44100,Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662021/
44101,Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367488/
44102,A framework for assessing selection and misclassification bias in mendelian randomisation studies: an illustrative example between body mass index and covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277657/
44103,"Prediction of COVID-19 positive cases, a nation-wide SARS-CoV-2 wastewater-based epidemiology study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845016/
44104,First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203460/
44105,Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487451/
44106,"Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424019/
44107,Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922441/
44108,Cardio-Oncology Care in the Era of the Coronavirus Disease 2019 (COVID-19) Pandemic: An International Cardio-Oncology Society (ICOS) Statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934086/
44109,A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328528/
44110,On the road to ending the COVID-19 pandemic: Are we there yet?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908885/
44111,"Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923112/
44112,Sci Adv. 2022 Sep; 8(39): eabq0593. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524836/
44113,Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002419/
44114,Recommendations for breastfeeding during Coronavirus Disease 2019 (COVID-19) pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995694/
44115,Potential Associations Between Microbiome and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727742/
44116,Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421299/
44117,Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644631/
44118,"COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024512/
44119,An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541100/
44120,Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638644/
44121,A molecular single-cell lung atlas of lethal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814825/
44122,Nature. 2021; 598(7882): E2. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498978/
44123,An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012276/
44124,Human phospho‐signaling networks of SARS‐CoV‐2 infection are rewired by population genetic variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112486/
44125,Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971049/
44126,Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724638/
44127,Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358730/
44128,"Curcumin, a traditional spice component, can hold the promise against COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832734/
44129,"A Timely Call to Arms: COVID-19, the Circadian Clock, and Critical Care",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882674/
44130,COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469902/
44131,Risks of mental health outcomes in people with covid-19: cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847881/
44132,Perceptions of Romanian Physicians on Lockdowns for COVID-19 Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831077/
44133,Management of environmental health to prevent an outbreak of COVID-19: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237497/
44134,A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159580/
44135,The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2–associated multisystem inflammatory syndrome in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797337/
44136,A Review of the Current Status of Clinical Management of COVID-19 in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043417/
44137,SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792266/
44138,"COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023852/
44139,Role of the Immune Microenvironment in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114753/
44140,Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101352/
44141,COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179175/
44142,The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242000/
44143,Diagnosing COVID-19; towards a feasible COVID-19 rule-out protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885724/
44144,"An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075622/
44145,Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790360/
44146,From acute SARS-CoV-2 infection to pulmonary hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806360/
44147,Mechanisms of immunothrombosis in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490282/
44148,SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253747/
44149,The COVID-19 pandemic face mask waste: A blooming threat to the marine environment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836388/
44150,Chemosphere. 2022 Jan; 287: 132411. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487163/
44151,Insights into the Role of Neutrophils and Neutrophil Extracellular Traps in Causing Cardiovascular Complications in Patients with COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104617/
44152,A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598903/
44153,SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831879/
44154,"Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575538/
44155,Ongoing COVID-19 Pandemic: A Concise but Updated Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042461/
44156,Rapid Antigen Tests during the COVID-19 Era in Korea and Their Implementation as a Detection Tool for Other Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045740/
44157,"Non-respiratory presentations of COVID-19, a clinical review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513760/
44158,TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887073/
44159,"SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087584/
44160,Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489279/
44161,Building capacity of community health centers to overcome data challenges with the development of an agile COVID-19 public health registry: a multistate quality improvement effort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524633/
44162,"A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/
44163,"Global prevalence of prolonged gastrointestinal symptoms in COVID-19
survivors and potential pathogenesis: A systematic review and
meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171196/
44164,Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243673/
44165,An update on COVID-19 and pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438995/
44166,Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766817/
44167,"Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325376/
44168,SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222651/
44169,ESCMID rapid guidelines for assessment and management of long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849856/
44170,COVID-19 in patients with B cell immune deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450485/
44171,Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910780/
44172,Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915056/
44173,"COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685956/
44174,PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706086/
44175,"Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530739/
44176,Black Fungus and beyond: COVID-19 associated infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308173/
44177,ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378714/
44178,Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974902/
44179,COVID-19: Why does disease severity vary among individuals?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934673/
44180,Mecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059041/
44181,"Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522523/
44182,SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751040/
44183,Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805061/
44184,A SARS-CoV-2: Companion Animal Transmission and Variants Classification,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302237/
44185,Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646264/
44186,"The Immunological Role of the Placenta in SARS-CoV-2 Infection—Viral Transmission, Immune Regulation, and Lactoferrin Activity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198160/
44187,Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265168/
44188,Host genetic basis of COVID-19: from methodologies to genes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135575/
44189,The Multisystem Impact of Long COVID: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10855167/
44190,Recent insights into SARS‐CoV‐2 omicron variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347414/
44191,Myocarditis associated with COVID-19 and its vaccines - a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596182/
44192,"Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797499/
44193,Clinical outcomes of COVID‐19 infection among patients with Alzheimer's disease or mild cognitive impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073985/
44194,Vitamin D supplementation for the treatment of COVID‐19: a living systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406457/
44195,"Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836742/
44196,Nutrition in the Actual COVID-19 Pandemic. A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228835/
44197,Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542865/
44198,Administration of COVID-19 vaccines in immunocompromised patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316069/
44199,"From pandemic to endemic: Divergence of COVID-19 positive-tests and hospitalization numbers from SARS-CoV-2 RNA levels in wastewater of Rochester, Minnesota",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10955309/
44200,Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698513/
44201,Understanding and managing uncertainty and variability for wastewater monitoring beyond the pandemic: Lessons learned from the United Kingdom national COVID-19 surveillance programmes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498793/
44202,Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856753/
44203,SARS-CoV-2 RNA monitoring in wastewater as a potential early warning system for COVID-19 transmission in the community: A temporal case study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718102/
44204,Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646667/
44205,Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410022/
44206,Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754636/
44207,Implications of COVID-19 in pediatric rheumatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270517/
44208,Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560824/
44209,Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548880/
44210,SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694470/
44211,"The Application
of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851365/
44212,"SARS-CoV-2, ACE2 expression, and systemic organ invasion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900915/
44213,Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931657/
44214,Delayed production of neutralizing antibodies correlates with fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785364/
44215,Nat Med. 2021; 27(7): 1309. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212078/
44216,"Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514194/
44217,"Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566856/
44218,Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538076/
44219,Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446766/
44220,A Perspective on COVID-19 Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070140/
44221,Microarray patches enable the development of skin-targeted vaccines against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060128/
44222,Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126214/
44223,Unlocking capacities of viral genomics for the COVID-19 pandemic response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095210/
44224,Nat Methods. 2022 Apr; 19(4): 374–380. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467803/
44225,"Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923678/
44226,Lancet. 2022 Jun 11; 399(10342): 2190. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183211/
44227,Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472457/
44228,Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052472/
44229,Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119432/
44230,The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167683/
44231,"COVID-19 and SARS-CoV-2. Modeling the present, looking at the future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386394/
44232,COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111566/
44233,SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294655/
44234,The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715214/
44235,TRP channels in COVID-19 disease: Potential targets for prevention and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217345/
44236,Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704638/
44237,Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244549/
44238,J Infect Dis. 2023 Feb 15; 227(4): 603. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384521/
44239,Environmental Determinants of Coronavirus Disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934813/
44240,Endotheliopathy in Acute COVID-19 and Long COVID,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179170/
44241,New insights into human immune memory from SARS‐CoV‐2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538469/
44242,Network Meta‐Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID‐19 Pathologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014161/
44243,The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929333/
44244,SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988593/
44245,Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11041741/
44246,Higher SARS-CoV-2 viral loads correlated with smaller thyroid volumes on ultrasound among male COVID-19 survivors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408037/
44247,Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799202/
44248,"Accelerated COVID-19 vaccine development: milestones, lessons, and prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328682/
44249,Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340053/
44250,A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID‐19 patients by phytotherapeutic melatonin and epigallocatechin‐3‐gallate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347991/
44251,Potential Prophylactic Treatments for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310088/
44252,COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System: A Target Trial Emulation Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697485/
44253,Exercise-Based Stroke Rehabilitation: Clinical Considerations Following the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721549/
44254,IL10RB as a key regulator of COVID-19 host susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183086/
44255,NPJ Genom Med. 2022; 7: 52. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441828/
44256,SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686889/
44257,Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060337/
44258,First detection of SARS-CoV-2 genetic material in the vicinity of COVID-19 isolation Centre in Bangladesh: Variation along the sewer network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870435/
44259,Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385074/
44260,Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607623/
44261,Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628202/
44262,Lancet Rheumatol. 2023 Mar; 5(3): e139–e150. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940330/
44263,Human Organoids as a Promising Platform for Fighting COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771829/
44264,COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042214/
44265,COVID-19 in clinical practice: A narrative synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524428/
44266,Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255975/
44267,Gastrointestinal manifestations and possible mechanisms of COVID‐19 in different periods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652439/
44268,Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102076/
44269,Instructing durable humoral immunity for COVID-19 and other vaccinable diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085459/
44270,Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604936/
44271,Standardized two-step testing of antibody activity in COVID-19 convalescent plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653399/
44272,Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834812/
44273,COVID-19 Case and Mortality Surveillance using Daily SARS-CoV-2 in Wastewater Samples adjusting for Meteorological Conditions and Sample pH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370245/
44274,Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837764/
44275,Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884367/
44276,Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766450/
44277,SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720045/
44278,COVID‐19 and coagulopathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444678/
44279,Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758535/
44280,Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141297/
44281,A step toward better sample management of COVID-19: On-spot detection by biometric technology and artificial intelligence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334987/
44282,Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844029/
44283,COVID-19 and the digestive system: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180220/
44284,"Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272679/
44285,"Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934933/
44286,I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656138/
44287,"Vivid COVID-19 LAMP is an ultrasensitive, quadruplexed test using LNA-modified primers and a zinc ion and 5-Br-PAPS colorimetric detection system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979146/
44288,Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375168/
44289,Antiandrogens as Therapies for COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10814161/
44290,Stability and transmissibility of SARS‐CoV‐2 in the environment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537778/
44291,Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271528/
44292,Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212255/
44293,Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238578/
44294,Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975696/
44295,"Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19: A Retrospective Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745119/
44296,"Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366996/
44297,Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533701/
44298,"Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675079/
44299,COVID-19-neutralizing antibodies predict disease severity and survival,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837114/
44300,"COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923340/
44301,"Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843034/
44302,Increase of mast cells in COVID‐19 pneumonia may contribute to pulmonary fibrosis and thrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877713/
44303,"Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226825/
44304,A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313489/
44305,Autophagy Receptor p62 Regulates SARS-CoV-2-Induced Inflammation in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177105/
44306,A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273573/
44307,Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462926/
44308,Uncovering common pathobiological processes between COVID‐19 and pulmonary arterial hypertension by integrating Omics data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880519/
44309,Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530282/
44310,"A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity—ORCHESTRA Project",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747427/
44311,Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649265/
44312,Dynamics of SARS-CoV-2 spreading under the influence of environmental factors and strategies to tackle the pandemic: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925199/
44313,SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642744/
44314,Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288583/
44315,Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813939/
44316,"Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661833/
44317,Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825803/
44318,Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148218/
44319,"Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230714/
44320,"Computing the Effects of SARS-CoV-2 on Respiration
Regulatory Mechanisms in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422910/
44321,Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384395/
44322,"COVID-19 Treatment—Current Status, Advances, and Gap",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611637/
44323,Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546310/
44324,Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588020/
44325,Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607235/
44326,The presence of SARS-CoV-2 in multiple clinical specimens of a fatal case of COVID-19: a case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773521/
44327,The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623509/
44328,Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815883/
44329,COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145709/
44330,"Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833119/
44331,Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265778/
44332,Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402710/
44333,Higher premorbid serum testosterone predicts COVID-19-related mortality risk in men,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175556/
44334,"Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310416/
44335,Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774087/
44336,COVID-19: Consequences on pregnant women and neonates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295334/
44337,SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111829/
44338,"Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809561/
44339,The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404857/
44340,Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493415/
44341,Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245563/
44342,Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249725/
44343,A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257820/
44344,"HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922572/
44345,Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675148/
44346,Dysregulated transcriptional responses to SARS-CoV-2 in the periphery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889643/
44347,The role of vitamin D in reducing SARS-CoV-2 infection: An update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052476/
44348,Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536551/
44349,Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916227/
44350,T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222887/
44351,Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430299/
44352,COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037457/
44353,"Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646370/
44354,Current status of traditional Chinese medicine for the treatment of COVID-19 in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314260/
44355,An overview of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205601/
44356,"Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660979/
44357,Actualización de las recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664833/
44358,Neutrophil autophagy and NETosis in COVID-19: perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980466/
44359,Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610590/
44360,Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115073/
44361,Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877748/
44362,"Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555370/
44363,Euro Surveill. 2021 Nov 25; 26(47): 211125c. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619875/
44364,Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714830/
44365,The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087394/
44366,NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088279/
44367,"Association between any underlying health condition and COVID-19-associated hospitalization by age group, Washington State, 2020–2021: a retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062257/
44368,Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680845/
44369,"Epidemiological comparison of the first and second waves of the COVID-19 pandemic in Nigeria, February 2020–April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602923/
44370,Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646041/
44371,Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791976/
44372,"Covid-19, an unfinished story",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395148/
44373,Laboratory Diagnosis for SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141924/
44374,ACE2-independent infection of T lymphocytes by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914143/
44375,Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341451/
44376,The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10886368/
44377,COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282479/
44378,Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509225/
44379,Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073144/
44380,"SARS-CoV-2 RNA surveillance in large to small centralized wastewater treatment plants preceding the third COVID-19 resurgence in Bangkok, Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540006/
44381,Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623941/
44382,Neuroinflammation and Its Impact on the Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652056/
44383,Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874909/
44384,Immunosenescence and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975602/
44385,"The triangle relationship between human genome, gut microbiome, and COVID-19: opening of a Pandora’s box",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344606/
44386,First expert elicitation of knowledge on drivers of emergence of the COVID‐19 in pets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405184/
44387,Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460849/
44388,SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300719/
44389,Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242786/
44390,Genome-wide association studies of COVID-19: Connecting the dots,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584840/
44391,Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898834/
44392,COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957287/
44393,A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445915/
44394,SARS-CoV-2 infections in children: Understanding diverse outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769938/
44395,COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577231/
44396,Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359502/
44397,Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674730/
44398,The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982143/
44399,Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10896918/
44400,Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092762/
44401,SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784649/
44402,Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641254/
44403,"Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258784/
44404,Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750814/
44405,A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705928/
44406,Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988550/
44407,COVID-19 Morbidity and Severity in Patients With Age-Related Macular Degeneration: A Korean Nationwide Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179838/
44408,"COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392210/
44409,Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450870/
44410,A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855826/
44411,Neurological manifestations of long-COVID syndrome: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859684/
44412,"COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524871/
44413,Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589879/
44414,Antimicrobial peptides: A plausible approach for COVID-19 treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935455/
44415,Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351445/
44416,Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784861/
44417,Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622938/
44418,SARS-CoV-2 infection: The role of cytokines in COVID-19 disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265853/
44419,The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994070/
44420,A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580318/
44421,Safety perspectives on presently considered drugs for the treatment of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404855/
44422,"COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552794/
44423,Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814445/
44424,"Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238057/
44425,Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486578/
44426,Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309102/
44427,Incidence of COVID-19 recurrence among large cohort of healthcare employees,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061784/
44428,COVID-19 and Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683860/
44429,Antioxidants and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452284/
44430,Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924897/
44431,Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867981/
44432,Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164584/
44433,Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177169/
44434,Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304720/
44435,Altered infective competence of the human gut microbiome in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995755/
44436,Pathogenesis and Preventive Tactics of Immune-Mediated Non-Pulmonary COVID-19 in Children and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696849/
44437,Antibodies to watch in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833761/
44438,Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426217/
44439,COVID-19 Cluster in the Hematology/Respirology Ward of a University Hospital during the Seventh Wave of the SARS-CoV-2 Pandemic in Japan: A Descriptive Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208769/
44440,Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308747/
44441,Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111473/
44442,"The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262394/
44443,Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492612/
44444,Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652288/
44445,The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061894/
44446,JMIR Public Health Surveill. 2021 May; 7(5): e30007. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129882/
44447,Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937508/
44448,Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794588/
44449,COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831801/
44450,Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896882/
44451,Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799469/
44452,Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123523/
44453,Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663786/
44454,Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341957/
44455,"Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527398/
44456,Impact of COVID-19 on the thyroid gland: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688298/
44457,"MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641602/
44458,Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769897/
44459,A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477714/
44460,"Impact of Early Pandemic SARS-CoV-2 Lineages Replacement with the Variant of Concern P.1 (Gamma) in Western Bahia, Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611628/
44461,Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941276/
44462,Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407385/
44463,Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271896/
44464,Cochrane Database Syst Rev. 2020; 2020(7): CD013600. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389743/
44465,An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982669/
44466,COVID-19 Antiviral and Treatment Candidates: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937511/
44467,Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355563/
44468,mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733218/
44469,Management of COVID-19 Patients in the Emergency Department,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537207/
44470,Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463609/
44471,Sex and Gender-Related Differences in COVID-19 Diagnoses and SARS-CoV-2 Testing Practices During the First Wave of the Pandemic: The Dutch Lifelines COVID-19 Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721498/
44472,The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799175/
44473,Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815408/
44474,Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957318/
44475,Laboratory diagnosis of COVID-19 in China: A review of challenging cases and analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568515/
44476,Presence of SARS‐CoV‐2 virus in wastewater in the Kingdom of Bahrain during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642395/
44477,Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885829/
44478,Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023344/
44479,Can the Nasal Cavity Help Tackle COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537957/
44480,"After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10815681/
44481,"AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737523/
44482,Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817383/
44483,J Immunother Cancer. 2021; 9(10): e001931corr1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515430/
44484,J Immunother Cancer. 2022; 10(3): e001931corr2. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915336/
44485,Going Viral in the Islet: Mediators of SARS-CoV-2 Entry Beyond ACE2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622140/
44486,SARS-CoV-2: Receptor and Co-receptor Tropism Probability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923825/
44487,COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543694/
44488,"Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19 Pandemic Era - A Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098920/
44489,Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484586/
44490,SARS-CoV-2 shedding sources in wastewater and implications for wastewater-based epidemiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908579/
44491,Guidelines for Reopening a Nation in a SARS-CoV-2 Pandemic: A Path Forward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153561/
44492,The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632784/
44493,"A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673828/
44494,Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166837/
44495,Viral vector and nucleic acid vaccines against COVID-19: A narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470835/
44496,Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146933/
44497,Real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590774/
44498,Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965487/
44499,"Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068212/
44500,COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445067/
44501,SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980144/
44502,A Review of SARS-CoV-2 and the Ongoing Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177898/
44503,Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734101/
44504,Factors leading to high morbidity and mortality of COVID‐19 in patients with type 2 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405270/
44505,What Happens to the Immune System after Vaccination or Recovery from COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619084/
44506,Assessment and management of asymptomatic COVID-19 infection: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025627/
44507,Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062180/
44508,"Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929009/
44509,Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047201/
44510,"Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267353/
44511,"A systematic review of the case findings, testing and management of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194520/
44512,"Detection of SARS-CoV-2 RNA in wastewater and comparison to COVID-19 cases in two sewersheds, North Carolina, USA",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639408/
44513,Role of COVID-19 Vaccines in SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165056/
44514,A proteome-scale map of the SARS-CoV-2–human contactome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849141/
44515,"Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728410/
44516,Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204098/
44517,Spotlight on non-motor symptoms and Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270874/
44518,American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014184/
44519,Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527649/
44520,SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889713/
44521,Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187864/
44522,Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648369/
44523,"Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610070/
44524,Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792455/
44525,"COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128298/
44526,Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913826/
44527,"β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163236/
44528,SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295491/
44529,Novel insights on the pulmonary vascular consequences of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414237/
44530,An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353660/
44531,Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809350/
44532,SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051779/
44533,Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515944/
44534,The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503392/
44535,A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826949/
44536,Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042647/
44537,A Review of Hematological Complications and Treatment in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594461/
44538,SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976534/
44539,Revisiting potential value of antitumor drugs in the treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526459/
44540,SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553736/
44541,Deep dissection of the antiviral immune profile of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677724/
44542,Diagnostic evaluation of qRT-PCR-based kit and dPCR-based kit for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441239/
44543,COVID-19’s immuno-pathology and cardiovascular diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850087/
44544,Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176388/
44545,Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014076/
44546,Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241220/
44547,"Low-Threshold Testing for SARS-CoV-2 (COVID-19) in Long-Term Care
Facilities Early in the First Pandemic Wave, the Twente Region, the Netherlands:
A Possible Factor in Reducing Morbidity and Mortality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127376/
44548,Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276969/
44549,The oral manifestations and related mechanisms of COVID-19 caused by SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846147/
44550,Endemic coronavirus humoral immunity is associated with post-acute sequelae of COVID-19 in individuals with rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764151/
44551,Therapeutic management of patients with COVID-19: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162768/
44552,An Analysis Review of Detection Coronavirus Disease 2019 (COVID-19) Based on Biosensor Application,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729752/
44553,"Current Technologies for Detection of COVID-19: Biosensors, Artificial Intelligence and Internet of Medical Things (IoMT): Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824404/
44554,COVID-19 and androgen targeted therapy for prostate cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546583/
44555,An Executed Plan to Combat COVID-19 in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276922/
44556,Assessing airborne transmission risks in COVID-19 hospitals by systematically monitoring SARS-CoV-2 in the air,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714815/
44557,Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027327/
44558,“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912998/
44559,Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889099/
44560,"Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953707/
44561,"Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130795/
44562,sFlt-1/PlGF Ratio Is Not a Good Predictor of Severe COVID-19 nor of Adverse Outcome in Pregnant Women with SARS-CoV-2 Infection—A Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690365/
44563,COVID-19 Crisis Creates Opportunity towards Global Monitoring & Surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996165/
44564,Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255436/
44565,Evaluation of SARS-CoV-2 transmission in COVID-19 isolation wards: On-site sampling and numerical analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106403/
44566,"EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956763/
44567,Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476467/
44568,The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859007/
44569,Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160927/
44570,ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652413/
44571,Tracking COVID-19 in the United States With Surveillance of Aggregate Cases and Deaths,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040484/
44572,Towards precision medicine: Omics approach for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846903/
44573,Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822773/
44574,The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270430/
44575,Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157490/
44576,Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230320/
44577,A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949372/
44578,Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699589/
44579,Mass spectrometry‐based proteomic platforms for better understanding of SARS‐CoV‐2 induced pathogenesis and potential diagnostic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250252/
44580,SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995753/
44581,Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642679/
44582,Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190989/
44583,Potential diagnostics and therapeutic approaches in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419266/
44584,Highlights on molecular targets in the management of COVID-19: Possible role of pharmacogenomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893104/
44585,COVID-19: Therapeutics and interventions currently under consideration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386392/
44586,Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201692/
44587,Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845137/
44588,Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154542/
44589,The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279953/
44590,Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420462/
44591,SARS‐CoV‐2 research using human pluripotent stem cells and organoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550698/
44592,Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206857/
44593,Characteristics of hematological parameters on admission in COVID-19 Omicron variant infected in Chinese population: a large-scale retrospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683119/
44594,SARS‐CoV‐2 vaccination and infection in ozanimod‐treated participants with relapsing multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578897/
44595,Circulating SARS-CoV-2+ megakaryocytes are associated with severe viral infection in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022176/
44596,"SARS‐CoV‐2 cold‐chain transmission: Characteristics, risks, and strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088485/
44597,Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540788/
44598,Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014456/
44599,"A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666991/
44600,Optimal Inflammatory Bowel Disease Management During the Global COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285035/
44601,Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665323/
44602,The role of antirheumatics in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009617/
44603,Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669527/
44604,Diabetes Care. 2022 Jun; 45(6): 1489. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210517/
44605,Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492401/
44606,Risks and burdens of incident dyslipidaemia in long COVID: a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873268/
44607,How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710593/
44608,A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260518/
44609,Long-chain polyphosphates impair SARS-CoV-2 infection and replication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432949/
44610,High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918088/
44611,SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798705/
44612,Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298611/
44613,NPJ Biofilms Microbiomes. 2021; 7: 90. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672330/
44614,COVID-19 and the heart,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561576/
44615,Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644109/
44616,SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247841/
44617,Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018421/
44618,Effects of COVID-19 on the Nervous System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437501/
44619,Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422837/
44620,Antibiotic Use and Bacterial Infection in COVID-19 Patients in the Second Phase of the SARS-CoV-2 Pandemic: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331316/
44621,Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017959/
44622,Remdesivir against COVID-19 and Other Viral Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566896/
44623,Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749002/
44624,Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444937/
44625,The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031156/
44626,Risk for Subsequent SARS-CoV-2 Infection and Severe COVID-19 Among Community-Dwellers With Pre-Existing Cervicocephalic Atherosclerosis: A Population-Based Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796101/
44627,The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194602/
44628,COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047540/
44629,Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611930/
44630,Central nervous system outcomes of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482653/
44631,TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907958/
44632,A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010752/
44633,Sci Adv. 2021 Nov; 7(46): eabj0274. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580318/
44634,"NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386183/
44635,"Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19–Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250055/
44636,A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765762/
44637,Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776252/
44638,Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129960/
44639,Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255230/
44640,COVID-19 vaccines and a perspective on Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832054/
44641,"Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992272/
44642,Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382605/
44643,Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462004/
44644,Clinical and biochemical indexes of 11 COVID‐19 patients and the genome sequence analysis of the tested SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646603/
44645,A perspective on SARS-CoV-2 virus-like particles vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832101/
44646,Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995697/
44647,Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058057/
44648,Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878640/
44649,Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547373/
44650,"SARS-CoV-2 detection and inactivation in water and wastewater: review on analytical methods, limitations and future research recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286680/
44651,Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132274/
44652,NPJ Digit Med. 2022; 5: 27. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904579/
44653,Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901229/
44654,Vitamin D and COVID-19: An Overview of Recent Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509048/
44655,Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962416/
44656,COVID-19: What Should the General Practitioner Know?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800435/
44657,"Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989611/
44658,Understanding protection from SARS-CoV-2 using metabolomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257707/
44659,Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655040/
44660,COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154547/
44661,SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202384/
44662,"COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698537/
44663,Will Auranofin Become a Golden New Treatment Against COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492993/
44664,Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360309/
44665,Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608032/
44666,"Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565932/
44667,"Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis–Tianjin, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755169/
44668,Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907883/
44669,Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715100/
44670,PD-L1 Dysregulation in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215357/
44671,Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy – An overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205284/
44672,miRNA expression in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288248/
44673,Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216788/
44674,The Relevance of Monoclonal Antibodies in the Treatment of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229508/
44675,"Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955262/
44676,Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005987/
44677,"Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917896/
44678,"Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115984/
44679,Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952283/
44680,"A Retrospective Cross-Sectional Study on the Risk of Getting Sick with COVID-19, the Course of the Disease, and the Impact of the National Vaccination Program against SARS-CoV-2 on Vaccination among Health Professionals in Poland",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223641/
44681,Integrated gut virome and bacteriome dynamics in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946006/
44682,Treatment Options for COVID-19–Related Guillain-Barré Syndrome: A Systematic Review of Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423032/
44683,Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309529/
44684,"Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728067/
44685,Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743352/
44686,Application of microfluidic technologies on COVID-19 diagnosis and drug discovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951611/
44687,Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528184/
44688,Coronavirus global pandemic: An overview of current findings among pediatric patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646267/
44689,Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481883/
44690,Immune response scenario and vaccine development for SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846221/
44691,"Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624152/
44692,"Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10706757/
44693,"COVID-19: Update on Its Ocular Involvements, and Complications From Its Treatments and Vaccinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673850/
44694,Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442559/
44695,COVID-19-associated coagulopathy and disseminated intravascular coagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648664/
44696,The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989070/
44697,Shedding Lights on the Extracellular Vesicles as Functional Mediator and Therapeutic Decoy for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052528/
44698,Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069896/
44699,Indian food habit & food ingredients may have a role in lowering the severity & high death rate from COVID-19 in Indians: findings from the first nutrigenomic analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438415/
44700,Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411846/
44701,"Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452404/
44702,Coronavirus vaccine development: from SARS and MERS to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749790/
44703,"Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194848/
44704,"The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276660/
44705,The Influence of Cross-Reactive T Cells in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10967880/
44706,Potential mechanisms of cerebrovascular diseases in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856859/
44707,COVID-19 and the Nervous System from a Cuban Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525829/
44708,Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677421/
44709,"Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109427/
44710,Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389434/
44711,JAMA Intern Med. 2022 Nov; 182(11): 1234. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641534/
44712,A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824943/
44713,Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895915/
44714,"Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533559/
44715,Long COVID headache,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340759/
44716,Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610764/
44717,A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760069/
44718,Challenges of vaccination and herd immunity in COVID‐19 and management strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539035/
44719,Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647470/
44720,COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664207/
44721,Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685722/
44722,Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917188/
44723,Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782894/
44724,Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610888/
44725,Innate immunity to SARS-CoV-2 infection: a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354479/
44726,Protective neutralizing epitopes in SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348472/
44727,Insights into new-onset autoimmune diseases after COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/
44728,Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646019/
44729,COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10905512/
44730,Genetic Load of SARS-CoV-2 in Aerosols Collected in Operating Theaters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552596/
44731,Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361788/
44732,ESCMID COVID-19 living guidelines: drug treatment and clinical management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606314/
44733,Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772957/
44734,The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718727/
44735,Cytokine Profiling in Different SARS-CoV-2 Genetic Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692520/
44736,Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004226/
44737,A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181264/
44738,Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233910/
44739,Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652495/
44740,An Approach to the Treatment of Children With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281416/
44741,SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182818/
44742,Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586311/
44743,Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329620/
44744,COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805556/
44745,COVID-19 Research: Lessons from Non-Human Primate Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402317/
44746,SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909907/
44747,Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689907/
44748,Comparison of COVID‐19 laboratory diagnosis by commercial kits: Effectivity of RT‐PCR to the RT‐LAMP,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015626/
44749,J Med Virol. 2022 Jul; 94(7): 3470. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11062049/
44750,Does normalization of SARS-CoV-2 concentrations by Pepper Mild Mottle Virus improve correlations and lead time between wastewater surveillance and clinical data in Alberta (Canada): comparing twelve SARS-CoV-2 normalization approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508694/
44751,The Significance of Low Magnesium Levels in COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965430/
44752,Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916402/
44753,Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322532/
44754,Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050566/
44755,COVID-19 — Toward a comprehensive understanding of the disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016030/
44756,Current COVID-19 treatments: Rapid review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068411/
44757,CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731227/
44758,Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076978/
44759,"Mechanisms and management of prothrombotic state in COVID-19
disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785300/
44760,Activation or exhaustion of CD8+ T cells in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374113/
44761,"Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316279/
44762,Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632361/
44763,"Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676828/
44764,Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781318/
44765,Tracking SARS-CoV-2 in rivers as a tool for epidemiological surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334864/
44766,Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508521/
44767,The Role of Ionizing Radiation for Diagnosis and Treatment against COVID-19: Evidence and Considerations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834503/
44768,Clinical features and independent predictors for recurrence of positive SARS‐CoV‐2 RNA: A propensity score‐matched analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662258/
44769,Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427004/
44770,J Med Virol. 2023 Jan; 95(1): e28282. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117282/
44771,Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641610/
44772,"miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047241/
44773,Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428784/
44774,COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155782/
44775,Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010732/
44776,Alzheimers Res Ther. 2021; 13: 110. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189279/
44777,COVID-19 and Possible Pharmacological Preventive Options,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781281/
44778,Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247235/
44779,Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319493/
44780,"COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161353/
44781,Advances and gaps in SARS-CoV-2 infection models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757994/
44782,Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177449/
44783,COVID-19: Direct and Indirect Mechanisms of Statins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073792/
44784,COVID-19: a pandemic converged with global tobacco epidemic and widespread vaping—state of the evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344766/
44785,Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897552/
44786,Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584854/
44787,Consequences of COVID-19 for the Pancreas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776154/
44788,COVID-19 and Fungal infections: a double debacle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400371/
44789,COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060025/
44790,Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499054/
44791,SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795434/
44792,COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691999/
44793,The Spike of SARS-CoV-2: Uniqueness and Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297464/
44794,The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm—A Powerful Therapeutic Tool for COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295896/
44795,Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961475/
44796,Compliance with Barrier Gestures during COVID-19 Pandemic as a Function of the Context: A Longitudinal Observational Survey at the University of Liège,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517517/
44797,"COVID‐19 induces gastrointestinal symptoms and affects patients’
prognosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575454/
44798,"Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060567/
44799,Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877317/
44800,Searching and Analyzing Patent-relevant COVID-19 Information,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769884/
44801,COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692725/
44802,Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715386/
44803,A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743667/
44804,Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758544/
44805,COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365308/
44806,Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757367/
44807,"A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812224/
44808,Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293258/
44809,Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316693/
44810,The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the Walk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693045/
44811,The characterization of CD8+ T-cell responses in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10786432/
44812,Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581003/
44813,SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144800/
44814,Emerging role of complement in COVID-19 and other respiratory virus diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874912/
44815,Neurological consequences of COVID-19: what have we learned and where do we go from here?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525232/
44816,IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655819/
44817,Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538907/
44818,Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228778/
44819,"Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930898/
44820,SARS-CoV-2 and the DNA damage response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10768691/
44821,Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308419/
44822,Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629776/
44823,Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335398/
44824,Nanotechnology and COVID-19: quo vadis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901091/
44825,Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262242/
44826,The success of SARS-CoV-2 vaccines and challenges ahead,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279572/
44827,Coronavirus disease 2019 and acute cerebrovascular events: a comprehensive overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337831/
44828,Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187929/
44829,"Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2, the pathophysiology of COVID-19 and the identification of microRNAs that can modulate the expression of these mediators (Review)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722767/
44830,The relationship between chronic immune response and neurodegenerative damage in long COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800881/
44831,COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537799/
44832,"Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537066/
44833,"Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320021/
44834,COVID-19 Oral Sequelae: Persistent Gustatory and Saliva Secretory Dysfunctions after Recovery from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601698/
44835,Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478222/
44836,Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763517/
44837,Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466313/
44838,Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882054/
44839,WGO Guidance for the Care of Patients With COVID-19 and Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713641/
44840,COVID-19 vaccination and liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827578/
44841,"Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833886/
44842,Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279585/
44843,Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601210/
44844,COVID-19 and Multiorgan Response: The Long-Term Impact,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122551/
44845,The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10742813/
44846,Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015288/
44847,Lab Invest. 2022 Oct; 102(10): 1162. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108349/
44848,COVID-19 and the eye: Systemic and laboratory risk factors for retinopathy and detection of tear film SARS-CoV-2 RNA with a triplex RT-PCR assay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645628/
44849,Immune reactivity during COVID-19: Implications for treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787505/
44850,Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430330/
44851,SARS-CoV-2 Infection and Possible Neonatal Neurological Outcomes: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143946/
44852,Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695397/
44853,Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113152/
44854,The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782551/
44855,Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439635/
44856,Passive sampling to scale wastewater surveillance of infectious disease: Lessons learned from COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020839/
44857,Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434153/
44858,SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558553/
44859,Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697571/
44860,Is the COVID‐19 thrombotic catastrophe complement‐connected?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436532/
44861,"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680080/
44862,"Racial/Ethnic Disparities in Exposure, Disease Susceptibility, and Clinical Outcomes during COVID-19 Pandemic in National Cohort of Adults, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622253/
44863,Long term detection and quantification of SARS-CoV-2 RNA in wastewater in Bahrain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088096/
44864,Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446609/
44865,"A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196235/
44866,Interactions of SARS-CoV-2 with the Blood–Brain Barrier,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961671/
44867,Biomarker based biosensors: An opportunity for diagnosis of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111147/
44868,Do we miss rare adverse events induced by COVID-19 vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589063/
44869,Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856599/
44870,Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745234/
44871,Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782181/
44872,A review on computer‐aided chemogenomics and drug repositioning for rational COVID‐19 drug discovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539342/
44873,The striking mimics between COVID-19 and malaria: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445119/
44874,Are the chilblain‐like lesions observed during the COVID‐19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657348/
44875,"A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628199/
44876,Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549085/
44877,SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251492/
44878,"COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262656/
44879,New‐onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877852/
44880,The Role of Vitamin D in Supporting Health in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998275/
44881,Myocarditis With COVID-19 mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340726/
44882,Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449465/
44883,Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021373/
44884,"A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806010/
44885,miRNAs: The Key Regulator of COVID-19 Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637033/
44886,Human Development Index Is Associated with COVID-19 Case Fatality Rate in Brazil: An Ecological Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102208/
44887,I’ve looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411647/
44888,"Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817396/
44889,Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331939/
44890,Clinical Features and Management of COVID-19–Associated Hypercoagulability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556574/
44891,"A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339420/
44892,Sexual dimorphism in COVID-19: potential clinical and public health implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803381/
44893,Study of ongoing registered clinical trials on COVID-19: a narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673863/
44894,"Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP ""PERFECT-study"" protocol (RIA2020EF-3000)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491536/
44895,"Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638655/
44896,Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755743/
44897,SARS-CoV-2: characteristics and current advances in research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387805/
44898,Potential Cardiac Tamponade Development Secondary to SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494860/
44899,Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444935/
44900,Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631787/
44901,"Characterization of demographic data, clinical signs, comorbidities, and outcomes according to the race in hospitalized individuals with COVID-19 in Brazil: An observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309002/
44902,Cross‐neutralization of RBD mutant strains of SARS‐CoV‐2 by convalescent patient derived antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420279/
44903,"Knowledge, attitude and practices towards SARS-CoV-2 genetic mutations and emerging variants among the population in Bangladesh: a cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689417/
44904,Hematological Abnormalities in COVID-19: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045618/
44905,Euphorbia neriifolia Leaf Juice on Mild and Moderate COVID-19 Patients: Implications in OMICRON Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357524/
44906,Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659290/
44907,Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398935/
44908,"Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539158/
44909,The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730674/
44910,Performance Evaluation of a BZ COVID-19 NALF Assay for Rapid Diagnosis of SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047401/
44911,Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744033/
44912,"Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084477/
44913,Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250244/
44914,SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526287/
44915,"Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573470/
44916,"Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2
Infection Among Hospital Health Care Workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437910/
44917,COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922043/
44918,Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031706/
44919,Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490452/
44920,Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124632/
44921,Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433531/
44922,The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204801/
44923,SARS-CoV-2 infection as a potential risk factor for the development of cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518417/
44924,Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059055/
44925,Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528388/
44926,Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783581/
44927,Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333573/
44928,The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468749/
44929,"Five-week warning of COVID-19 peaks prior to the Omicron surge in Detroit, Michigan using wastewater surveillance",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239917/
44930,Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464379/
44931,Rapid and unamplified identification of COVID-19 with morpholino-modified graphene field-effect transistor nanosensor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008786/
44932,Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122552/
44933,Inflammation in COVID-19 and the Effects of Non-Pharmacological Interventions during the Pandemic: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779440/
44934,Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700011/
44935,Leveraging the Electronic Health Record to Address the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059945/
44936,COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239414/
44937,Tuberculosis and COVID-19 co-infection: description of the global cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588566/
44938,Return to Work: Managing Employee Population Health During the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875125/
44939,Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874612/
44940,Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527880/
44941,APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340718/
44942,An aberrant STAT pathway is central to COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545020/
44943,Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816428/
44944,The impact of COVID-19 and COVID vaccination on cardiovascular outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021497/
44945,"Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646123/
44946,SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316052/
44947,"SARS-CoV-2 tests, confirmed infections and COVID-19-related hospital admissions in children and young people: birth cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437731/
44948,Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465644/
44949,Arterial Thromboembolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495465/
44950,Res Pract Thromb Haemost. 2022 Jan; 6(1): e12663. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819191/
44951,Interrelations between COVID-19 and other disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/
44952,Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051442/
44953,What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979618/
44954,"Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024438/
44955,"Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS‐CoV‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349520/
44956,"Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092643/
44957,Immunonutrition and SARS-CoV-2 Infection in Children with Obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101404/
44958,Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187014/
44959,Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779898/
44960,Acute SARS-CoV-2 Infection and Incidence and Outcomes of Out-of-Hospital Cardiac Arrest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559182/
44961,Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020981/
44962,Cell. 2021 Sep 16; 184(19): 4953–4968.e16. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373821/
44963,Online Information of COVID-19: Visibility and Characterization of Highest Positioned Websites by Google between March and April 2020—A Cross-Country Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835343/
44964,Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966396/
44965,"COVID-19 Associated Cardiovascular Disease—Risks, Prevention and Management: Heart at Risk Due to COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969474/
44966,COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205279/
44967,COVID-19 in Children With Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991080/
44968,Changes in Dietary Patterns and Clinical Health Outcomes in Different Countries during the SARS-CoV-2 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539259/
44969,Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910541/
44970,The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722729/
44971,Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021–January 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10877268/
44972,Defying convention in the time of COVID-19: Insights into the role of γδ T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403327/
44973,Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849522/
44974,The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855786/
44975,Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666810/
44976,COVID-19: Autopsy findings in six patients between 26 and 46 years of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172269/
44977,Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272717/
44978,Threading the Pieces Together: Integrative Perspective on SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694192/
44979,SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491510/
44980,Sci Transl Med. 2021 Mar 15 : eabf7872. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128284/
44981,Healthcare Innovations to Address the Challenges of the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423029/
44982,SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632769/
44983,Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915713/
44984,Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438656/
44985,Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096096/
44986,COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343962/
44987,P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877512/
44988,The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574122/
44989,Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667450/
44990,"Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250867/
44991,Advances in the computational landscape for repurposed drugs against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323501/
44992,Before the “cytokine storm”: Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741331/
44993,Long COVID in autoimmune rheumatic diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061411/
44994,Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816887/
44995,Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880376/
44996,Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260809/
44997,Nat Commun. 2021; 12: 4846. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341258/
44998,Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348179/
44999,The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407158/